Results 1-1000 of 2804 (Search time: 0.123 seconds).

Issue DateTitleAuthor(s)SourcescopusWOSFulltext/Archive link
12021Whole genome deep sequencing analysis of viral quasispecies diversity and evolution in HBeAg seroconvertersLin, Su Ru; Yang, Ta Yu; Peng, Cheng Yuan; Lin, You Yu; Dai, Chia Yen; HURNG-YI WANG ; TUNG-HUNG SU; Tseng, Tai Chung; Liu, I. Jung; Cheng, Huei Ru; Shen, Yueh Chi; Wu, Fang Yi; CHUN-JEN LIU; DING-SHINN CHEN; Chen, Pei-Jer; HUNG-CHIH YANG; Kao, Jia-HorngJHEP Reports2
22021Wdhd1 is essential for early mouse embryogenesisFan, Hsiang-Hsuan; Lee, Kuo-Hong; YOU-TZUNG CHEN ; Lin, Li-Jyuan; Yang, Tsung-Lin; Lin, Shu-Wha; Yu, I-ShingBiochimica et biophysica acta. Molecular cell research0
32021A Preconditioning Strategy to Augment Retention and Engraftment Rate of Donor Cells during Hepatocyte TransplantationHsu, Yu-Chen; Yu, I-Shing; Tsai, Yu-Fei; Wu, Yao-Ming; YOU-TZUNG CHEN ; Sheu, Jin-Chuan; Lin, Shu-WhaTransplantation0
42021Management consensus guideline for hepatocellular carcinoma: 2020 update on surveillance, diagnosis, and systemic treatment by the Taiwan Liver Cancer Association and the Gastroenterological Society of TaiwanYu-Yun Shao; Shen-Yung Wang; Shi-Ming Lin; Diagnosis Group; Systemic Therapy Group; KAI-WEN HUANG Journal of the Formosan Medical Association = Taiwan yi zhi
52021Taiwan Society of Colon and Rectal Surgeons (TSCRS) Consensus for Cytoreduction Selection in Metastatic Colorectal CancerLin, Chun-Chi; Chen, Te-Hung; Wu, Yu-Chung; Fang, Chuan-Yin; Wang, Jaw-Yuan; Chen, Chou-Pin; KAI-WEN HUANG ; Jiang, Jeng-KaiAnnals of surgical oncology
62021Improved second harmonic generation and two-photon excitation fluorescence microscopy-based quantitative assessments of liver fibrosis through auto-correction and optimal samplingHsiao, Chih Yang; Teng, Xiao; TUNG-HUNG SU; PO-HUANG LEE; Kao, Jia-Horng; KAI-WEN HUANG Quantitative Imaging in Medicine and Surgery1
72021The origin and past demography of murine astrovirus 1 in laboratory miceSu, Chia Ming; Cheng, Ying Chien; HURNG-YI WANG ; Hsieh, Chia Hung; CHO-HUA WANJournal of General Virology1
82021Linear radiofrequency ablation using dual switching-control mode achieves rapid and bloodless liver resection, an experimental researchHsiao, Chih-Yang; Yang, Po-Chih; KAI-WEN HUANG International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group
92021Sub-multiplicative interaction between polygenic risk score and household coal use in relation to lung adenocarcinoma among never-smoking women in AsiaBlechter B.; Wong J.Y.Y.; Agnes Hsiung C.; Hosgood H.D.; Yin Z.; Shu X.-O.; Zhang H.; Shi J.; Song L.; Song M.; Zheng W.; Wang Z.; Caporaso N.; Burdette L.; Yeager M.; Berndt S.I.; Teresa Landi M.; Chen C.-J.; Chang G.-C.; Hsiao C.-F.; Tsai Y.-H.; Chen K.-Y.; Huang M.-S.; Su W.-C.; Chen Y.-M.; Chien L.-H.; Chen C.-H.; Yang T.-Y.; Wang C.-L.; Hung J.-Y.; Lin C.-C.; Perng R.-P.; Chen C.-Y.; Chen K.-C.; Li Y.-J.; Yu C.-J.; Chen Y.-S.; Chen Y.-H.; Tsai F.-Y.; Jie Seow W.; Bassig B.A.; Hu W.; Ji B.-T.; Wu W.; Guan P.; He Q.; Gao Y.-T.; Cai Q.; Chow W.-H.; Xiang Y.-B.; Lin D.; Wu C.; Wu Y.-L.; Shin M.-H.; Hong Y.-C.; Matsuo K.; Chen K.; Pik Wong M.; Lu D.; Jin L.; Wang J.-C.; Seow A.; Wu T.; Shen H.; Fraumeni J.F.; PAN-CHYR YANG ; Chang I.-S.; Zhou B.; Chanock S.J.; Rothman N.; Chatterjee N.; Lan Q.Environment International2
102021MITF functions as a tumor suppressor in non-small cell lung cancer beyond the canonically oncogenic roleHsiao Y.-J.; Chang W.-H.; Chen H.-Y.; Hsu Y.-C.; Chiu S.-C.; Chiang C.-C.; Chang G.-C.; Chen Y.-J.; Wang C.-Y.; Chen Y.-M.; Lin C.-Y.; Chen Y.-J.; PAN-CHYR YANG ; Chen J.J.W.; Yu S.-L.Aging0
112021Monitoring levels of vimentin-positive circulating cancer stem cells and tumor cells in patients with advanced EGFR-mutated non-small cell lung cancerHsu C.-L.; Tsai T.-H.; Huang C.-K.; Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Ruan S.-Y.; Chen K.-Y.; Shih J.-Y.; PAN-CHYR YANG Lung Cancer2
122021Integrating site-specific peptide reporters and targeted mass spectrometry enables rapid substrate-specific kinase assay at the nanogram cell levelReyes A.J.F.; Kitata R.B.; dela Rosa M.A.C.; Wang Y.-T.; Lin P.-Y.; PAN-CHYR YANG ; Friedler A.; Yitzchaik S.; Chen Y.-J.Analytica Chimica Acta0
132021Humanized COVID-19 decoy antibody effectively blocks viral entry and prevents SARS-CoV-2 infectionHuang K.-Y.; Lin M.-S.; Kuo T.-C.; Chen C.-L.; Lin C.-C.; Chou Y.-C.; Chao T.-L.; Pang Y.-H.; Kao H.-C.; Huang R.-S.; Lin S.; Chang S.-Y.; PAN-CHYR YANG EMBO Molecular Medicine2
142021Enhanced Targeting and Immune Activation of Tumor Microenvironment by Nanomodified Anti-PD1 in Liver CancerOu D.-L.; Tseng S.-J.; Kempson I.M.; Hsu C.-L.; PAN-CHYR YANG ; Liao Z.-X.Advanced Therapeutics0
152021Fibroblast Growth Factor Receptor Inhibitors Reduce Adipogenesis of Orbital Fibroblasts and Enhance Myofibroblastic Differentiation in Graves’ OrbitopathyShih S.-R.; Liao S.-L.; Shih C.-W.; Wei Y.-H.; Lu T.-X.; Chou C.-H.; Yen E.-Y.; Chang Y.-C.; Lin C.-C.; Chi Y.-C.; WEI-SHIUNG YANG ; Tsai F.-C.Ocular Immunology and Inflammation1
162021A randomized trial to investigate the efficacy and safety of insulin glargine in hyperglycemic acute stroke patients receiving intensive careTang S.-C.; Shih S.-R.; Lin S.-Y.; Chen C.-H.; Yeh S.-J.; Tsai L.-K.; WEI-SHIUNG YANG ; Jeng J.-S.Scientific Reports0
172021Impact of adiposity on muscle function and clinical events among elders with dynapenia, presarcopenia and sarcopenia: a communitybased cross-sectional studyKao T.-W.; Peng T.-C.; Chen W.-L.; Han D.-S.; Chen C.-L.; WEI-SHIUNG YANG Aging0
182021Serum hepatitis B core-related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral loadTseng T.-C.; Liu C.-J.; Yang W.-T.; Hsu C.-Y.; Hong C.-M.; Su T.-H.; Tsai C.-H.; Chen C.-L.; Yang H.-C.; Liu C.-H.; Chen H.-H.; PEI-JER CHEN ; Kao J.-H.Alimentary Pharmacology and Therapeutics2
192021Autophagy restricts mitochondrial DNA damage-induced release of ENDOG (endonuclease G) to regulate genome stabilityChao T.; Shih H.-T.; Hsu S.-C.; PEI-JER CHEN ; Fan Y.-S.; Jeng Y.-M.; Shen Z.-Q.; Tsai T.-F.; Chang Z.-F.Autophagy2
202021Chapter XX Antiviral Treatment and Cancer ControlShih W.-L.; Fang C.-T.; PEI-JER CHEN Recent Results in Cancer Research0
212021Genetic characteristics and epidemiology of inherited retinal degeneration in TaiwanChen T.-C.; Huang D.-S.; Lin C.-W.; Yang C.-H.; Yang C.-M.; Wang V.Y.; Lin J.-W.; Luo A.C.; Hu F.-R.; PEI-LUNG CHEN npj Genomic Medicine3
222021Genetic study of young-onset dementia using targeted gene panel sequencing in TaiwanHsu J.-L.; Lin C.-H.; PEI-LUNG CHEN ; Lin K.-J.; Chen T.-F.American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics0
232021Metabolic syndromes as important comorbidities in patients of inherited retinal degenerations: Experiences from the nationwide health database and a large hospital-based cohortChiou G.-J.; Huang D.-S.; Hu F.-R.; Yang C.-M.; Yang C.-H.; Huang C.-W.; Lin J.-W.; Lin C.-W.; Ho T.-C.; Hsieh Y.-T.; Lai T.-T.; Chen H.-M.; PEI-LUNG CHEN ; Hsiao C.K.; Chen T.-C.International Journal of Environmental Research and Public Health0
242021Next-generation sequencing and bioinformatics to identify genetic causes of malignant hyperthermiaYeh H.-M.; Liao M.-H.; Chu C.-L.; Lin Y.-H.; Sun W.-Z.; Lai L.-P.; PEI-LUNG CHEN Journal of the Formosan Medical Association1
252021Investigating DYT1 in a Taiwanese dystonia cohortWu M.-C.; Chang Y.-Y.; Chen Y.-F.; Lan M.-Y.; PEI-LUNG CHEN ; Tai C.-H.; Lin C.-H.Journal of the Formosan Medical Association0
262021Hereditary hearing impairment with cutaneous abnormalitiesLee T.-L.; Lin P.-H.; PEI-LUNG CHEN ; Hong J.-B.; Wu C.-C.Genes0
272021Vaccine Allocation and Ethics in PandemicDANIEL FU-CHANG TSAI ; Kar-Fai Foo; Yu-Chen Juang; Li-Min HuangFormosan Journal of Medicine0
282021The Exceptions for Physician's Confidentiality ObligationI-Ling Chen; Yu-Chen Juang; DANIEL FU-CHANG TSAI Formosan Journal of Medicine0
292021Endocytosis of peroxiredoxin 1 links sterile inflammation to immunoparalysis in pediatric patients following cardiopulmonary bypassLiu C.-H.; Huang Z.-H.; Huang S.-C.; TZUU-SHUH JOU Redox Biology0
302021Improved second harmonic generation and two-photon excitation fluorescence microscopy-based quantitative assessments of liver fibrosis through auto-correction and optimal samplingHsiao C.-Y.; Teng X.; Su T.-H.; Lee P.-H.; JIA-HORNG KAO ; Huang K.-W.Quantitative Imaging in Medicine and Surgery1
312021Letter: elevated HBV DNA predicts poor survival in hepatocellular carcinoma after hepatic resection—authors' replyTseng T.-C.; JIA-HORNG KAO Alimentary Pharmacology and Therapeutics0
322021Systemic therapy for hepatocellular carcinoma: New agents and therapeutic hierarchySu T.-H.; Hsu S.-J.; JIA-HORNG KAO Journal of the Formosan Medical Association0
332021Reply to: “Sofosbuvir and the risk of kidney dysfunction”Liu C.-H.; JIA-HORNG KAO Journal of Hepatology0
342021Transition rates to cirrhosis and liver cancer by age, gender, disease and treatment status in Asian chronic hepatitis B patientsLiu M.; Tseng T.-C.; Jun D.W.; Yeh M.-L.; Trinh H.; Wong G.L.H.; Chen C.-H.; Peng C.-Y.; Kim S.E.; Oh H.; Kwak M.-S.; Cheung M.; Toyoda H.; Hsu Y.-C.; Jeong J.Y.; Yoon E.L.; Ungtrakul T.; Zhang J.; Xie Q.; Ahn S.B.; Enomoto M.; Shim J.-J.; Cunningham C.; Jeong S.W.; Cho Y.K.; Ogawa E.; Huang R.; Lee D.-H.; Takahashi H.; Tsai P.-C.; Huang C.-F.; Dai C.-Y.; Tseng C.-H.; Yasuda S.; Kozuka R.; Li J.; Wong C.; Wong C.C.; Zhao C.; Hoang J.; Eguchi Y.; Wu C.; Tanaka Y.; Gane E.; Tanwandee T.; Cheung R.; Yuen M.-F.; Lee H.-S.; Yu M.-L.; JIA-HORNG KAO ; Yang H.-I.; Nguyen M.H.Hepatology International0
352021Long-term outcome of liver complications in patients with chronic HBV/HCV co-infection after antiviral therapy: a real-world nationwide study on Taiwanese Chronic Hepatitis C Cohort (T-COACH)Yeh M.-L.; Hung C.-H.; Tseng K.-C.; Lai H.-C.; Chen C.-Y.; Kuo H.-T.; Wang J.-H.; Chen J.-J.; Lee P.-L.; Chien R.-N.; Yang C.-C.; Lo G.-H.; Tai C.-M.; Lin C.-W.; JIA-HORNG KAO ; Liu C.-H.; Yan S.-L.; Bair M.-J.; Lin C.-Y.; Su W.-W.; Chu C.-H.; Chen C.-J.; Tung S.-Y.; Lo C.-C.; Cheng P.-N.; Chiu Y.-C.; Wang C.-C.; Cheng J.-S.; Tsai W.-L.; Lin H.-C.; Huang Y.-H.; Huang C.-F.; Huang J.-F.; Dai C.-Y.; Chuang W.-L.; Tsai P.-C.; Peng C.-Y.; Liu C.-J.; Yu M.-L.Hepatology International0
362021One-year Fibrosis-4 index helps identify minimal HCC risk in non-cirrhotic chronic hepatitis B patients with antiviral treatmentTseng T.-C.; Choi J.; Nguyen M.H.; Peng C.-Y.; Siakavellas S.; Papatheodoridis G.; Wang C.-C.; Lim Y.-S.; Lai H.-C.; Trinh H.N.; Wong C.; Wong C.; Zhang J.; Li J.; JIA-HORNG KAO Hepatology International1
372021Serum PIVKA-II and alpha-fetoprotein at virological remission predicts hepatocellular carcinoma in chronic hepatitis B related cirrhosisSu T.-H.; Peng C.-Y.; Chang S.-H.; Tseng T.-C.; Liu C.-J.; Chen C.-L.; Liu C.-H.; Yang H.-C.; Chen P.-J.; JIA-HORNG KAO Journal of the Formosan Medical Association0
382021Iodized oil computed tomography versus ultrasound-guided radiofrequency ablation for early hepatocellular carcinomaWu C.-H.; Liang P.-C.; Su T.-H.; Lin M.-C.; Chang Y.-H.; Shih T.T.-F.; JIA-HORNG KAO Hepatology International1
392021APASL guidance on stopping nucleos(t)ide analogues in chronic hepatitis B patientsJIA-HORNG KAO ; Jeng W.-J.; Ning Q.; Su T.-H.; Tseng T.-C.; Ueno Y.; Yuen M.-F.Hepatology International1
402021Response to letter to the editor “Factors predicting outcomes of hepatitis B-related cirrhosis patients with long-term antiviral therapy”Lin C.-L.; JIA-HORNG KAO Journal of the Formosan Medical Association0
412021Factors associated with treatment failure of direct-acting antivirals for chronic hepatitis C: A real-world nationwide hepatitis C virus registry programme in TaiwanChen C.-Y.; Huang C.-F.; Cheng P.-N.; Tseng K.-C.; Lo C.-C.; Kuo H.-T.; Huang Y.-H.; Tai C.-M.; Peng C.-Y.; Bair M.-J.; Chen C.-H.; Yeh M.-L.; Lin C.-L.; Lin C.-Y.; Lee P.-L.; Chong L.-W.; Hung C.-H.; Huang J.-F.; Yang C.-C.; Hu J.-T.; Lin C.-W.; Chen C.-T.; Wang C.-C.; Su W.-W.; Hsieh T.-Y.; Lin C.-L.; Tsai W.-L.; Lee T.-H.; Chen G.-Y.; Wang S.-J.; Chang C.-C.; Mo L.-R.; Yang S.-S.; Wu W.-C.; Huang C.-S.; Hsiung C.-K.; Kao C.-N.; Tsai P.-C.; Liu C.-H.; Lee M.-H.; Liu C.-J.; Dai C.-Y.; JIA-HORNG KAO ; Chuang W.-L.; Lin H.-C.; Yu M.-L.Liver International3
422021Reply to “Tacrolimus concentrations were not affected by glecaprevir/pibrentasvir treatment for hepatitis C virus infection in an adult living donor liver transplant recipient with uremia”Yu M.-L.; JIA-HORNG KAO Journal of the Formosan Medical Association0
432021Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in TaiwanLiu C.-H.; Chen P.-Y.; Chen J.-J.; Lo C.-C.; Su W.-W.; Tseng K.-C.; Liu C.-J.; Huang C.-S.; Huang K.-J.; Yang S.-S.; Peng C.-Y.; Tsai M.-C.; Kao W.-Y.; Chang C.-Y.; Shih Y.-L.; Fang Y.-J.; Chen C.-Y.; Lee P.-L.; Huang J.-J.; Su P.-Y.; Tseng C.-W.; Hung C.-C.; Chang C.-H.; Huang Y.-J.; Lai H.-C.; Chang C.-C.; Lee F.-J.; Hsieh T.?Y.; JIA-HORNG KAO Hepatology International0
442021Serum hepatitis B core-related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral loadTseng T.-C.; Liu C.-J.; Yang W.-T.; Hsu C.-Y.; Hong C.-M.; Su T.-H.; Tsai C.-H.; Chen C.-L.; Yang H.-C.; Liu C.-H.; Chen H.-H.; Chen P.-J.; JIA-HORNG KAO Alimentary Pharmacology and Therapeutics2
452021Response to letter to the editor “The impact of cytokine change after hepatitis C virus clearance by direct antiviral agents on the risk of hepatocellular carcinoma”Cheng Y.-M.; Tzeng I.-S.; JIA-HORNG KAO ; Wang C.-C.Journal of the Formosan Medical Association0
462021The impact of cytokine change after hepatitis C virus clearance by direct antiviral agents on the risk of hepatocellular carcinomaWang C.-C.; Tseng K.-C.; Tzeng I.-S.; JIA-HORNG KAO Journal of the Formosan Medical Association3
472021Characteristics of patients with hepatitis C virus infection and antiviral treatment initiation in Taiwan: The MOSAIC studyYu M.-L.; Tsai W.-L.; Chu C.-J.; JIA-HORNG KAO Kaohsiung Journal of Medical Sciences0
482021Clinical manifestations and outcomes of patients with scirrhous hepatocellular carcinomaHuang S.-C.; Liao S.-H.; Su T.-H.; Jeng Y.-M.; JIA-HORNG KAO Hepatology International0
492021The metabolic profiles and body composition of lean metabolic associated fatty liver diseaseCheng Y.-M.; JIA-HORNG KAO ; Wang C.-C.Hepatology International1
502021Artificial intelligence in precision medicine in hepatologySu T.-H.; Wu C.-H.; JIA-HORNG KAO Journal of Gastroenterology and Hepatology (Australia)3
512021HighlightsJIA-HORNG KAO Journal of the Formosan Medical Association0
522020Implication of single year seasonal sampling to genetic diversity fluctuation that coordinates with oceanographic dynamics in torpedo scads near TaiwanSu, Yong Chao; Su, Shan Hui; Li, Han Yun; HURNG-YI WANG ; Lee, Sin CheScientific Reports0
532020Medical students' affective reactions to workplace experiences: qualitative investigation in a Chinese cultural contextYeh, Huei-Ming; Chien, Wan-Hsi; DANIEL FU-CHANG TSAI ; Dornan, Tim; Lai, Ling-Ping; Chu, Chun-LinBMC medical education0
542020The origin and underlying driving forces of the SARS-CoV-2 outbreakChaw, Shu Miaw; Tai, Jui Hung; Chen, Shi Lun; Hsieh, Chia Hung; SUI-YUAN CHANG; Shiou-Hwei Yeh; WEI-SHIUNG YANG; Chen, Pei-Jer; HURNG-YI WANG Journal of Biomedical Science25
552020MTL-CEBPA, a small activating RNA therapeutic up-regulating C/EBP-α, in patients with advanced liver cancer: a first-in-human, multi-centre, open-label, phase I trialSarker, Debashis; Plummer, Ruth; Meyer, Tim; Sodergren, Mikael; Basu, Bristi; Chee, Cheng Ean; KAI-WEN HUANG ; Palmer, Daniel H; Ma, Yuk Ting; Evans, T R Jeffry; Spalding, Duncan Rc; Pai, Madhava; Sharma, Rohini; Pinato, David J; Spicer, James; Hunter, Sarah; Kwatra, Vineet; Nicholls, Joanna P; Collin, David; Nutbrown, Robert; Glenny, Helen; Fairbairn, Sonia; Reebye, Vikash; Voutila, Jon; Dorman, Stephanie; Andrikakou, Pinelopi; Lloyd, Peter; Felstead, Steve; Vasara, Jenni; Habib, Robert; Wood, Chris; Sætrom, Pål; Huber, Hans E; Blakey, David C; Rossi, John J; Habib, NagyClinical cancer research : an official journal of the American Association for Cancer Research319
562020Tuberculosis infection and lung adenocarcinoma: Mendelian randomization and pathway analysis of genome-wide association study data from never-smoking Asian womenWong J.Y.Y.; PAN-CHYR YANG et al. Genomics33
572020Predicting lung cancer occurrence in never-smoking females in Asia: TNSF-SQ, a prediction modelChien L.-H.; PAN-CHYR YANG et al. Cancer Epidemiology Biomarkers and Prevention75
582020Precision Management of Advanced Non-Small Cell Lung CancerYang C.-Y.; Yang J.C.-H.; PAN-CHYR YANG Annual Review of Medicine2325
592020Precision radiotherapy for non-small cell lung cancerYang W.-C.; Hsu F.-M.; PAN-CHYR YANG Journal of Biomedical Science33
602020Nanomodified strategies to overcome EGFR-tyrosine kinase inhibitors resistance in non-small cell lung cancerLiao Z.-X.; Huang K.-Y.; Kempson I.M.; Li H.-J.; Tseng S.-J.; PAN-CHYR YANG Journal of Controlled Release43
612020Use of DosR Dormancy Antigens from Mycobacterium tuberculosis for Serodiagnosis of Active and Latent TuberculosisShi S.-D.; Hsueh P.-R.; PAN-CHYR YANG ; Chou C.-C.ACS Infectious Diseases21
622020A Randomized Phase 2 Study of Gefitinib With or Without Pemetrexed as First-line Treatment in Nonsquamous NSCLC With EGFR Mutation: Final Overall Survival and Biomarker AnalysisYang J.C.-H.; PAN-CHYR YANG et al. Journal of Thoracic Oncology1414
632020Suppression of Drug-Resistant Non-Small-Cell Lung Cancer with Inhibitors Targeting Minichromosomal Maintenance ProteinLin C.-Y.; PAN-CHYR YANG et al. Journal of Medicinal Chemistry55
642020Monocarboxylate Transporter 4 Is a Therapeutic Target in Non-small Cell Lung Cancer with Aerobic Glycolysis PreferenceKuo T.-C.; PAN-CHYR YANG et al. Molecular Therapy - Oncolytics3
652020Expression of large tumour suppressor (LATS) kinases modulates chemotherapy response in advanced non-small cell lung cancerLuo S.Y.; Kwok H.-H.; PAN-CHYR YANG ; Ip M.S.-M.; Minna J.D.; Lam D.C.-L.Translational Lung Cancer Research2
662020Proteogenomics of Non-smoking Lung Cancer in East Asia Delineates Molecular Signatures of Pathogenesis and ProgressionChen Y.-J.; PAN-CHYR YANG et al. Cell3534
672020Impact of cooking oil fume exposure and fume extractor use on lung cancer risk in non-smoking Han Chinese womenChen T.-Y.; PAN-CHYR YANG et al. Scientific Reports88
682020Landscape of mitochondria genome and clinical outcomes in stage 1 lung adenocarcinomaRaghav L.; PAN-CHYR YANG et al. Cancers1
692020Recent advances: The imbalance of immune cells and cytokines in the pathogenesis of hepatocellular carcinomaJayant K.; Habib N.; KAI-WEN HUANG ; Warwick J.; Arasaradnam R.Diagnostics03
702020Prognostic factor analysis of irreversible electroporation for locally advanced pancreatic cancer – A multi-institutional clinical study in AsiaYang P.-C.; KAI-WEN HUANG ; Pua U.; Kim M.-D.; Li S.-P.; Li X.-Y.; Liang P.-C.European Journal of Surgical Oncology62
712020Immunological basis of genesis of hepatocellular carcinoma: Unique challenges and potential opportunities through immunomodulationJayant K.; Habib N.; KAI-WEN HUANG ; Podda M.; Warwick J.; Arasaradnam R.Vaccines04
722020Liver Activation of Hepatocellular Nuclear Factor-4α by Small Activating RNA Rescues Dyslipidemia and Improves Metabolic ProfileKAI-WEN HUANG ; Reebye V.; Czysz K.; Ciriello S.; Dorman S.; Reccia I.; Lai H.-S.; Peng L.; Kostomitsopoulos N.; Nicholls J.; Habib R.S.; Tomalia D.A.; S?trom P.; Wilkes E.; Cutillas P.; Rossi J.J.; Habib N.A.Molecular Therapy - Nucleic Acids310
732020Improved quantitative assessment of HBV-associated liver fibrosis using second-harmonic generation microscopy with feature selectionHsiao C.-Y.; Teng X.; Su T.-H.; Lee P.-H.; Kao J.-H.; KAI-WEN HUANG Clinics and Research in Hepatology and Gastroenterology22
742020Antimetabolite pemetrexed primes a favorable tumor microenvironment for immune checkpoint blockade therapyLu, Chia-Sing; PAN-CHYR YANG et al. Journal for ImmunoTherapy of Cancer3
752020Humanized COVID‐19 decoy antibody effectively blocks viral entry and prevents SARS‐CoV‐2 infectionHuang, Kuo‐Yen; PAN-CHYR YANG et al. EMBO Molecular Medicine2
762020Virtue Ethics and Its Application to BioethicsDANIEL FU-CHANG TSAI ; Yu-Chen ChouFormosan Journal of Medicine00
772020A rapid insect species identification system using mini-barcode pyrosequencingHsieh C.-H.; Huang C.-G.; Wu W.-J.; HURNG-YI WANG Pest Management Science00
782020Arterial Stiffness Is Associated with Clinical Outcome and Cardiorenal Injury in Lateralized Primary AldosteronismChan C.-K.; WEI-SHIUNG YANG ; Lin Y.-H.; Huang K.-H.; Lu C.-C.; Hu Y.-H.; Wu V.-C.; Chueh J.S.; Chu T.-S.; Chen A.-M.Journal of Clinical Endocrinology and Metabolism2
792020Circulating Diabetic Candidate Neurotrophic Factors, Brain-Derived Neurotrophic Factor and Fibroblast Growth Factor 21, in Sleeve GastrectomyYen H.-H.; Hsieh S.-T.; Chen C.-L.; WEI-SHIUNG YANG ; Lee P.-C.; Lin M.-T.; Chen C.-N.; Yang P.-J.Scientific Reports2
802020Impact of 3D-CT-Based Gastric Wall Volume on Weight Loss after Laparoscopic Sleeve GastrectomyLin C.-H.; Hsu Y.; Chen C.-L.; WEI-SHIUNG YANG ; Lee P.-C.; Chen C.-N.; Lin M.-T.; Wu C.-H.; Yang P.-J.Obesity Surgery1
812020Plasma Leucine-Rich α-2-Glycoprotein 1 Predicts Cardiovascular Disease Risk in End-Stage Renal DiseaseYang F.-J.; Hsieh C.-Y.; Shu K.-H.; Chen I.-Y.; Pan S.-Y.; Chuang Y.-F.; Chiu Y.-L.; WEI-SHIUNG YANG Scientific Reports5
822020Protective effect of fenofibrate on oxidative stress-induced apoptosis in retinal–choroidal vascular endothelial cells: Implication for diabetic retinopathy treatmentHsu Y.-J.; Lin C.-W.; Cho S.-L.; WEI-SHIUNG YANG ; Yang C.-M.; Yang C.-H.Antioxidants5
832020Association between low-grade inflammation and left ventricular diastolic dysfunction in patients with metabolic syndrome and hyperuricemiaLiu C.-W.; Chen J.-H.; Tseng G.-S.; Chen K.-H.; Hwang J.-J.; WEI-SHIUNG YANG ; Wu Y.-W.Acta Cardiologica Sinica3
842020The origin and underlying driving forces of the SARS-CoV-2 outbreakChaw S.-M.; Tai J.-H.; Chen S.-L.; Hsieh C.-H.; Chang S.-Y.; Yeh S.-H.; WEI-SHIUNG YANG ; Chen P.-J.; Wang H.-Y.Journal of Biomedical Science25
852020Gender difference in the association between metabolic factors and hepatocellular carcinomaChen C.-L.; Kuo M.-J.; Ming-Fang Yen A.; WEI-SHIUNG YANG ; Kao J.-H.; Chen P.-J.; Chen H.-H.JNCI Cancer Spectrum1
862020Racial difference in bioavailability of oral ibandronate between Caucasian and Taiwanese postmenopausal womenChiu W.-Y.; Lin C.-J.; WEI-SHIUNG YANG ; Tsai K.-S.; Reginster J.-Y.Osteoporosis International1
872020Cell-Free Virus-Host Chimera DNA From Hepatitis B Virus Integration Sites as a Circulating Biomarker of Hepatocellular CancerLi C.-L.; Ho M.-C.; Lin Y.-Y.; Tzeng S.-T.; Chen Y.-J.; Pai H.-Y.; Wang Y.-C.; Chen C.-L.; Lee Y.-H.; Chen D.-S.; Yeh S.-H.; PEI-JER CHEN Hepatology9
882020High risk of clinical relapse in patients with chronic Hepatitis B virus infection after cessation of prophylactic antiviral therapy for rituximab-containing chemotherapyChang W.-Y.; Chiu Y.-C.; Chiu F.-W.; Hsu Y.-C.; Tseng T.-C.; Cheng P.-N.; Yang S.-S.; Liu C.-J.; Su T.-H.; Yang H.-C.; Liu C.-H.; PEI-JER CHEN ; Chen D.-S.; Kao J.-H.Journal of Infectious Diseases3
892020Longitudinal change of metabolite profile and its relation to multiple risk factors for the risk of developing hepatitis B-related hepatocellular carcinomaHuang B.-Y.; Tsai M.-R.; Hsu J.-K.; Lin C.-Y.; Lin C.-L.; Hu J.-T.; Huang Y.-W.; Liu C.-J.; Wu W.-J.; Wu C.-F.; Sung F.-Y.; PEI-JER CHEN ; Liang H.-J.; Lin S.-M.; Yu M.-W.Molecular Carcinogenesis0
902020Furin Inhibitors Block SARS-CoV-2 Spike Protein Cleavage to Suppress Virus Production and Cytopathic EffectsCheng Y.-W.; Chao T.-L.; Li C.-L.; Chiu M.-F.; Kao H.-C.; Wang S.-H.; Pang Y.-H.; Lin C.-H.; Tsai Y.-M.; Lee W.-H.; Tao M.-H.; Ho T.-C.; Wu P.-Y.; Jang L.-T.; PEI-JER CHEN ; Chang S.-Y.; Yeh S.-H.Cell Reports41
912020Twelve weeks of ledipasvir/sofosbuvir all-oral regimen for patients with chronic hepatitis C genotype 2 infection: Integrated analysis of three clinical trialsAsahina Y.; Liu C.-J.; Gane E.; Itoh Y.; Kawada N.; Ueno Y.; Youn J.; Wang C.-Y.; Llewellyn J.; Matsuda T.; Gaggar A.; Mo H.; Dvory-Sobol H.; Crans G.; Chuang W.-L.; PEI-JER CHEN ; Enomoto N.Hepatology Research3
922020Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysisLiu C.-H.; Peng C.-Y.; Fang Y.-J.; Kao W.-Y.; Yang S.-S.; Lin C.-K.; Lai H.-C.; Su W.-P.; Fang S.-U.; Chang C.-C.; Su T.-H.; Liu C.-J.; PEI-JER CHEN ; Chen D.-S.; Kao J.-H.Scientific Reports1
932020Ropeginterferon alfa-2b every 2?weeks as a novel pegylated interferon for patients with chronic hepatitis BHuang Y.-W.; Hsu C.-W.; Lu S.-N.; Yu M.-L.; Su C.-W.; Su W.-W.; Chien R.-N.; Hsu C.-S.; Hsu S.-J.; Lai H.-C.; Qin A.; Tseng K.-C.; PEI-JER CHEN Hepatology International3
942020Sofosbuvir/velpatasvir/voxilaprevir plus ribavirin for chronic hepatitis C patients with direct acting antiviral failures: Implications for viral elimination in TaiwanLiu C.-H.; Su T.-H.; Liu C.-J.; PEI-JER CHEN ; Chen D.-S.; Kao J.-H.Journal of the Formosan Medical Association2
952020Pathologic findings of patients with nonalcoholic fatty liver disease and the impact of concurrent hepatitis B virus infection in TaiwanSu H.-J.; Kao J.-H.; Tseng T.-C.; Yang H.-C.; Su T.-H.; PEI-JER CHEN ; Liu C.-J.Journal of the Formosan Medical Association3
962020Disease burden from foodborne illnesses in Taiwan, 2012–2015Lai Y.-H.; Chung Y.-A.; Wu Y.-C.; Fang C.-T.; PEI-JER CHEN Journal of the Formosan Medical Association9
9720202020 Taiwan consensus statement on the management of hepatitis C: Part (II) special populationsYu M.-L.; PEI-JER CHEN ; Dai C.-Y.; Hu T.-H.; Huang C.-F.; Huang Y.-H.; Hung C.-H.; Lin C.-Y.; Liu C.-H.; Liu C.-J.; Peng C.-Y.; Lin H.-C.; Kao J.-H.; Chuang W.-L.Journal of the Formosan Medical Association21
982020Permanent Inactivation of HBV Genomes by CRISPR/Cas9-Mediated Non-cleavage Base EditingYang Y.-C.; Chen Y.-H.; Kao J.-H.; Ching C.; Liu I.-J.; Wang C.-C.; Tsai C.-H.; Wu F.-Y.; Liu C.-J.; PEI-JER CHEN ; Chen D.-S.; Yang H.-C.Molecular Therapy - Nucleic Acids12
992020Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C in Taiwan: Real-world dataHong C.-M.; Liu C.-H.; Su T.-H.; Yang H.-C.; PEI-JER CHEN ; Chen Y.-W.; Kao J.-H.; Liu C.-J.Journal of Microbiology, Immunology and Infection12
1002020Antiviral therapy against chronic hepatitis C is associated with a reduced risk of oral cancerSu T.-H.; Tseng T.-C.; Liu C.-J.; Chou S.-W.; Liu C.-H.; Yang H.-C.; PEI-JER CHEN ; Chen D.-S.; Chen C.-L.; Kao J.-H.International Journal of Cancer2
1012020Performance of commercially available anti-HDV enzyme-linked immunosorbent assays in TaiwanLin G.-Y.; Wu Y.-L.; Wang C.-S.; Ko C.-Y.; Chen C.-H.; PEI-JER CHEN ; Peng P.-H.; Hsu C.-W.Virology Journal2
1022020Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19)Chang F.-Y.; Chen H.-C.; PEI-JER CHEN ; Ho M.-S.; Hsieh S.-L.; Lin J.-C.; Liu F.-T.; Sytwu H.-K.Journal of Biomedical Science14
1032020The origin and underlying driving forces of the SARS-CoV-2 outbreakChaw S.-M.; Tai J.-H.; Chen S.-L.; Hsieh C.-H.; Chang S.-Y.; Yeh S.-H.; Yang W.-S.; PEI-JER CHEN ; Wang H.-Y.Journal of Biomedical Science25
1042020The role of phylogenetic analysis in clarifying the infection source of a COVID-19 patientWang J.-T.; Lin Y.-Y.; Chang S.-Y.; Yeh S.-H.; Hu B.-H.; PEI-JER CHEN ; Chang S.-C.Journal of Infection8
1052020Elimination of hepatitis B in highly endemic settings: Lessons learned in Taiwan and challenges aheadLiu C.-J.; PEI-JER CHEN Viruses5
1062020Baseline Mac-2 Binding Protein Glycosylation Isomer Level Stratifies Risks of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Oral Antiviral TherapyTseng T.-C.; Peng C.-Y.; Hsu Y.-C.; Su T.-H.; Wang C.-C.; Liu C.-J.; Yang H.-C.; Yang W.-T.; Lin C.-H.; Yu M.-L.; Lai H.-C.; Tanaka Y.; Nguyen M.H.; Liu C.-H.; PEI-JER CHEN ; Chen D.-S.; Kao J.-H.Liver Cancer6
1072020Diminished hepatic IFN response following HCV clearance triggers HBV reactivation in coinfectionCheng X.; Uchida T.; Xia Y.; Umarova R.; Liu C.-J.; PEI-JER CHEN ; Gaggar A.; Suri V.; M?cke M.M.; Vermehren J.; Zeuzem S.; Teraoka Y.; Osawa M.; Aikata H.; Tsuji K.; Mori N.; Hige S.; Karino Y.; Imamura M.; Chayama K.; Liang T.J.Journal of Clinical Investigation18
1082020Complement C1q mediates the expansion of periportal hepatic progenitor cells in senescence-associated inflammatory liverHo T.-C.; Wang E.-Y.; Yeh K.-H.; Jeng Y.-M.; Horng J.-H.; Wu L.-L.; Chen Y.-T.; Huang H.-C.; Hsu C.-L.; PEI-JER CHEN ; Yeh S.-H.; Chen D.-S.Proceedings of the National Academy of Sciences of the United States of America3
1092020HEV superinfection accelerates disease progression in patients with chronic HBV infection and increases mortality in those with cirrhosisTseng T.-C.; Liu C.-J.; Chang C.T.; Su T.-H.; Yang W.-T.; Tsai C.-H.; Chen C.-L.; Yang H.-C.; Liu C.-H.; PEI-JER CHEN ; Chen D.-S.; Kao J.-H.Journal of Hepatology9
11020202020 Taiwan consensus statement on the management of hepatitis C: part (I) general populationYu M.-L.; PEI-JER CHEN ; Dai C.-Y.; Hu T.-H.; Huang C.-F.; Huang Y.-H.; Hung C.-H.; Lin C.-Y.; Liu C.-H.; Liu C.-J.; Peng C.-Y.; Lin H.-C.; Kao J.-H.; Chuang W.-L.Journal of the Formosan Medical Association16
1112020Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection: Real-world effectiveness and safety in TaiwanLiu C.-H.; Liu C.-J.; Hung C.-C.; Hsieh S.-M.; Su T.-H.; Sun H.-Y.; Tseng T.-C.; PEI-JER CHEN ; Chen D.-S.; Kao J.-H.Liver International9
1122020Evolution of eGFR in chronic HCV patients receiving sofosbuvir-based or sofosbuvir-free direct-acting antiviralsLiu C.-H.; Lee M.-H.; Lin J.-W.; Liu C.-J.; Su T.-H.; Tseng T.-C.; PEI-JER CHEN ; Chen D.-S.; Kao J.-H.Journal of Hepatology15
1132020HBV X protein-based therapeutic vaccine accelerates viral antigen clearance by mobilizing monocyte infiltration into the liver in HBV carrier miceHorng J.-H.; Lin W.-H.; Wu C.-R.; Lin Y.-Y.; Wu L.-L.; Chen D.-S.; PEI-JER CHEN Journal of Biomedical Science3
1142020Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection and severe renal impairmentLiu C.-H.; Yang S.-S.; Peng C.-Y.; Lin W.-T.; Liu C.-J.; Su T.-H.; Tseng T.-C.; PEI-JER CHEN ; Chen D.-S.; Kao J.-H.Journal of Viral Hepatitis8
1152020A unique B cell epitope-based particulate vaccine shows effective suppression of hepatitis B surface antigen in miceZhang T.-Y.; Guo X.-R.; Wu Y.-T.; Kang X.-Z.; Zheng Q.-B.; Qi R.-Y.; Chen B.-B.; Lan Y.; Wei M.; Wang S.-J.; Xiong H.-L.; Cao J.-L.; Zhang B.-H.; Qiao X.-Y.; Huang X.-F.; Wang Y.-B.; Fang M.-J.; Zhang Y.-L.; Cheng T.; Chen Y.-X.; Zhao Q.-J.; Li S.-W.; Ge S.-X.; PEI-JER CHEN ; Zhang J.; Yuan Q.; Xia N.-S.Gut11
1162020Cost-effectiveness of preventing hepatitis B virus reactivation in patients with lymphoma and resolved HBV infectionTsou H.-H.; Yang H.-C.; Hsiao C.-F.; Hsiung C.A.; Liu T.-W.; Chuang M.-H.; Wu H.-Y.; Hsu Y.-T.; Tsui C.-W.; PEI-JER CHEN ; Cheng A.-L.; Hsu C.; Taiwan Cooperative Oncology GroupJournal of the Formosan Medical Association4
1172020Serum Mac-2-Binding Protein Glycosylation Isomer at Virological Remission Predicts Hepatocellular Carcinoma and Death in Chronic Hepatitis B-Related CirrhosisSu T.-H.; Peng C.-Y.; Tseng T.-C.; Yang H.-C.; Liu C.-J.; Liu C.-H.; PEI-JER CHEN ; Chen D.-S.; Kao J.-H.Journal of Infectious Diseases5
1182020Asialo GM1-positive liver-resident CD8 T cells that express CD44 and LFA-1 are essential for immune clearance of hepatitis B virusSung C.-C.; Horng J.-H.; Siao S.-H.; Chyuan I.-T.; Tsai H.-F.; PEI-JER CHEN ; Hsu P.-N.Cellular and Molecular Immunology4
1192020Gender difference in the association between metabolic factors and hepatocellular carcinomaChen C.-L.; Kuo M.-J.; Ming-Fang Yen A.; Yang W.-S.; Kao J.-H.; PEI-JER CHEN ; Chen H.-H.JNCI Cancer Spectrum1
1202020An integrative approach for pediatric auditory neuropathy spectrum disorders: revisiting etiologies and exploring the prognostic utility of auditory steady-state responseLin P.-H.; Hsu C.-J.; Lin Y.-H.; Lin Y.-H.; Yang S.-Y.; Yang T.-H.; PEI-LUNG CHEN ; Wu C.-C.; Liu T.-C.Scientific Reports0
1212020The efficacy and safety of topical rapamycin–calcitriol for facial angiofibromas in patients with tuberous sclerosis complex: a prospective, double-blind, randomized clinical trialPEI-LUNG CHEN ; Hong J.B.; Shen L.J.; Chen Y.T.; Wang S.J.; Liao Y.H.British Journal of Dermatology5
1222020Genotypes predispose phenotypes—clinical features and genetic spectrum of abca4-associated retinal dystrophiesSung Y.-C.; Yang C.-H.; Yang C.-M.; Lin C.-W.; Huang D.-S.; Huang Y.-S.; Hu F.-R.; PEI-LUNG CHEN ; Chen T.-C.Genes2
1232020Cerebral microbleeds in autosomal dominant polycystic kidney diseaseTsai L.-K.; PEI-LUNG CHEN ; Tsai H.-H.; Chen Y.-F.; Wu P.-C.; Jeng J.-S.; Huang J.-W.; Chu T.-S.; Kao J.T.-W.Journal of Stroke2
1242020Genotype-phenotype correlations of adult-onset PLA2G6-associated Neurodegeneration: Case series and literature reviewChu Y.-T.; Lin H.-Y.; PEI-LUNG CHEN ; Lin C.-H.BMC Neurology8
1252020Burden of Illness and Quality of Life in Tuberous Sclerosis Complex: Findings From the TOSCA StudyPEI-LUNG CHEN Frontiers in Neurology5
1262020Natural clusters of tuberous sclerosis complex (TSC)-associated neuropsychiatric disorders (TAND): New findings from the TOSCA TAND research projectPEI-LUNG CHEN Journal of Neurodevelopmental Disorders0
1272020Clinical impact of irreversible electroporation ablation for unresectable hilar cholangiocarcinomaHsiao, Chih-Yang; Yang, Po-Chih; Li, Xiaoyong; KAI-WEN HUANG Scientific reports3
1282020The Ethics and Guidelines of Next-Generation Sequencing Genetic Testing and CounselingDANIEL FU-CHANG TSAI ; Yu-Chen Juang; Yin-Hsiu Chien; Ni-Chung Lee; Hung Chih-Yu Wang; Shuan-Pei Lin; Wuh-Liang HwuFormosan Journal of Medicine0
1292020The Ethical and Legal Implication of Using Medical Record and Health Data in ResearchDANIEL FU-CHANG TSAI ; Yu-Chen Juang; Yu-Hsuan Chen; Hsiao-Yi YehFormosan Journal of Medicine0
1302020The Intensive Care Medical Resource Allocation and Ethics in PandemicDANIEL FU-CHANG TSAI ; Kar-Fai Foo; Shih-Chi Ku; Cheng-Chung FangFormosan Journal of Medicine0
1312020The Medical Application and Ethical Guidelines of Artificial IntelligenceDANIEL FU-CHANG TSAI ; Foo Kar FaiCheng Ching Medical Journal
1322020Ethical Legal Issues of Inflight Medical EmergenciesTzu-Jung Chou; DANIEL FU-CHANG TSAI Formosan Journal of Medicine0
1332020Effect of 3-Hydroxy-3-Methyl-Glutaryl-Coenzyme A Reductase Inhibitors on the Meibomian Gland Morphology in Patients with DyslipidemiaWu K.-I.; Chen C.-Y.; TZUU-SHUH JOU ; Jimmy Juang J.-M.; Lu J.-Y.; Wang I.-J.American Journal of Ophthalmology1
1342020Exploring a peptidomimetic approach of N-cadherin in modulating fibroblast growth factor receptor signaling for corneal endothelial regenerationSu C.-C.; Ho W.-T.; Peng F.-T.; Gao C.-M.; TZUU-SHUH JOU ; Wang I.-J.FASEB Journal0
1352020Modelling NAFLD disease burden in four Asian regions—2019-2030Estes C.; Chan H.L.Y.; Chien R.N.; Chuang W.-L.; Fung J.; Goh G.B.-B.; Hu T.H.; Huang J.-F.; Jang B.K.; Jun D.W.; JIA-HORNG KAO ; Lee J.-W.; Lin H.-C.; Razavi-Shearer K.; Seto W.-K.; Wong G.L.H.; Wong V.W.S.; Razavi H.Alimentary Pharmacology and Therapeutics19
1362020HEV superinfection accelerates disease progression in patients with chronic HBV infection and increases mortality in those with cirrhosisTseng T.-C.; Liu C.-J.; Chang C.T.; Su T.-H.; Yang W.-T.; Tsai C.-H.; Chen C.-L.; Yang H.-C.; Liu C.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO Journal of Hepatology9
13720202020 Taiwan consensus statement on the management of hepatitis C: part (I) general populationYu M.-L.; Chen P.-J.; Dai C.-Y.; Hu T.-H.; Huang C.-F.; Huang Y.-H.; Hung C.-H.; Lin C.-Y.; Liu C.-H.; Liu C.-J.; Peng C.-Y.; Lin H.-C.; JIA-HORNG KAO ; Chuang W.-L.Journal of the Formosan Medical Association16
1382020Evolution of eGFR in chronic HCV patients receiving sofosbuvir-based or sofosbuvir-free direct-acting antiviralsLiu C.-H.; Lee M.-H.; Lin J.-W.; Liu C.-J.; Su T.-H.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO Journal of Hepatology15
1392020Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection and severe renal impairmentLiu C.-H.; Yang S.-S.; Peng C.-Y.; Lin W.-T.; Liu C.-J.; Su T.-H.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO Journal of Viral Hepatitis8
1402020Hepatitis B virus: Advances in prevention, diagnosis, and therapyNguyen M.H.; Wong G.; Gane E.; JIA-HORNG KAO ; Dusheiko G.Clinical Microbiology Reviews38
1412020The clinical manifestations and management of COVID-19-related liver injurySu T.-H.; JIA-HORNG KAO Journal of the Formosan Medical Association12
1422020HighlightsJIA-HORNG KAO Journal of the Formosan Medical Association0
1432020HighlightsJIA-HORNG KAO Journal of the Formosan Medical Association0
1442020An Open-Label, Randomized, Active-Controlled Trial of 8 Versus 12 Weeks of Elbasvir/Grazoprevir for Treatment-Naive Patients with Chronic Hepatitis C Genotype 1b Infection and Mild Fibrosis (EGALITE Study): Impact of Baseline Viral Loads and NS5A Resistance-Associated SubstitutionsHuang C.-F.; Hung C.-H.; Cheng P.-N.; Bair M.-J.; Huang Y.-H.; JIA-HORNG KAO ; Hsu S.-J.; Lee P.-L.; Chen J.-J.; Chien R.-N.; Peng C.-Y.; Lin C.-Y.; Hsieh T.-Y.; Cheng C.-H.; Dai C.-Y.; Huang J.-F.; Chuang W.-L.; Yu M.-L.Journal of Infectious Diseases8
1452020Baseline Mac-2 Binding Protein Glycosylation Isomer Level Stratifies Risks of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Oral Antiviral TherapyTseng T.-C.; Peng C.-Y.; Hsu Y.-C.; Su T.-H.; Wang C.-C.; Liu C.-J.; Yang H.-C.; Yang W.-T.; Lin C.-H.; Yu M.-L.; Lai H.-C.; Tanaka Y.; Nguyen M.H.; Liu C.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO Liver Cancer6
1462020Resistance-associated substitution and ledipasvir/sofosbuvir therapy in Mongolian chronic hepatitis C patientsHsu S.-J.; Enkhzaya S.; Lin Y.-Y.; Tseng T.-C.; Khosbayar T.; Tsai C.-H.; Wang T.-S.; Enkhtuya D.; Ivshinkhorol D.; Naranzul N.; Jargalsaikhan B.; Amarsanaa J.; Baatarkhuu O.; JIA-HORNG KAO Journal of the Formosan Medical Association2
1472020Serum Mac-2-Binding Protein Glycosylation Isomer at Virological Remission Predicts Hepatocellular Carcinoma and Death in Chronic Hepatitis B-Related CirrhosisSu T.-H.; Peng C.-Y.; Tseng T.-C.; Yang H.-C.; Liu C.-J.; Liu C.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO Journal of Infectious Diseases5
1482020Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection: Real-world effectiveness and safety in TaiwanLiu C.-H.; Liu C.-J.; Hung C.-C.; Hsieh S.-M.; Su T.-H.; Sun H.-Y.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO Liver International9
1492020Improved quantitative assessment of HBV-associated liver fibrosis using second-harmonic generation microscopy with feature selectionHsiao C.-Y.; Teng X.; Su T.-H.; Lee P.-H.; JIA-HORNG KAO ; Huang K.-W.Clinics and Research in Hepatology and Gastroenterology2
1502020Gender difference in the association between metabolic factors and hepatocellular carcinomaChen C.-L.; Kuo M.-J.; Ming-Fang Yen A.; Yang W.-S.; JIA-HORNG KAO ; Chen P.-J.; Chen H.-H.JNCI Cancer Spectrum1
1512020HighlightsJIA-HORNG KAO Journal of the Formosan Medical Association0
1522020HighlightsJIA-HORNG KAO Journal of the Formosan Medical Association0
1532020Hepatitis C virus cure rates are reduced in patients with active but not inactive hepatocellular carcinoma: A practice implicationOgawa E.; Toyoda H.; Iio E.; Jun D.W.; Huang C.-F.; Enomoto M.; Hsu Y.-C.; Haga H.; Iwane S.; Wong G.; Lee D.H.; Tada T.; Liu C.-H.; Chuang W.-L.; Hayashi J.; Cheung R.; Yasuda S.; Tseng C.-H.; Takahashi H.; Tran S.; Yeo Y.H.; Henry L.; Barnett S.D.; Nomura H.; Nakamuta M.; Dai C.-Y.; Huang J.-F.; Yang H.-I.; Lee M.-H.; Jun M.J.; JIA-HORNG KAO ; Eguchi Y.; Ueno Y.; Tamori A.; Furusyo N.; Yu M.-L.; Tanaka Y.; Nguyen M.H.; Ahn S.B.; Azuma K.; Dohmen K.; Jeong J.Y.; Jung J.H.; Kajiwara E.; Kato M.; Kawano A.; Koyanagi T.; Ooho A.; Park S.H.; Satoh T.; Shimoda S.; Song D.S.; Takahashi K.; Yeh M.-L.; Yoon E.L.; Real-World Evidence from the Asia Liver Consortium InvestigatorsClinical Infectious Diseases12
1542020Successful antiviral therapy reduces risk of schizophrenia among chronic hepatitis c patients: A nationwide real-world Taiwanese cohort (T-COACH)Tsai P.-C.; Chen C.-Y.; Kuo H.-T.; Hung C.-H.; Tseng K.-C.; Lai H.-C.; Peng C.-Y.; Wang J.-H.; Chen J.-J.; Lee P.-L.; Chien R.-N.; Yang C.-C.; Lo G.-H.; JIA-HORNG KAO ; Liu C.-J.; Liu C.-H.; Yan S.-L.; Bair M.-J.; Lin C.-Y.; Su W.-W.; Chu C.-H.; Chen C.-J.; Tung S.-Y.; Tai C.-M.; Lin C.-W.; Lo C.-C.; Cheng P.-N.; Chiu Y.-C.; Wang C.-C.; Cheng J.-S.; Tsai W.-L.; Lin H.-C.; Huang Y.-H.; Yeh M.-L.; Huang C.-F.; Hsieh M.-H.; Huang J.-F.; Dai C.-Y.; Chung W.-L.; Ke C.-L.K.; Yu M.-L.; T-COACH Study GroupOpen Forum Infectious Diseases0
1552020High risk of clinical relapse in patients with chronic Hepatitis B virus infection after cessation of prophylactic antiviral therapy for rituximab-containing chemotherapyChang W.-Y.; Chiu Y.-C.; Chiu F.-W.; Hsu Y.-C.; Tseng T.-C.; Cheng P.-N.; Yang S.-S.; Liu C.-J.; Su T.-H.; Yang H.-C.; Liu C.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO Journal of Infectious Diseases3
1562020Relationship between serum gamma-glutamyl transferase level and colorectal adenomaHong T.-C.; Yang H.-C.; Chen C.-L.; JIA-HORNG KAO ; Liu C.-J.; Chen M.-J.; Wang H.-Y.; Kuo Y.-C.; Yu L.-Y.; Hu K.-C.PLoS ONE0
1572020East Asia expert opinion on treatment initiation for chronic hepatitis BJIA-HORNG KAO ; Hu T.-H.; Jia J.; Kurosaki M.; Lim Y.-S.; Lin H.-C.; Sinn D.H.; Tanaka Y.; Wai-Sun Wong V.; Yuen M.-F.Alimentary Pharmacology and Therapeutics10
1582020The association of vitamin D with hepatitis B virus replication: Bystander rather than offenderWang C.-C.; Tzeng I.-S.; Su W.-C.; Li C.-H.; Lin H.H.; Yang C.-C.; JIA-HORNG KAO Journal of the Formosan Medical Association3
1592020Factors predicting outcomes of hepatitis B-related cirrhosis patients with long-term antiviral therapyLin C.-L.; Tseng K.-C.; Chen K.-Y.; Liao L.-Y.; JIA-HORNG KAO Journal of the Formosan Medical Association4
1602020Reply to letter to the editor: Successful eradication of HCV by short-course DAAs in HCV positive donor to HCV-Negative recipient during Haplo-HSCTHuang C.-F.; JIA-HORNG KAO Journal of the Formosan Medical Association0
1612020HighlightsJIA-HORNG KAO Journal of the Formosan Medical Association0
1622020HighlightsJIA-HORNG KAO Journal of the Formosan Medical Association0
1632020Clinical practice guidance for hepatology and liver transplant providers during the COVID-19 pandemic: APASL expert panel consensus recommendationsGregory C.; Rino G.; Richard G.; Ghazinyan H.; Dokmeci K.; Tatsuo K.; JIA-HORNG KAO ; George L.; Laurentius L.; Ismail M.; Masao O.; Diana P.; Teerha P.; Sarin S.K.; Manoj S.; Jose S.; Simone S.; Tawesak T.; Jafri W.; Lai W.; Mo Y.J.; Osamu Y.; Lau G.; Sharma M.; APASL Covid-19 Task ForceHepatology International31
1642020Editorial: increasing burden of nonalcoholic fatty liver disease—a call to action. Authors' replyEstes C.; Chan H.L.Y.; Chien R.N.; Chuang W.-L.; Fung J.; Goh G.B.-B.; Hu T.H.; Huang J.-F.; Jang B.K.; Jun D.W.; JIA-HORNG KAO ; Lee J.-W.; Lin H.-C.; Razavi-Shearer K.; Seto W.-K.; Wong G.L.H.; Wong V.W.S.; Razavi H.Alimentary Pharmacology and Therapeutics0
16520202020 Taiwan consensus statement on the management of hepatitis C: Part (II) special populationsYu M.-L.; Chen P.-J.; Dai C.-Y.; Hu T.-H.; Huang C.-F.; Huang Y.-H.; Hung C.-H.; Lin C.-Y.; Liu C.-H.; Liu C.-J.; Peng C.-Y.; Lin H.-C.; JIA-HORNG KAO ; Chuang W.-L.Journal of the Formosan Medical Association21
1662020Permanent Inactivation of HBV Genomes by CRISPR/Cas9-Mediated Non-cleavage Base EditingYang Y.-C.; Chen Y.-H.; JIA-HORNG KAO ; Ching C.; Liu I.-J.; Wang C.-C.; Tsai C.-H.; Wu F.-Y.; Liu C.-J.; Chen P.-J.; Chen D.-S.; Yang H.-C.Molecular Therapy - Nucleic Acids12
1672020Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C in Taiwan: Real-world dataHong C.-M.; Liu C.-H.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen Y.-W.; JIA-HORNG KAO ; Liu C.-J.Journal of Microbiology, Immunology and Infection12
1682020Hepatitis B: Immunization and Impact on Natural History and Cancer IncidenceLin C.-L.; JIA-HORNG KAO Gastroenterology clinics of North America5
1692020Hepatitis B reactivation: diagnosis and managementHuang S.-C.; Yang H.-C.; JIA-HORNG KAO Expert Review of Gastroenterology and Hepatology6
1702020HighlightsJIA-HORNG KAO Journal of the Formosan Medical Association0
1712020HighlightsJIA-HORNG KAO Journal of the Formosan Medical Association0
1722020Sustained virological response to hepatitis C therapy does not decrease the incidence of systemic lupus erythematosus or rheumatoid arthritisHsu W.-F.; Chen C.-Y.; Tseng K.-C.; Lai H.-C.; Kuo H.-T.; Hung C.-H.; Tung S.-Y.; Wang J.-H.; Chen J.-J.; Lee P.-L.; Chien R.-N.; Lin C.-Y.; Yang C.-C.; Lo G.-H.; Tai C.-M.; Lin C.-W.; JIA-HORNG KAO ; Liu C.-J.; Liu C.-H.; Yan S.-L.; Bair M.-J.; Su W.-W.; Chu C.-H.; Chen C.-J.; Lo C.-C.; Cheng P.-N.; Chiu Y.-C.; Wang C.-C.; Cheng J.-S.; Tsai W.-L.; Lin H.-C.; Huang Y.-H.; Tsai P.-C.; Huang J.-F.; Dai C.-Y.; Chuang W.-L.; Yu M.-L.; Peng C.-Y.Scientific Reports4
1732020The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver diseaseEslam M.; Sarin S.K.; Wong V.W.-S.; Fan J.-G.; Kawaguchi T.; Ahn S.H.; Zheng M.-H.; Shiha G.; Yilmaz Y.; Gani R.; Alam S.; Dan Y.Y.; JIA-HORNG KAO ; Hamid S.; Cua I.H.; Chan W.-K.; Payawal D.; Tan S.-S.; Tanwandee T.; Adams L.A.; Kumar M.; Omata M.; George J.Hepatology International77
1742020Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysisLiu C.-H.; Peng C.-Y.; Fang Y.-J.; Kao W.-Y.; Yang S.-S.; Lin C.-K.; Lai H.-C.; Su W.-P.; Fang S.-U.; Chang C.-C.; Su T.-H.; Liu C.-J.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO Scientific Reports1
1752020Sofosbuvir/velpatasvir/voxilaprevir plus ribavirin for chronic hepatitis C patients with direct acting antiviral failures: Implications for viral elimination in TaiwanLiu C.-H.; Su T.-H.; Liu C.-J.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO Journal of the Formosan Medical Association2
1762020Letter: elevated aspartate aminotransferase and aspartate aminotransferase to alanine aminotransferase ratio predicts poor survival in hepatocellular carcinoma after resection—Authors' replyWai-Sun Wong V.; JIA-HORNG KAO Alimentary Pharmacology and Therapeutics0
1772020HighlightsJIA-HORNG KAO Journal of the Formosan Medical Association0
1782020Extrahepatic Malignancy Among Patients With Chronic Hepatitis C After Antiviral Therapy: A Real-World Nationwide Study on Taiwanese Chronic Hepatitis C Cohort (T-COACH)Huang C.-F.; Lai H.-C.; Chen C.-Y.; Tseng K.-C.; Kuo H.-T.; Hung C.-H.; Wang J.-H.; Chen J.-J.; Lee P.-L.; Chien R.-N.; Yang C.-C.; Lo G.-H.; Tai C.-M.; Lin C.-W.; JIA-HORNG KAO ; Liu C.-J.; Liu C.-H.; Yan S.-L.; Bair M.-J.; Lin C.-Y.; Su W.-W.; Chu C.-H.; Chen C.-J.; Tung S.-Y.; Lo C.-C.; Cheng P.-N.; Chiu Y.-C.; Wang C.-C.; Cheng J.-S.; Tsai W.-L.; Lin H.-C.; Huang Y.-H.; Yeh M.-L.; Huang J.-F.; Dai C.-Y.; Chuang W.-L.; Tsai P.-C.; Peng C.-Y.; Yu M.-L.The American journal of gastroenterology7
1792020Incidence, Factors, and Patient-Level Data for Spontaneous HBsAg Seroclearance: A Cohort Study of 11,264 PatientsYeo Y.H.; Tseng T.-C.; Hosaka T.; Cunningham C.; Fung J.Y.Y.; Ho H.J.; Kwak M.-S.; Trinh H.N.; Ungtrakul T.; Yu M.-L.; Kobayashi M.; Le A.K.; Henry L.; Li J.; Zhang J.; Sriprayoon T.; Jeong D.; Tanwandee T.; Gane E.; Cheung R.C.; Wu C.-Y.; Lok A.S.; Lee H.-S.; Suzuki F.; Yuen M.-F.; JIA-HORNG KAO ; Yang H.-I.; Nguyen M.H.Clinical and translational gastroenterology1
1802020Hepatitis C virus genotypes 1–3 infections regulate lipogenic signaling and suppress cholesterol biosynthesis in hepatocytesHsu C.-S.; Liu W.-L.; Li Q.; Lowey B.; Hertz L.; Chao Y.-C.; Liang T.J.; Chen D.-S.; JIA-HORNG KAO Journal of the Formosan Medical Association0
1812020Antiviral therapy against chronic hepatitis C is associated with a reduced risk of oral cancerSu T.-H.; Tseng T.-C.; Liu C.-J.; Chou S.-W.; Liu C.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chen C.-L.; JIA-HORNG KAO International Journal of Cancer2
1822020Pathologic findings of patients with nonalcoholic fatty liver disease and the impact of concurrent hepatitis B virus infection in TaiwanSu H.-J.; JIA-HORNG KAO ; Tseng T.-C.; Yang H.-C.; Su T.-H.; Chen P.-J.; Liu C.-J.Journal of the Formosan Medical Association3
1832020Progress towards elimination goals for viral hepatitisCox A.L.; El-Sayed M.H.; JIA-HORNG KAO ; Lazarus J.V.; Lemoine M.; Lok A.S.; Zoulim F.Nature Reviews Gastroenterology and Hepatology18
1842020Towards elimination of viral hepatitis in Taiwan by 2025: In memory of Professor Ding-Shinn Chen (1943–2020)Yang H.-C.; JIA-HORNG KAO Journal of the Formosan Medical Association0
1852020HIGHLIGHTSJIA-HORNG KAO Journal of the Formosan Medical Association0
1862020HighlightsJIA-HORNG KAO Journal of the Formosan Medical Association0
1872020Real-world effectiveness from the asia pacific rim liver consortium for hbv risk score for the prediction of hepatocellular carcinoma in chronic hepatitis b patients treated with oral antiviral therapyYang H.-I.; Yeh M.-L.; Wong G.L.; Peng C.-Y.; Chen C.-H.; Trinh H.N.; Cheung K.-S.; Xie Q.; Su T.-H.; Kozuka R.; Lee D.-H.; Ogawa E.; Zhao C.; Ning H.-B.; Huang R.; Li J.; Zhang J.Q.; Ide T.; Xing H.; Iwane S.; Takahashi H.; Wong C.; Wong C.; Lin C.-H.; Hoang J.; Le A.; Henry L.; Toyoda H.; Ueno Y.; Gane E.J.; Eguchi Y.; Kurosaki M.; Wu C.; Liu C.; Shang J.; Furusyo N.; Enomoto M.; JIA-HORNG KAO ; Yuen M.-F.; Yu M.-L.; Nguyen M.H.Journal of Infectious Diseases16
1882020Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairmentLiu C.-H.; Chen C.-Y.; Su W.-W.; Tseng K.-C.; Lo C.-C.; Liu C.-J.; Chen J.-J.; Peng C.-Y.; Shih Y.-L.; Yang S.-S.; Huang C.-S.; Huang K.-J.; Chang C.-Y.; Tsai M.-C.; Kao W.-Y.; Fang Y.-J.; Chen P.-Y.; Su P.-Y.; Tseng C.-W.; Huang J.-J.; Lee P.-L.; Lai H.-C.; Hsieh T.-Y.; Chang C.-H.; Huang Y.-J.; Lee F.-J.; Chang C.-C.; JIA-HORNG KAO Gut0
1892020Letter: hepatitis B virus infection and risk of multiple myeloma—a meta-analysis of cohort studies. Authors' replySu T.-H.; Chen C.-L.; JIA-HORNG KAO Alimentary Pharmacology and Therapeutics0
1902020Risk of hepatocellular carcinoma development after hepatitis C virus eradicated by direct-acting antivirals: Fact or fiction?Hsu S.-J.; Yang S.-S.; JIA-HORNG KAO Journal of the Formosan Medical Association7
1912020Hepatobiliary and Pancreatic: Biliary hamartoma manifests as liver cystsLin H.-H.; Liao S.-H.; Huang Y.-L.; Liu K.-L.; JIA-HORNG KAO Journal of Gastroenterology and Hepatology (Australia)0
1922020Systematic review: chronic viral hepatitis and metabolic derangementWang C.-C.; Cheng P.-N.; JIA-HORNG KAO Alimentary Pharmacology and Therapeutics20
1932019Neutrophil Extracellular Traps Enhance Staphylococcus Aureus Vegetation Formation through Interaction with Platelets in Infective EndocarditisHsu, Chih-Chieh; RON-BIN HSU; Ohniwa, Ryosuke L; Chen, Jeng-Wei; Yuan, Chang-Tsu; JEAN-SAN CHIA ; Jung, Chiau-JingThrombosis and haemostasis1111
1942019Generation of induced pluripotent stem cell line-NTUHi001-A from a premature ovarian failure patient with Turner's syndrome mosaicismLu, Chen-Yu; Chen, Yu-An; Syu, Shih-Han; Lu, Huai-En; HONG-NERNG HO; HSIN-FU CHEN Stem cell research11
1952019P53 ICE CRIM mouse: A tool to generate mutant allelic series in somatic cells and germ lines for cancer studiesFan H.-H.; Shing Yu I.; Lin Y.-H.; Wang S.-Y.; Liaw Y.-H.; Chen P.-L.; Yang T.-L.; Lin S.-W.; YOU-TZUNG CHEN FASEB Journal00
1962019Embryonic Cul4b is important for epiblast growth and location of primitive streak layer cellsChen C.-Y.; Yu I.-S.; Pai C.-H.; Lin C.-Y.; Lin S.-R.; YOU-TZUNG CHEN ; Lin S.-W.PLoS ONE00
19720194(1H)-quinolone derivatives overcome acquired resistance to anti-microtubule agents by targeting the colchicine site of β-tubulinLin M.-S.; PAN-CHYR YANG et al. European Journal of Medicinal Chemistry75
1982019Correction to: CCN2 inhibits lung cancer metastasis through promoting DAPK-dependent anoikis and inducing EGFR degradation (Cell Death & Differentiation, (2013), 20, 3, (443-455), 10.1038/cdd.2012.136)Chang C.-C.; PAN-CHYR YANG et al. Cell Death and Differentiation11
1992019Cancer-associated fibroblasts produce netrin-1 to control cancer cell plasticitySung P.-J.; PAN-CHYR YANG et al. Cancer Research2018
2002019Discovery of an Oleanolic Acid/Hederagenin-Nitric Oxide Donor Hybrid as an EGFR Tyrosine Kinase Inhibitor for Non-Small-Cell Lung CancerChen Z.; PAN-CHYR YANG et al. Journal of Natural Products109
2012019Tumor mutation burden and recurrent tumors in hereditary lung cancerHsu Y.-C.; PAN-CHYR YANG et al. Cancer Medicine42
2022019Hypoxia-induced Slug SUMOylation enhances lung cancer metastasis 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis 06 Biological Sciences 0601 Biochemistry and Cell BiologyHung P.-F.; PAN-CHYR YANG et al. Journal of Experimental and Clinical Cancer Research1210
2032019A prospective, multi-institution assessment of irreversible electroporation for treatment of locally advanced pancreatic adenocarcinoma: initial outcomes from the AHPBA pancreatic registryHolland M.M.; Bhutiani N.; Kruse E.J.; Weiss M.J.; Christein J.D.; White R.R.; KAI-WEN HUANG ; Martin R.C.G.; IIHPB2617
2042019Targeted Delivery of C/EBPα-saRNA by RNA Aptamers Shows Anti-tumor Effects in a Mouse Model of Advanced PDACYoon S.; KAI-WEN HUANG ; Andrikakou P.; Vasconcelos D.; Swiderski P.; Reebye V.; Sodergren M.; Habib N.; Rossi J.J.Molecular Therapy - Nucleic Acids37
2052019Graptopetalum paraguayense inhibits liver fibrosis by blocking TGF-β signaling in vivo and in vitroHsu W.-H.; Liao S.-C.; Chyan Y.-J.; KAI-WEN HUANG ; Hsu S.-L.; Chen Y.-C.; Siu M.-L.; Chang C.-C.; Chung Y.-S.; Huang C.-Y.F.International Journal of Molecular Sciences33
2062019Anti-inflammatory Activity of MTL-CEBPA, a Small Activating RNA Drug, in LPS-Stimulated Monocytes and Humanized MiceZhou J.; Li H.; Xia X.; Herrera A.; Pollock N.; Reebye V.; Sodergren M.H.; Dorman S.; Littman B.H.; Doogan D.; KAI-WEN HUANG ; Habib R.; Blakey D.; Habib N.A.; Rossi J.J.Molecular Therapy66
2072019Mechanisms involved in the activation of C/EBPα by small activating RNA in hepatocellular carcinomaZhao X.; Reebye V.; Hitchen P.; Fan J.; Jiang H.; S?trom P.; Rossi J.; Habib N.A.; KAI-WEN HUANG Oncogene97
2082019The Ethical Legal Issues in Organ Donation after Circulatory DeathSin-Bao Huang; DANIEL FU-CHANG TSAI Formosan Journal of Medicine00
2092019The Ethical Issues Arising from Genetic Testing for Non-Medical PurposesDANIEL FU-CHANG TSAI ; Yu-Chen Juang; Yen-Hou Liao; Hung Chih-Yu Wang; Yin-Hsiu Chien; Wuh-Liang HwuFormosan Journal of Medicine00
2102019The Ethical Issues in Genetic Testing and Counselling of Autism Spectrum DisorderDANIEL FU-CHANG TSAI ; Yu-Ren Hsu; Yu-Chen Juang; Yi-Ling Chien; Wen-Che TsaiFormosan Journal of Medicine00
2112019Ethical Legal Analysis of Germline Gene Editing: An Example of Gene Editing Baby in ChinaDANIEL FU-CHANG TSAI ; Yu-Chen Juang; Pin-Yu LaiFormosan Journal of Medicine00
2122019Impact of major illnesses and geographic regions on do-not-resuscitate rate and its potential cost savings in TaiwanCheng, Ming-Tai; Shih, Fuh-Yuan; Tsai, Chu-Lin; Tsai, Hung-Bin; DANIEL FU-CHANG TSAI ; Fang, Cheng-ChungPloS one00
2132019Clonality of fluconazole-nonsusceptible Candida tropicalis in bloodstream infections, Taiwan, 2011-2017Chen P.-Y.; Chuang Y.-C.; Wu U.-I.; Sun H.-Y.; Wang J.-T.; Sheng W.-H.; Lo H.-J.; HURNG-YI WANG ; Chen Y.-C.; Chang S.-C.Emerging Infectious Diseases1416
2142019Genetic Load and Potential Mutational Meltdown in Cancer Cell PopulationsZhang Y.; Li Y.; Li T.; Shen X.; Zhu T.; Tao Y.; Li X.; Wang D.; Ma Q.; Hu Z.; Liu J.; Ruan J.; Cai J.; HURNG-YI WANG ; Lu X.Molecular Biology and Evolution56
2152019Lymphocyte Antigen 6 Complex, Locus C+ Monocytes and Kupffer Cells Orchestrate Liver Immune Responses Against Hepatitis B Virus in MiceWu L.-L.; Peng W.-H.; Wu H.-L.; Miaw S.-C.; Yeh S.-H.; Yang H.-C.; Liao P.-H.; Lin J.-S.; Chen Y.-R.; Hong Y.-T.; HURNG-YI WANG ; Chen P.-J.; Chen D.-S.Hepatology1117
2162019Effects of indoor residual spraying and outdoor larval control on Anopheles coluzzii from S?o Tom? and Pr?ncipe, two islands with pre-eliminated malariaChen Y.-A.; Lien J.-C.; Tseng L.-F.; Cheng C.-F.; Lin W.-Y.; HURNG-YI WANG ; Tsai K.-H.Malaria Journal23
2172019Newly diagnosed and growing subependymal giant cell astrocytoma in adults with tuberous sclerosis complex: Results from the International TOSCA StudyPEI-LUNG CHEN Frontiers in Neurology12
2182019Clinical characteristics of subependymal giant cell astrocytoma in tuberous sclerosis complexPEI-LUNG CHEN Frontiers in Neurology8
2192019Epilepsy in tuberous sclerosis complex: Findings from the TOSCA StudyPEI-LUNG CHEN Epilepsia Open0
2202019Taiwan's health-care system and administration are independent of ChinaTsai D.-H.; Lee M.-H.; Chen D.-S.; Liaw Y.-F.; PAN-CHYR YANG ; Huang Y.-H.; Chen C.-J.The Lancet11
2212019A novel TNF-α-targeting aptamer for TNF-α-mediated acute lung injury and acute liver failureLai W.-Y.; Wang J.-W.; Huang B.-T.; Lin E.P.-Y.; PAN-CHYR YANG Theranostics2834
2222019EGFR-Mutant SCLC Exhibits Heterogeneous Phenotypes and Resistance to Common Antineoplastic DrugsLin C.-A.; Yu S.-L.; Chen H.-Y.; Chen H.-W.; Lin S.-U.; Chang C.-C.; Yu C.-J.; PAN-CHYR YANG ; Ho C.-C.Journal of Thoracic Oncology53
2232019Lymphocyte Antigen 6 Complex, Locus C+ Monocytes and Kupffer Cells Orchestrate Liver Immune Responses Against Hepatitis B Virus in MiceWu L.-L.; Peng W.-H.; Wu H.-L.; Miaw S.-C.; Yeh S.-H.; Yang H.-C.; Liao P.-H.; Lin J.-S.; Chen Y.-R.; Hong Y.-T.; Wang H.-Y.; PEI-JER CHEN ; Chen D.-S.Hepatology17
2242019Plectin Mutations in Progressive Familial Intrahepatic CholestasisWu S.-H.; Hsu J.S.; Chen H.-L.; Chien M.-M.; Wu J.-F.; Ni Y.-H.; Liou B.-Y.; Ho M.-C.; Jeng Y.-M.; Chang M.-H.; PEI-LUNG CHEN ; Chen H.-L.Hepatology3
2252019Baseline Level of Hepatitis B Core Antibody Predicts Spontaneous Hepatitis B e Antigen (HBeAg) Seroconversion in HBeAg-Positive Children With a Normal Alanine Aminotransferase LevelChen H.-S.; Wu J.-F.; Su T.-H.; Chen H.-L.; Hsu H.-Y.; Xia N.-S.; PEI-JER CHEN ; Chang M.-H.Hepatology3
2262019Cell and Animal Models for Studying Hepatitis B Virus Infection and Drug DevelopmentHu J.; Lin Y.-Y.; PEI-JER CHEN ; Watashi K.; Wakita T.Gastroenterology37
2272019Distinctive genetic variation of long-segment Hirschsprung's disease in TaiwanYang W.; Chen S.-C.; Lai J.-Y.; Ming Y.-C.; Chen J.-C.; PEI-LUNG CHEN Neurogastroenterology and Motility1
2282019Specific diacylglycerols generated by hepatic lipogenesis stimulate the oncogenic androgen receptor activity in male hepatocytesCheng Y.-W.; Chen K.-W.; Kuo H.-C.; Kuo C.-H.; Lin W.-H.; PEI-JER CHEN ; Yeh S.-H.International Journal of Obesity1
2292019P53 ICE CRIM mouse: A tool to generate mutant allelic series in somatic cells and germ lines for cancer studiesFan H.-H.; Shing Yu I.; Lin Y.-H.; Wang S.-Y.; Liaw Y.-H.; PEI-LUNG CHEN ; Yang T.-L.; Lin S.-W.; Chen Y.-T.FASEB Journal0
2302019Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non-cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysisLiu C.-H.; Shih Y.-L.; Yang S.-S.; Lin C.-L.; Fang Y.-J.; Cheng P.-N.; Chen C.-Y.; Peng C.-Y.; Hsieh T.-Y.; Chiu Y.-C.; Su T.-H.; Liu C.-J.; Yang H.-C.; PEI-JER CHEN ; Chen D.-S.; Kao J.-H.Journal of Gastroenterology and Hepatology (Australia)3
2312019Expression of Metastatic Tumor Antigen 1 Splice Variant Correlates With Early Recurrence and Aggressive Features of Hepatitis B Virus–Associated Hepatocellular CarcinomaLi Y.-T.; Wu H.-L.; Kao J.-H.; Cheng H.-R.; Ho M.-C.; Wang C.-C.; PEI-JER CHEN ; Chen D.-S.; Liu C.-J.Hepatology2
2322019Effect of Empagliflozin on Cardiac Function, Adiposity, and Diffuse Fibrosis in Patients with Type 2 Diabetes MellitusHsu J.-C.; Wang C.-Y.; Su M.-Y.M.; Lin L.-Y.; WEI-SHIUNG YANG Scientific Reports14
2332019Androgen Receptor Enhances Hepatic Telomerase Reverse Transcriptase Gene Transcription After Hepatitis B Virus Integration or Point Mutation in Promoter RegionLi C.-L.; Li C.-Y.; Lin Y.-Y.; Ho M.-C.; Chen D.-S.; PEI-JER CHEN ; Yeh S.-H.Hepatology21
2342019Cilostazol Attenuates Retinal Oxidative Stress and Inflammation in a Streptozotocin-Induced Diabetic Animal ModelYeh P.-T.; Huang Y.-H.; Chang S.-W.; Wang L.-C.; Yang C.-M.; WEI-SHIUNG YANG ; Lin C.-W.; Yang C.-H.Current Eye Research6
2352019Smoking and Hepatitis B Virus–Related Hepatocellular Carcinoma Risk: The Mediating Roles of Viral Load and Alanine AminotransferaseWang Y.-H.; Chuang Y.-H.; Wu C.-F.; Jan M.-C.; Wu W.-J.; Lin C.-L.; Liu C.-J.; Yang Y.-C.; PEI-JER CHEN ; Lin S.-M.; Tsai M.-H.; Huang Y.-W.; Yu M.-W.Hepatology8
2362019A Higher Preoperative Glycemic Profile Is Associated with Rapid Gastric Emptying After Sleeve Gastrectomy for Obese SubjectsYang P.-J.; Cheng M.-F.; WEI-SHIUNG YANG ; Tsai M.-S.; Lee P.-C.; Chen C.-N.; Lin M.-T.; Tseng P.-H.Obesity Surgery7
2372019Taiwan consensus statement on the management of chronic hepatitis BChien R.-N.; Kao J.-H.; Peng C.-Y.; Chen C.-H.; Liu C.-J.; Huang Y.-H.; Hu T.-H.; Yang H.-I.; Lu S.-N.; Ni Y.-H.; Chuang W.-L.; Lee C.-M.; Wu J.-C.; PEI-JER CHEN ; Liaw Y.-F.Journal of the Formosan Medical Association20
2382019Efficacy and safety of 12 weeks of daclatasvir, asunaprevir plus ribavirin for HCV genotype-1b infection without NS5A resistance-associated substitutionsYu M.-L.; Hung C.-H.; Huang Y.-H.; Peng C.-Y.; Lin C.-Y.; Cheng P.-N.; Chien R.-N.; Hsu S.-J.; Liu C.-H.; Huang C.-F.; Su C.-W.; Huang J.-F.; Liu C.-J.; Kao J.-H.; Chuang W.-L.; PEI-JER CHEN ; Chen D.-S.Journal of the Formosan Medical Association7
2392019High Level of Hepatitis B Core–Related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral LoadTseng T.-C.; Liu C.-J.; Hsu C.-Y.; Hong C.-M.; Su T.-H.; Yang W.-T.; Chen C.-L.; Yang H.-C.; Huang Y.-T.; Fang-Tzu Kuo S.; Liu C.-H.; PEI-JER CHEN ; Chen D.-S.; Kao J.-H.Gastroenterology35
2402019Antiviral treatment for hepatitis B in infancy: Still an issue for debateChen H.-L.; Ni Y.-H.; PEI-JER CHEN ; Chang M.-H.Journal of Hepatology0
2412019Genetic epidemiology and clinical features of hereditary hearing impairment in the Taiwanese populationWu C.-C.; Tsai C.-Y.; Lin Y.-H.; Chen P.-Y.; Lin P.-H.; Cheng Y.-F.; Wu C.-M.; Lin Y.-H.; Lee C.-Y.; Erdenechuluun J.; Liu T.-C.; PEI-LUNG CHEN ; Hsu C.-J.Genes6
2422019Profile and value of FIB-4 in patients with dual chronic hepatitis C and BLiu C.-J.; Tseng T.-C.; Yang W.-T.; Su T.-H.; Yang H.-C.; Liu C.-H.; PEI-JER CHEN ; Chen D.-S.; Kao J.-H.Journal of Gastroenterology and Hepatology (Australia)5
2432019A clinical and genetic study of early-onset and familial parkinsonism in taiwan: An integrated approach combining gene dosage analysis and next-generation sequencingLin C.-H.; PEI-LUNG CHEN ; Tai C.-H.; Lin H.-I.; Chen C.-S.; Chen M.-L.; Wu R.-M.Movement Disorders29
2442019Serum levels of insulin-like growth factor 1 are negatively associated with log transformation of thyroid-stimulating hormone in Graves' disease patients with hyperthyroidism or subjects with euthyroidism: A prospective observational studyTseng F.-Y.; Chen Y.-T.; Chi Y.-C.; Chen P.-L.; WEI-SHIUNG YANG Medicine1
2452019Association Between High Levels of Hepatitis B Core Antibody and Seroclearance of Hepatitis B e Antigen in Individuals With Chronic Hepatitis B Virus InfectionLiu J.; Hu H.-H.; Chang C.-L.; Jen C.-L.; Lee M.-H.; Lu S.-N.; Wang L.-Y.; Yuan Q.; Xia N.-S.; Sugiyama M.; Nishida N.; Mizokami M.; Chen C.-J.; PEI-JER CHEN ; Yang H.-I.Clinical Gastroenterology and Hepatology3
2462019Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myelomaSu T.-H.; Liu C.-J.; Tseng T.-C.; Chou S.-W.; Liu C.-H.; Yang H.-C.; Wu S.-J.; PEI-JER CHEN ; Chen D.-S.; Chen C.-L.; Kao J.-H.Alimentary Pharmacology and Therapeutics14
2472019Effect of Fenofibrate on the Expression of Inflammatory Mediators in a Diabetic Rat ModelYeh P.-T.; Wang L.-C.; Chang S.-W.; WEI-SHIUNG YANG ; Yang C.-M.; Yang C.-H.Current Eye Research4
2482019Level of Hepatitis B (HB) Core Antibody Associates With Seroclearance of HBV DNA and HB Surface Antigen in HB e Antigen-Seronegative PatientsHu H.-H.; Liu J.; Chang C.-L.; Jen C.-L.; Lee M.-H.; Lu S.-N.; Wang L.-Y.; Quan Y.; Xia N.-S.; Chen C.-J.; PEI-JER CHEN ; Yang H.-I.Clinical Gastroenterology and Hepatology8
2492019NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer stagingSu T.-H.; Liao S.-H.; Hong C.-M.; Liu C.-J.; Tseng T.-C.; Liu C.-H.; Yang H.-C.; PEI-JER CHEN ; Chen D.-S.; Chen C.-L.; Adhoute X.; Bourli?re M.; Kao J.-H.Journal of Gastroenterology and Hepatology (Australia)1
2502019Targeted Next-Generation Sequencing Facilitates Genetic Diagnosis and Provides Novel Pathogenetic Insights into Deafness with Enlarged Vestibular AqueductLin Y.-H.; Wu C.-C.; Lin Y.-H.; Lu Y.-C.; Chen C.-S.; Liu T.-C.; PEI-LUNG CHEN ; Hsu C.-J.Journal of Molecular Diagnostics5
2512019HSD3B1 gene polymorphism and female pattern hair loss in women with polycystic ovary syndromeTu Y.-A.; Lin S.-J.; PEI-LUNG CHEN ; Chou C.-H.; Huang C.-C.; Ho H.-N.; Chen M.-J.Journal of the Formosan Medical Association6
2522019Serum levels of insulin-like growth factor 1 are negatively associated with log transformation of thyroid-stimulating hormone in Graves' disease patients with hyperthyroidism or subjects with euthyroidism: A prospective observational studyTseng F.-Y.; Chen Y.-T.; Chi Y.-C.; PEI-LUNG CHEN ; Yang W.-S.Medicine1
2532019Serum fibroblast growth factor 23 and mineral metabolism in patients with euthyroid Graves’ diseases: a case-control studyLin C.-H.; Chang C.-K.; Shih C.-W.; Li H.-Y.; Chen K.-Y.; WEI-SHIUNG YANG ; Tsai K.-S.; Wang C.-Y.; Shih S.-R.Osteoporosis International2
2542019Sofosbuvir-based direct acting antiviral therapies for patients with hepatitis C virus genotype 2 infectionLiu C.-H.; Su T.-H.; Liu C.-J.; Hong C.-M.; Yang H.-C.; Tseng T.-C.; PEI-JER CHEN ; Chen D.-S.; Kao J.-H.Journal of Gastroenterology and Hepatology (Australia)11
2552019A phase of diabetes care at the verge of paradigm shiftWEI-SHIUNG YANG Journal of the Formosan Medical Association0
2562019The serum level of a novel lipogenic protein Spot 14 was reduced in metabolic syndromeChen Y.-T.; Tseng P.-H.; Tseng F.-Y.; Chi Y.-C.; Han D.-S.; WEI-SHIUNG YANG PLoS ONE1
2572019Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infectionSu T.-H.; Liu C.-J.; Tseng T.-C.; Chou S.-W.; Liu C.-H.; Yang H.-C.; Wu S.-J.; PEI-JER CHEN ; Chen D.-S.; Chen C.-L.; Kao J.-H.Alimentary Pharmacology and Therapeutics6
2582019Targeting non-muscle myosin II promotes corneal endothelial migration through regulating lamellipodial dynamicsHo W.-T.; Chang J.-S.; Chou S.-F.; Hwang W.-L.; Shih P.-J.; Chang S.-W.; Yang M.-H.; TZUU-SHUH JOU ; Wang I.-J.Journal of Molecular Medicine1
2592019Novel interleukin-10 gene polymorphism is linked to gestational diabetes in taiwanese populationKang J.; Liu C.-H.; Lee C.-N.; Li H.-Y.; Yang C.-W.; Huang S.-C.; Lin S.-Y.; TZUU-SHUH JOU Frontiers in Genetics4
2602019Efficacy and safety of 12 weeks of daclatasvir, asunaprevir plus ribavirin for HCV genotype-1b infection without NS5A resistance-associated substitutionsYu M.-L.; Hung C.-H.; Huang Y.-H.; Peng C.-Y.; Lin C.-Y.; Cheng P.-N.; Chien R.-N.; Hsu S.-J.; Liu C.-H.; Huang C.-F.; Su C.-W.; Huang J.-F.; Liu C.-J.; JIA-HORNG KAO ; Chuang W.-L.; Chen P.-J.; Chen D.-S.Journal of the Formosan Medical Association7
2612019Genetic variation in FCER1A predicts peginterferon alfa-2a-induced hepatitis B surface antigen clearance in East Asian patients with chronic hepatitis BWei L.; Pavlovic V.; Bansal A.T.; Chen X.; Foster G.R.; He H.; JIA-HORNG KAO ; Lampertico P.; Liaw Y.-F.; Motoc A.; Papatheodoridis G.V.; Piratvisuth T.; Plesniak R.; Wat C.Journal of Viral Hepatitis2
2622019Peginterferon alfa-2a (40 kD) stopping rules in chronic hepatitis B: A systematic review and meta-analysis of individual participant dataPavlovic V.; Yang L.; Chan H.L.-Y.; Hou J.; Janssen H.L.; JIA-HORNG KAO ; Lampertico P.; Peng C.-Y.; Piratvisuth T.; Thompson A.J.; Wedemeyer H.; Wei L.; Wat C.Antiviral Therapy7
2632019Taiwan consensus statement on the management of chronic hepatitis BChien R.-N.; JIA-HORNG KAO ; Peng C.-Y.; Chen C.-H.; Liu C.-J.; Huang Y.-H.; Hu T.-H.; Yang H.-I.; Lu S.-N.; Ni Y.-H.; Chuang W.-L.; Lee C.-M.; Wu J.-C.; Chen P.-J.; Liaw Y.-F.Journal of the Formosan Medical Association20
2642019Editorial: comorbidities, concomitant medications and potential drug-drug interactions with interferon-free direct-acting anti-viral agents in chronic hepatitis C – authors’ replyLiu C.-H.; JIA-HORNG KAO Alimentary Pharmacology and Therapeutics0
2652019Profile and value of FIB-4 in patients with dual chronic hepatitis C and BLiu C.-J.; Tseng T.-C.; Yang W.-T.; Su T.-H.; Yang H.-C.; Liu C.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO Journal of Gastroenterology and Hepatology (Australia)5
2662019Clinical Manifestations and Outcomes of Patients with Sarcomatoid Hepatocellular CarcinomaLiao S.-H.; Su T.-H.; Jeng Y.-M.; Liang P.-C.; Chen D.-S.; Chen C.-H.; JIA-HORNG KAO Hepatology26
2672019Editorial: nephrotoxicity and oral anti-viral therapy for HBV-facts or fiction?Liu C.-H.; JIA-HORNG KAO Alimentary Pharmacology and Therapeutics0
2682019Large and middle hepatitis B surface antigen: The lower the better?Lin H.-H.; Tseng T.-C.; JIA-HORNG KAO Gut1
2692019Quantification of HBV core antibodies may help revisit infectious occult hepatitis B virusYang H.-C.; JIA-HORNG KAO Gut1
2702019Factors Associated With Rates of HBsAg Seroclearance in Adults With Chronic HBV Infection: A Systematic Review and Meta-analysisYeo Y.H.; Ho H.J.; Yang H.-I.; Tseng T.-C.; Hosaka T.; Trinh H.N.; Kwak M.-S.; Park Y.M.; Fung J.Y.Y.; Buti M.; Rodr?guez M.; Treeprasertsuk S.; Preda C.M.; Ungtrakul T.; Charatcharoenwitthaya P.; Li X.; Li J.; Zhang J.; Le M.H.; Wei B.; Zou B.; Le A.; Jeong D.; Chien N.; Kam L.; Lee C.-C.; Riveiro-Barciela M.; Istratescu D.; Sriprayoon T.; Chong Y.; Tanwandee T.; Kobayashi M.; Suzuki F.; Yuen M.-F.; Lee H.-S.; JIA-HORNG KAO ; Lok A.S.; Wu C.-Y.; Nguyen M.H.Gastroenterology63
2712019APASL clinical practice recommendation: how to treat HCV-infected patients with renal impairment?Kanda T.; Lau G.K.K.; Wei L.; Moriyama M.; Yu M.-L.; Chuang W.-L.; Ibrahim A.; Lesmana C.R.A.; Sollano J.; Kumar M.; Jindal A.; Sharma B.C.; Hamid S.S.; Dokmeci A.K.; Mamun-Al-Mahtab, McCaughan G.W.; Wasim J.; Crawford D.H.G.; JIA-HORNG KAO ; Yokosuka O.; Sarin S.K.; Omata M.Hepatology International19
2722019Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myelomaSu T.-H.; Liu C.-J.; Tseng T.-C.; Chou S.-W.; Liu C.-H.; Yang H.-C.; Wu S.-J.; Chen P.-J.; Chen D.-S.; Chen C.-L.; JIA-HORNG KAO Alimentary Pharmacology and Therapeutics14
2732019Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infectionSu T.-H.; Liu C.-J.; Tseng T.-C.; Chou S.-W.; Liu C.-H.; Yang H.-C.; Wu S.-J.; Chen P.-J.; Chen D.-S.; Chen C.-L.; JIA-HORNG KAO Alimentary Pharmacology and Therapeutics6
2742019Quantification of Hepatitis B Core Antibody Helps Predict Clinical Relapse After Cessation of Nucleos(t)ide Analogues in Chronic Hepatitis B Patients: More Needs to Be DoneHsu Y.-C.; Tseng C.-H.; JIA-HORNG KAO Clinical Gastroenterology and Hepatology1
2752019The Role of Hepatitis B Surface Antigen in Nucleos(t)ide Analogue Cessation Among Asian Chronic Hepatitis B Patients: Friend or Foe?Wang C.-C.; JIA-HORNG KAO Hepatology1
2762019HighlightsJIA-HORNG KAO Journal of the Formosan Medical Association0
2772019HighlightsJIA-HORNG KAO Journal of the Formosan Medical Association0
2782019HighlightsJIA-HORNG KAO Journal of the Formosan Medical Association0
2792019Real-world anti-viral treatment decisions among chronic hepatitis C patients in Taiwan: The INITIATE studyLiu C.-H.; Yu M.-L.; Peng C.-Y.; Hsieh T.-Y.; Huang Y.-H.; Su W.-W.; Cheng P.-N.; Lin C.-L.; Lo C.-C.; Chen C.-Y.; Chen J.-J.; Ma Q.; Brooks-Rooney C.; JIA-HORNG KAO Journal of the Formosan Medical Association7
2802019Expression of Metastatic Tumor Antigen 1 Splice Variant Correlates With Early Recurrence and Aggressive Features of Hepatitis B Virus–Associated Hepatocellular CarcinomaLi Y.-T.; Wu H.-L.; JIA-HORNG KAO ; Cheng H.-R.; Ho M.-C.; Wang C.-C.; Chen P.-J.; Chen D.-S.; Liu C.-J.Hepatology2
2812019Real-world effectiveness and safety of glecaprevir/pibrentasvir in Asian patients with chronic hepatitis CHsu S.-J.; Chiu M.-C.; Fang Y.-J.; Yang T.-H.; Yu J.-J.; Chen C.-C.; Kuo C.-C.; Lee J.-Y.; Chen C.-H.; Chen D.-S.; JIA-HORNG KAO Journal of the Formosan Medical Association8
2822019Clinical evaluation of IntelliPlexTM HCV genotyping kit for hepatitis C virus genotypingJIA-HORNG KAO ; Lin C.-Y.; Chuang W.-L.; Cheng Y.-Y.; Hu J.-Y.; Liang W.-K.; Friebe P.; Palmer S.; Huang C.-S.Diagnostic Microbiology and Infectious Disease0
2832019Letter: contraindicated drug-drug interactions before and after initiation of direct-acting anti-viral agents in chronic hepatitis C patients in Taiwan. Authors’ replyLiu C.-H.; JIA-HORNG KAO Alimentary Pharmacology and Therapeutics0
2842019HighlightsJIA-HORNG KAO Journal of the Formosan Medical Association0
2852019HighlightsJIA-HORNG KAO Journal of the Formosan Medical Association0
2862019HighlightsJIA-HORNG KAO Journal of the Formosan Medical Association0
2872019HighlightsJIA-HORNG KAO Journal of the Formosan Medical Association0
2882019High Level of Hepatitis B Core–Related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral LoadTseng T.-C.; Liu C.-J.; Hsu C.-Y.; Hong C.-M.; Su T.-H.; Yang W.-T.; Chen C.-L.; Yang H.-C.; Huang Y.-T.; Fang-Tzu Kuo S.; Liu C.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO Gastroenterology35
2892019Nucleos(t)ide analogues in patients with chronic hepatitis B: To stop or not to stop?JIA-HORNG KAO ; Berg T.Gut3
2902019HighlightsJIA-HORNG KAO Journal of the Formosan Medical Association0
2912019Direct-acting antivirals in East Asian hepatitis C patients: real-world experience from the REAL-C ConsortiumHuang C.-F.; Iio E.; Jun D.W.; Ogawa E.; Toyoda H.; Hsu Y.-C.; Haga H.; Iwane S.; Enomoto M.; Lee D.H.; Wong G.; Liu C.-H.; Tada T.; Chuang W.-L.; Cheung R.; Hayashi J.; Tseng C.-H.; Yasuda S.; Tran S.; Kam L.; Henry L.; Jeong J.Y.; Nomura H.; Park S.H.; Nakamuta M.; Huang J.-F.; Tai C.-M.; Lo G.-H.; Lee M.-H.; Yang H.-I.; JIA-HORNG KAO ; Tamori A.; Eguchi Y.; Ueno Y.; Furusyo N.; Tanaka Y.; Yu M.-L.; Nguyen M.H.; For the REAL-C InvestigatorsHepatology International21
2922019APASL HCV guidelines of virus-eradicated patients by DAA on how to monitor HCC occurrence and HBV reactivationKanda T.; Lau G.K.K.; Wei L.; Moriyama M.; Yu M.-L.; Chuang W.-L.; Ibrahim A.; Lesmana C.R.A.; Sollano J.; Kumar M.; Jindal A.; Sharma B.C.; Hamid S.S.; Kadir Dokmeci A.; Mamun-Al-Mahtab, McCaughan G.W.; Wasim J.; Crawford D.H.G.; JIA-HORNG KAO ; Ooka Y.; Yokosuka O.; Sarin S.K.; Omata M.Hepatology International25
2932019Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non-cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysisLiu C.-H.; Shih Y.-L.; Yang S.-S.; Lin C.-L.; Fang Y.-J.; Cheng P.-N.; Chen C.-Y.; Peng C.-Y.; Hsieh T.-Y.; Chiu Y.-C.; Su T.-H.; Liu C.-J.; Yang H.-C.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO Journal of Gastroenterology and Hepatology (Australia)3
2942019NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer stagingSu T.-H.; Liao S.-H.; Hong C.-M.; Liu C.-J.; Tseng T.-C.; Liu C.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chen C.-L.; Adhoute X.; Bourli?re M.; JIA-HORNG KAO Journal of Gastroenterology and Hepatology (Australia)1
2952019Sofosbuvir-based direct acting antiviral therapies for patients with hepatitis C virus genotype 2 infectionLiu C.-H.; Su T.-H.; Liu C.-J.; Hong C.-M.; Yang H.-C.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO Journal of Gastroenterology and Hepatology (Australia)11
2962019Antiviral Therapy in Patients With Chronic Hepatitis C Is Associated With a Reduced Risk of ParkinsonismSu T.-H.; Yang H.-C.; Tseng T.-C.; Chou S.-W.; Lin C.-H.; Liu C.-H.; Liu C.-J.; Chen C.-L.; JIA-HORNG KAO Movement Disorders5
2972019HighlightsJIA-HORNG KAO Journal of the Formosan Medical Association0
2982019HighlightsJIA-HORNG KAO Journal of the Formosan Medical Association0
2992019HighlightsJIA-HORNG KAO Journal of the Formosan Medical Association0
3002018Induced pluripotent stem cell-derived endothelial progenitor cells attenuate ischemic acute kidney injury and cardiac dysfunctionShen, Wen-Ching; YU-HSIANG CHOU; HSIANG-PO HUANG; Sheen, Jenn-Feng; Hung, Shih-Chieh; HSIN-FU CHEN Stem cell research & therapy 1417
3012018Timely diagnosis and treatment of sleep apnea reduce cardiovascular sequelae in patients with myocardial infarctionLin, Ming Tzer; CHAO-LUN LAI ; PEI-LIN LEE; Shen, Min Huei; Chong-Jen Yu; CHI-TAI FANG; CHI-LING CHEN PLoS ONE 214
3022018Outcomes of research biopsies in clinical trials of EGFR mutation-positive non-small cell lung cancer patients pretreated with EGFR-tyrosine kinase inhibitorsLiao B.-C.; PAN-CHYR YANG et al. Journal of the Formosan Medical Association97
30320182-anilino-4-amino-5-aroylthiazole-type compound AS7128 inhibits lung cancer growth through decreased iASPP and p53 interactionCheng H.-W.; PAN-CHYR YANG et al. Cancer Science11
3042018Trajectories of caregiver burden and related factors in family caregivers of patients with lung cancerLee Y.-H.; PAN-CHYR YANG et al. Psycho-Oncology1211
3052018FAM198B is associated with prolonged survival and inhibits metastasis in lung adenocarcinoma via blockage of ERK-Mediated MMP-1 expressionHsu C.-Y.; PAN-CHYR YANG et al. Clinical Cancer Research910
3062018Epidermal growth factor receptor mutation predicts favorable outcomes in non-small cell lung cancer patients with brain metastases treated with stereotactic radiosurgeryYang W.-C.; PAN-CHYR YANG et al. Radiotherapy and Oncology1412
3072018The Definition, Regulation and Prevention of Research MisconductDANIEL FU-CHANG TSAI ; Yu-Chen JuangFormosan Journal of Medicine00
3082018迎向活力老化DANIEL FU-CHANG TSAI Health World = 健康世界
3092018Reflections on the research misconduct cases in East AsiaDANIEL FU-CHANG TSAI East Asian Science, Technology and Society00
3102018Serum levels of fetuin-A are negatively associated with log transformation levels of thyroid-stimulating hormone in patients with hyperthyroidism or euthyroidism: An observational study at a medical center in TaiwanTseng F.-Y.; Chen Y.-T.; Chi Y.-C.; Chen P.-L.; WEI-SHIUNG YANG Medicine (United States)2
3112018Identification of a novel LDLR disease-causing variant using capture-based next-generation sequencing screening of familial hypercholesterolemia patients in TaiwanHsiung Y.-C.; Lin P.-C.; Chen C.-S.; Tung Y.-C.; WEI-SHIUNG YANG ; Chen P.-L.; Su T.-C.Atherosclerosis6
3122018Thyrotropin receptor antibodies and a genetic hint in antithyroid drug-induced adverse drug reactionsChang L.-C.; Chang C.-C.; Chen P.-L.; Wang S.-H.; Chen Y.-H.; Tsai Y.-H.; Shih S.-R.; Chiu W.-Y.; Fann C.S.-J.; WEI-SHIUNG YANG ; Chang T.-C.Expert Opinion on Drug Safety3
3132018One-year weight management lowers lipopolysaccharide-binding protein and its implication in metainflammation and liver fibrosisNien H.-C.; Sheu J.-C.; Chi Y.-C.; Chen C.-L.; Kao J.-H.; WEI-SHIUNG YANG PLoS ONE2
3142018Blood Glucose Management of Type 2 Diabetes in the Older PeopleChen W.-C.; Lee C.-C.; Chien M.-N.; Liu S.-C.; Wang C.-H.; WEI-SHIUNG YANG International Journal of Gerontology9
31520182018 consensus of the Taiwan Society of Cardiology and the Diabetes Association of Republic of China (Taiwan) on the pharmacological management of patients with type 2 diabetes and cardiovascular diseasesChiang C.-E.; Lin S.-Y.; Lin T.-H.; Wang T.-D.; Yeh H.-I.; Chen J.-F.; Tsai C.-T.; Hung Y.-J.; Li Y.-H.; Liu P.-Y.; Chang K.-C.; Wang K.-L.; Chao T.-H.; Shyu K.-G.; WEI-SHIUNG YANG ; Ueng K.-C.; Chu P.-H.; Yin W.-H.; Wu Y.-W.; Cheng H.-M.; Shin S.-J.; Huang C.-N.; Chuang L.-M.; Lin S.-J.; Yeh S.-J.; Sheu W.H.-H.; Lin J.-L.Journal of the Chinese Medical Association13
3162018Difference between observed and predicted glycated hemoglobin at baseline and treatment response to vildagliptin-based dual oral therapy in patients with type 2 diabetesWang J.-S.; Hung Y.-J.; Lu Y.-C.; Tsai C.-L.; WEI-SHIUNG YANG ; Lee T.-I.; Hsiao Y.-C.; Sheu W.H.-H.Diabetes Research and Clinical Practice5
3172018Increased pancreatic echogenicity with Us: Relationship to glycemic progression and incident diabetesHung C.-S.; Tseng P.-H.; Tu C.-H.; Chen C.-C.; Liao W.-C.; Lee Y.-C.; Chiu H.-M.; Lin H.-J.; WEI-SHIUNG YANG ; Chen M.-F.; Wu M.-S.Radiology12
3182018Association between frailty and a measure of cognition: a cross-sectional study on community-dwelling older adultsHsueh J.-T.; Peng T.-C.; Chen W.-L.; Wu L.-W.; Chang Y.-W.; WEI-SHIUNG YANG ; Kao T.-W.European Geriatric Medicine2
3192018Resistance Training Improves Muscle Function and Cardiometabolic Risks but Not Quality of Life in Older People with Type 2 Diabetes Mellitus: A Randomized Controlled TrialHsieh P.-L.; Tseng C.-H.; Tseng Y.J.; WEI-SHIUNG YANG Journal of Geriatric Physical Therapy14
3202018Comprehensive human leukocyte antigen genotyping of patients with type 1 diabetes mellitus in TaiwanTung Y.-C.; Fann C.S.-J.; Chang C.-C.; Chu C.-C.; WEI-SHIUNG YANG ; Hwu W.-L.; Chen P.-L.; Tsai W.-Y.Pediatric Diabetes2
3212018The influence of alendronate and tooth extraction on the incidence of osteonecrosis of the jaw among osteoporotic subjectsChiu W.-Y.; WEI-SHIUNG YANG ; Chien J.-Y.; Lee J.-J.; Tsai K.-S.PLoS ONE10
3222018Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational studyLiu C.-H.; Huang Y.-J.; Yang S.-S.; Chang C.-H.; Yang S.-S.; Sun H.-Y.; Liu C.-J.; Liu W.-C.; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; PEI-JER CHEN ; Chen D.-S.; Hung C.-C.; Kao J.-H.Scientific Reports19
3232018Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in TaiwanLiu C.-H.; Liu C.-J.; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; PEI-JER CHEN ; Chen D.-S.; Kao J.-H.PLoS ONE5
3242018Evaluation of SH-SAW Biosensor in Whole BloodKano K.; Huang Y.-Q.; Kogai T.; Huang Y.-T.; Yatsuda H.; PEI-JER CHEN ; Liu S.-H.IEEE International Ultrasonics Symposium, IUS0
3252018Efficacy of Ledipasvir and Sofosbuvir Treatment of HCV Infection in Patients Coinfected With HBVLiu C.-J.; Chuang W.-L.; Sheen I.-S.; Wang H.-Y.; Chen C.-Y.; Tseng K.-C.; Chang T.-T.; Massetto B.; Yang J.C.; Yun C.; Knox S.J.; Osinusi A.; Camus G.; Jiang D.; Brainard D.M.; McHutchison J.G.; Hu T.-H.; Hsu Y.-C.; Lo G.-H.; Chu C.-J.; Chen J.-J.; Peng C.-Y.; Chien R.-N.; PEI-JER CHEN Gastroenterology66
3262018Boceprevir-based triple therapy to rescue HCV genotype 1/HBV dually infected patients refractory to peginterferon plus ribavirin combination therapy in TaiwanHsieh M.-H.; Yeh M.-L.; Su T.-H.; Liu T.-W.; Huang C.-F.; Huang C.-I.; Wang S.-C.; Huang J.-F.; Dai C.-Y.; Kao J.-H.; Chuang W.-L.; PEI-JER CHEN ; Liu C.-J.; Yu M.-L.Journal of the Formosan Medical Association4
3272018Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfectionLiu C.-H.; Sun H.-Y.; Liu C.-J.; Sheng W.-H.; Hsieh S.-M.; Lo Y.-C.; Liu W.-C.; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; PEI-JER CHEN ; Chen D.-S.; Hung C.-C.; Kao J.-H.Alimentary Pharmacology and Therapeutics17
3282018Quantification of HBV core antibodies may help predict HBV reactivation in patients with lymphoma and resolved HBV infectionYang H.-C.; Tsou H.-H.; Pei S.-N.; Chang C.-S.; Chen J.-H.; Yao M.; Lin S.-J.; Lin J.; Yuan Q.; Xia N.; Liu T.-W.; PEI-JER CHEN ; Cheng A.-L.; Hsu C.; Taiwan Cooperative Oncology GroupJournal of Hepatology38
3292018Vaccine-induced antigen-specific regulatory T cells attenuate the antiviral immunity against acute influenza virus infectionLin P.-H.; Wong W.-I.; Wang Y.-L.; Hsieh M.-P.; Lu C.-W.; Liang C.-Y.; Jui S.-H.; Wu F.-Y.; PEI-JER CHEN ; Yang H.-C.Mucosal Immunology20
3302018Fibrosis-4 index predicts cirrhosis risk and liver-related mortality in 2075 patients with chronic HBV infectionTseng T.-C.; Liu C.-J.; Su T.-H.; Yang W.-T.; Chen C.-L.; Yang H.-C.; Kuo S.F.-T.; Liu C.-H.; PEI-JER CHEN ; Chen D.-S.; Kao J.-H.Alimentary Pharmacology and Therapeutics13
3312018Acoustic radiation force impulse US imaging: Liver stiffness in patients with chronic hepatitis B with and without antiviral therapySu T.-H.; Liao C.-H.; Liu C.-H.; Huang K.-W.; Tseng T.-C.; Yang H.-C.; Liu C.-J.; PEI-JER CHEN ; Chen D.-S.; Kao J.-H.Radiology4
3322018Distinct Relapse Rates and Risk Predictors after Discontinuing Tenofovir and Entecavir TherapySu T.-H.; Yang H.-C.; Tseng T.-C.; Liou J.-M.; Liu C.-H.; Chen C.-L.; PEI-JER CHEN ; Chen D.-S.; Liu C.-J.; Kao J.-H.Journal of Infectious Diseases32
3332018The unique antibody suppresses HBV viremia and reduces hepatocarcinogenesis in HBV-transgenic miceKang X.-Z.; Guo X.-R.; Chen B.-B.; Zhang T.-Y.; Yuan Q.; PEI-JER CHEN ; Zhang J.; Xia N.-S.Human Vaccines and Immunotherapeutics2
3342018A research agenda for curing chronic hepatitis B virus infectionAlter H.; Block T.; Brown N.; Brownstein A.; Brosgart C.; Chang K.-M.; PEI-JER CHEN ; Chisari F.V.; Cohen C.; El-Serag H.; Feld J.; Gish R.; Glenn J.; Greten T.; Guo H.; Guo J.-T.; Hoshida Y.; Hu J.; Kowdley K.V.; Li W.; Liang J.; Locarnini S.; Lok A.S.; Mason W.; McMahon B.; Mehta A.; Perrillo R.; Revill P.; Rice C.M.; Rinaudo J.; Schinazi R.; Seeger C.; Shetty K.; Tavis J.; Zoulim F.Hepatology43
3352018Research priorities for the discovery of a cure for chronic hepatitis B: Report of a workshopBlock T.M.; Alter H.; Brown N.; Brownstein A.; Brosgart C.; Chang K.-M.; PEI-JER CHEN ; Cohen C.; El-Serag H.; Feld J.; Gish R.; Glenn J.; Greten T.F.; Guo J.-T.; Hoshida Y.; Kowdley K.V.; Li W.; Lok A.S.; McMahon B.; Mehta A.; Perrillo R.; Rice C.M.; Rinaudo J.; Schinazi R.F.; Shetty K.Antiviral Research13
3362018Real-world effectiveness and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with or without ribavirin for patients with chronic hepatitis C virus genotype 1b infection in TaiwanLiu C.-H.; Liu C.-J.; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; PEI-JER CHEN ; Chen D.-S.; Kao J.-H.Journal of Gastroenterology and Hepatology (Australia)19
3372018A noninvasive diagnosis of hepatic fibrosis by BioFibroScore? in chronic hepatitis C patientsLiu C.-H.; Liu C.-J.; Hong C.-M.; Su T.-H.; Yang H.-C.; Chen K.-M.; Huang Y.-P.; Yeh Y.-M.; Tien H.-L.; Liu Y.-C.; Kao J.-H.; Chen D.-S.; PEI-JER CHEN Journal of Gastroenterology and Hepatology (Australia)12
3382018Sofosbuvir-based Interferon-Free Direct Acting Antiviral Regimens for Heart Transplant Recipients with Chronic Hepatitis C Virus InfectionLiu C.-H.; Chen Y.-S.; Wang S.-S.; Liu C.-J.; Su T.-H.; Yang H.-C.; Hong C.-M.; PEI-JER CHEN ; Chen D.-S.; Kao J.-H.Clinical Infectious Diseases18
3392018Targeting histone deacetylase 4/ubiquitin-conjugating enzyme 9 impairs DNA repair for radiosensitization of hepatocellular carcinoma cells in miceTsai C.-L.; Liu W.-L.; Hsu F.-M.; Yang P.-S.; Yen R.-F.; Tzen K.-Y.; Cheng A.-L.; PEI-JER CHEN ; Cheng J.C.-H.Hepatology7
3402018Intracellular hepatitis B virus increases hepatic cholesterol deposition in alcoholic fatty liver via hepatitis B core proteinWang Y.; Wu T.; Hu D.; Weng X.; Wang X.; PEI-JER CHEN ; Luo X.; Wang H.; Ning Q.Journal of Lipid Research6
3412018The potential and challenges of CRISPR-Cas in eradication of hepatitis B virus covalently closed circular DNAYang H.-C.; PEI-JER CHEN Virus Research25
3422018Exploring new therapies for a serological cure of chronic hepatitis BHorng J.-H.; Wu C.-R.; PEI-JER CHEN Hepatitis B Virus and Liver Disease0
3432018Corrigendum to “Blockade of STAT3 activation by sorafenib derivatives through enhancing SHP-1 phosphatase activity” (Eur. J. Med. Chem. (2012) 55 (220–227)(S0223523412004497)(10.1016/j.ejmech.2012.07.023))Chen K.-F.; Tai W.-T.; Hsu C.-Y.; Huang J.-W.; Liu C.-Y.; PEI-JER CHEN ; Kim I.; Shiau C.-W.European Journal of Medicinal Chemistry1
3442018Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)PEI-LUNG CHEN Atherosclerosis73
3452018Serum levels of fetuin-A are negatively associated with log transformation levels of thyroid-stimulating hormone in patients with hyperthyroidism or euthyroidism: An observational study at a medical center in TaiwanTseng F.-Y.; Chen Y.-T.; Chi Y.-C.; PEI-LUNG CHEN ; Yang W.-S.Medicine (United States)2
3462018Unique spectra of deafness-associated mutations in Mongolians provide insights into the genetic relationships among Eurasian populationsErdenechuluun J.; Lin Y.-H.; Ganbat K.; Bataakhuu D.; Makhbal Z.; Tsai C.-Y.; Lin Y.-H.; Chan Y.-H.; Hsu C.-J.; Hsu W.-C.; PEI-LUNG CHEN ; Wu C.-C.PLoS ONE3
3472018The Lupus-Associated Fcγ Receptor IIb–I232T Polymorphism Results in Impairment in the Negative Selection of Low-Affinity Germinal Center B Cells Via c-Abl in MiceJhou J.-P.; Yu I.-S.; Hwai H.; Chen C.-S.; PEI-LUNG CHEN ; Tzeng S.-J.Arthritis and Rheumatology1
3482018Identification of a novel LDLR disease-causing variant using capture-based next-generation sequencing screening of familial hypercholesterolemia patients in TaiwanHsiung Y.-C.; Lin P.-C.; Chen C.-S.; Tung Y.-C.; Yang W.-S.; PEI-LUNG CHEN ; Su T.-C.Atherosclerosis6
3492018Thyrotropin receptor antibodies and a genetic hint in antithyroid drug-induced adverse drug reactionsChang L.-C.; Chang C.-C.; PEI-LUNG CHEN ; Wang S.-H.; Chen Y.-H.; Tsai Y.-H.; Shih S.-R.; Chiu W.-Y.; Fann C.S.-J.; Yang W.-S.; Chang T.-C.Expert Opinion on Drug Safety3
3502018A 1204-single nucleotide polymorphism and insertion–deletion polymorphism panel for massively parallel sequencing analysis of DNA mixturesHwa H.-L.; Chung W.-C.; PEI-LUNG CHEN ; Lin C.-P.; Li H.-Y.; Yin H.-I.; Lee J.C.-I.Forensic Science International: Genetics16
3512018Oncogenic Function of a KIF5B-MET Fusion Variant in Non-Small Cell Lung CancerGow C.-H.; Liu Y.-N.; Li H.-Y.; Hsieh M.-S.; Chang S.-H.; Luo S.-C.; Tsai T.-H.; PEI-LUNG CHEN ; Tsai M.-F.; Shih J.-Y.Neoplasia (United States)12
3522018Comprehensive human leukocyte antigen genotyping of patients with type 1 diabetes mellitus in TaiwanTung Y.-C.; Fann C.S.-J.; Chang C.-C.; Chu C.-C.; Yang W.-S.; Hwu W.-L.; PEI-LUNG CHEN ; Tsai W.-Y.Pediatric Diabetes2
3532018Using Ion Torrent sequencing to study genetic mutation profiles of fatal thyroid cancersLu J.-Y.; Cheng W.-C.; Chen K.-Y.; Lin C.-C.; Chang C.-C.; Kuo K.-T.; PEI-LUNG CHEN Journal of the Formosan Medical Association1
3542018Prediction Model for Audiological Outcomes in Patients with GJB2 MutationsChen P.-Y.; Lin Y.-H.; Liu T.-C.; Lin Y.-H.; Tseng L.-H.; Yang T.-H.; PEI-LUNG CHEN ; Wu C.-C.; Hsu C.-J.Ear and Hearing2
3552018ABO genotyping with next-generation sequencing to resolve heterogeneity in donors with serology discrepanciesWu P.C.; Lin Y.-H.; Tsai L.F.; Chen M.H.; PEI-LUNG CHEN ; Pai S.-C.Transfusion17
3562018Population-based cohort study reveals distinct associations between female lung cancer and breast cancer in TaiwanLin E.P.-Y.; Lin C.-H.; Yang C.-Y.; Lu T.-P.; Chang S.-N.; Hsiao T.-H.; Huang B.-T.; Yu C.-J.; Arnold Chan K.; PAN-CHYR YANG JCO Clinical Cancer Informatics23
3572018Mutational monitoring of EGFR T790M in cfDNA for clinical outcome prediction in EGFR-mutant lung adenocarcinomaSu K.-Y.; Tseng J.-S.; Liao K.-M.; Yang T.-Y.; Chen K.-C.; Hsu K.-H.; PAN-CHYR YANG ; Yu S.-L.; Chang G.-C.PLoS ONE78
3582018Correction: Combining MAD and CPAP as an effective strategy for treating patients with severe sleep apnea intolerant to high-pressure PAP and unresponsive to MADLiu, Hsiang-Wen; Chen, Yunn-Jy; Lai, Yi-Chun; Huang, Ching-Yi; Huang, Ya-Ling; Lin, Ming-Tzer; Han, Sung-Ying; CHI-LING CHEN ; Chong-Jen Yu; PEI-LIN LEEPloS one00
3592018A simple and efficient feeder-free culture system to up-scale iPSCs on polymeric material surface for use in 3D bioprintingWong C.-W.; YOU-TZUNG CHEN ; Chien C.-L.; Yu T.-Y.; Rwei S.-P.; Hsu S.-H.Materials Science and Engineering C46
3602018Correction: Combining MAD and CPAP as an effective strategy for treating patients with severe sleep apnea intolerant to high-pressure PAP and unresponsive to MADLiu, Hsiang-Wen; Chen, Yunn-Jy; Lai, Yi-Chun; Huang, Ching-Yi; Huang, Ya-Ling; Lin, Ming-Tzer; Han, Sung-Ying; CHI-LING CHEN ; Chong-Jen Yu; Lee, Pei-LinPloS one00
3612018Translating gene signatures into a pathologic feature: Tumor necrosis predicts disease relapse in operable and stage I lung adenocarcinomaLin E.P.; Hsiao T.-H.; Lu J.; Wong S.-H.; Lu T.-P.; Peck K.; Takahashi T.; PAN-CHYR YANG JCO Precision Oncology2
3622018Generation of induced pluripotent stem cells from a patient with hearing loss carrying GJB2 p.V37I mutationChan Y.-H.; Cheng Y.-F.; YOU-TZUNG CHEN ; Huang C.-Y.; Lin C.-H.; Hu C.-J.; Lu Y.-C.; Wu C.-C.; Hsu C.-J.Stem Cell Research11
3632018Application of three-dimensional collagen scaffolds to recapitulate and monitor the dynamics of epithelial-mesenchymal transition during tumor satellite formation of head and neck cancerChen C.-N.; YOU-TZUNG CHEN ; Yang T.-L.Biomaterials65
3642018Facilitating In Vivo Articular Cartilage Repair by Tissue-Engineered Cartilage Grafts Produced From Auricular ChondrocytesWong C.-C.; Chen C.-H.; Chiu L.-H.; Tsuang Y.-H.; Bai M.-Y.; Chung R.-J.; Lin Y.-H.; Hsieh F.-J.; YOU-TZUNG CHEN ; Yang T.-L.American Journal of Sports Medicine78
3652018A comprehensive characterization of aggravated aging-related changes in T lymphocytes and monocytes in end-stage renal disease: the iESRD studyChiu, Yen-Ling; Shu, Kai-Hsiang; Yang, Feng-Jung; Chou, Tzu-Ying; Chen, Ping-Min; Lay, Fang-Yun; Pan, Szu-Yu; Lin, Cheng-Jui; Litjens, Nicolle H R; Betjes, Michiel G H; Bermudez, Selma; Kao, Kung-Chi; JEAN-SAN CHIA ; Wang, George; Peng, Yu-Sen; Chuang, Yi-FangImmunity & ageing : I & A2024
3662018Prospects of Primary Ovarian Insufficiency Patient-Specific Pluripotent Stem Cells for Disease Modeling and Clinical ImpactsHSIN-FU CHEN ; HONG-NERNG HOCURRENT WOMENS HEALTH REVIEWS 01
3672018Targeting Tumor Microenvironment by Bioreduction-Activated Nanoparticles for Light-Triggered VirotherapyTseng S.-J.; Kempson I.M.; Huang K.-Y.; Li H.-J.; Fa Y.-C.; Ho Y.-C.; Liao Z.-X.; PAN-CHYR YANG ACS Nano2831
3682018A systematic review and meta-analysis comparing liver resection with the Rf-based device habib?-4X with the clamp-crush techniqueJayant K.; Sodergren M.H.; Reccia I.; Kusano T.; Zacharoulis D.; Spalding D.; Pai M.; Jiao L.R.; KAI-WEN HUANG Cancers35
3692018Magnetic tools for medical diagnosisChieh J.-J.; Liao S.-H.; Wang L.-M.; KAI-WEN HUANG ; Yang H.-C.; Horng H.-E.Nanotechnology Characterization Tools for Biosensing and Medical Diagnosis00
3702018Comparison of Radiofrequency Ablation and Transarterial Chemoembolization for Hepatocellular Carcinoma in the Caudate LobeLee B.-C.; Liu K.-L.; Wu C.-H.; KAI-WEN HUANG ; Ho C.-M.; Hu R.-H.; Ho M.-C.; Wu Y.-M.; Lee P.-H.; Liang P.-C.CardioVascular and Interventional Radiology46
3712018Gene activation of CEBPA using saRNA: Preclinical studies of the first in human saRNA drug candidate for liver cancerReebye V.; KAI-WEN HUANG ; Lin V.; Jarvis S.; Cutilas P.; Dorman S.; Ciriello S.; Andrikakou P.; Voutila J.; Saetrom P.; Mintz P.J.; Reccia I.; Rossi J.J.; Huber H.; Habib R.; Kostomitsopoulos N.; Blakey D.C.; Habib N.A.Oncogene2426
3722018Validation of Assaying Carcinoembryonic Antigen in Human Serum by Using Immunomagnetic ReductionWei P.-L.; Lee L.-T.; Tseng L.-M.; KAI-WEN HUANG Scientific Reports14
3732018Is the evolution in tumors Darwinian or non-Darwinian?HURNG-YI WANG ; Chen Y.; Tong D.; Ling S.; Hu Z.; Tao Y.; Lu X.; Wu C.-I.National Science Review915
3742018The efficacy of combination of induction chemotherapy and irreversible electroporation ablation for patients with locally advanced pancreatic adenocarcinomaKAI-WEN HUANG ; Yang P.-C.; Pua U.; Kim M.-D.; Li S.-P.; Qiu Y.-D.; Song T.-Q.; Liang P.-C.Journal of Surgical Oncology1823
3752018On the low reproducibility of cancer studiesWen H.; HURNG-YI WANG ; He X.; Wu C.-I.National Science Review1219
3762018家庭醫師給熟齡族的健康叮嚀DANIEL FU-CHANG TSAI Health World = 健康世界
3772018Acoustic radiation force impulse US imaging: Liver stiffness in patients with chronic hepatitis B with and without antiviral therapySu T.-H.; Liao C.-H.; Liu C.-H.; KAI-WEN HUANG ; Tseng T.-C.; Yang H.-C.; Liu C.-J.; Chen P.-J.; Chen D.-S.; Kao J.-H.Radiology54
3782018A novel photodynamic therapy-based drug delivery system layered on a stent for treating cholangiocarcinomaLiang P.-C.; KAI-WEN HUANG ; Tung C.-C.; Chang M.-C.; Chang F.-Y.; Wong J.-M.; Chang Y.-T.Biomedical Microdevices22
3792018Incidence of hepatitis B virus infection in young Chinese blood donors born after mandatory implementation of neonatal hepatitis B vaccination nationwideTang X.; Allain J.-P.; HURNG-YI WANG ; Rong X.; Chen J.; Huang K.; Xu R.; Wang M.; Huang J.; Liao Q.; Shan Z.; Luo S.; Li T.; Li C.; Fu Y.Journal of Viral Hepatitis34
3802018Ethical Issues in Health Databases and Biobanks ResearchYu-Chen Juang; DANIEL FU-CHANG TSAI Formosan Journal of Medicine00
3812018Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational studyLiu C.-H.; Huang Y.-J.; Yang S.-S.; Chang C.-H.; Yang S.-S.; Sun H.-Y.; Liu C.-J.; Liu W.-C.; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Hung C.-C.; JIA-HORNG KAO Scientific Reports19
3822018Comorbidities, concomitant medications and potential drug-drug interactions with interferon-free direct-acting antiviral agents in hepatitis C patients in TaiwanLiu C.-H.; Yu M.-L.; Peng C.-Y.; Hsieh T.-Y.; Huang Y.-H.; Su W.-W.; Cheng P.-N.; Lin C.-L.; Lo C.-C.; Chen C.-Y.; Chen J.-J.; Ma Q.; Brooks-Rooney C.; JIA-HORNG KAO Alimentary Pharmacology and Therapeutics26
3832018Sofosbuvir and ledipasvir are associated with high sustained virologic response and improvement of health-related quality of life in East Asian patients with hepatitis C virus infectionYounossi Z.M.; Stepanova M.; Henry L.; Han K.-H.; Ahn S.H.; Lim Y.-S.; Chuang W.-L.; JIA-HORNG KAO ; Nguyen K.V.; Lai C.L.; Chan H.L.-Y.; Wei L.Journal of Viral Hepatitis9
3842018Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in TaiwanLiu C.-H.; Liu C.-J.; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO PLoS ONE5
3852018A novel spontaneous hepatocellular carcinoma mouse model for studying T-cell exhaustion in the tumor microenvironmentLiu Y.-T.; Tseng T.-C.; Soong R.-S.; Peng C.-Y.; Cheng Y.-H.; Huang S.-F.; Chuang T.-H.; JIA-HORNG KAO ; Huang L.-R.Journal for ImmunoTherapy of Cancer11
3862018Serine/threonine protein phosphatase 5 is a potential therapeutic target in cholangiocarcinomaHu M.-H.; Huang T.-T.; Chao T.-I.; Chen L.-J.; Chen Y.-L.; Tsai M.-H.; Liu C.-Y.; JIA-HORNG KAO ; Chen K.-F.Liver International4
3872018Sarcopenia and chronic liver diseasesHsu C.-S.; JIA-HORNG KAO Expert Review of Gastroenterology and Hepatology30
3882018HighlightsJIA-HORNG KAO Journal of the Formosan Medical Association0
3892018Hepatitis b virus–specific t cells associate with viral control upon nucleos(t)ide-analogue therapy discontinuationRivino L.; Le Bert N.; Gill U.S.; Kunasegaran K.; Cheng Y.; Tan D.Z.M.; Becht E.; Hansi N.K.; Foster G.R.; Su T.-H.; Tseng T.-C.; Lim S.G.; JIA-HORNG KAO ; Newell E.W.; Kennedy P.T.F.; Bertoletti A.Journal of Clinical Investigation85
3902018A noninvasive diagnosis of hepatic fibrosis by BioFibroScore? in chronic hepatitis C patientsLiu C.-H.; Liu C.-J.; Hong C.-M.; Su T.-H.; Yang H.-C.; Chen K.-M.; Huang Y.-P.; Yeh Y.-M.; Tien H.-L.; Liu Y.-C.; JIA-HORNG KAO ; Chen D.-S.; Chen P.-J.Journal of Gastroenterology and Hepatology (Australia)12
3912018Sofosbuvir-based Interferon-Free Direct Acting Antiviral Regimens for Heart Transplant Recipients with Chronic Hepatitis C Virus InfectionLiu C.-H.; Chen Y.-S.; Wang S.-S.; Liu C.-J.; Su T.-H.; Yang H.-C.; Hong C.-M.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO Clinical Infectious Diseases18
3922018Hepatitis B virus and liver diseaseJIA-HORNG KAO ; Chen D.-S.Hepatitis B Virus and Liver Disease0
3932018PrefaceJIA-HORNG KAO ; Chen D.-S.Hepatitis B Virus and Liver Disease0
3942018HighlightsJIA-HORNG KAO Journal of the Formosan Medical Association0
3952018Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfectionLiu C.-H.; Sun H.-Y.; Liu C.-J.; Sheng W.-H.; Hsieh S.-M.; Lo Y.-C.; Liu W.-C.; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Hung C.-C.; JIA-HORNG KAO Alimentary Pharmacology and Therapeutics17
3962018The effect of interferon-free regimens on health-related quality of life in East Asian patients with chronic hepatitis CYounossi Z.M.; Stepanova M.; Henry L.; Han K.-H.; Ahn S.H.; Lim Y.-S.; Chuang W.-L.; JIA-HORNG KAO ; Kinh N.; Lai C.L.; Yuen M.-F.; Chan H.L.-Y.; Lai W.Liver International8
3972018Phase IV randomized clinical study: Peginterferon alfa-2a with adefovir or entecavir pre-therapy for HBeAg-positive chronic hepatitis BHsu C.-W.; Su W.-W.; Lee C.-M.; Peng C.-Y.; Chuang W.-L.; JIA-HORNG KAO ; Chu H.-C.; Huang Y.-H.; Chien R.-N.; Liaw Y.-F.Journal of the Formosan Medical Association16
3982018Fibrosis-4 index predicts cirrhosis risk and liver-related mortality in 2075 patients with chronic HBV infectionTseng T.-C.; Liu C.-J.; Su T.-H.; Yang W.-T.; Chen C.-L.; Yang H.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO Alimentary Pharmacology and Therapeutics13
3992018Acoustic radiation force impulse US imaging: Liver stiffness in patients with chronic hepatitis B with and without antiviral therapySu T.-H.; Liao C.-H.; Liu C.-H.; Huang K.-W.; Tseng T.-C.; Yang H.-C.; Liu C.-J.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO Radiology4
4002018Twelve-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin for non-cirrhotic HCV genotype 1 patients: A phase 2 studyJIA-HORNG KAO ; Yu M.-L.; Chen C.-Y.; Peng C.-Y.; Chen M.-Y.; Tang H.; Chen Q.; Wu J.J.Journal of Gastroenterology and Hepatology (Australia)10
4012018Review article: the prevention of hepatitis B-related hepatocellular carcinomaLin C.-L.; JIA-HORNG KAO Alimentary Pharmacology and Therapeutics22
4022018HighlightsJIA-HORNG KAO Journal of the Formosan Medical Association0
4032018HighlightsJIA-HORNG KAO Journal of the Formosan Medical Association0
4042018Glecaprevir/Pibrentasvir Treatment in Liver or Kidney Transplant Patients With Hepatitis C Virus InfectionReau N.; Kwo P.Y.; Rhee S.; Brown R.S.; Jr.; Agarwal K.; Angus P.; Gane E.; JIA-HORNG KAO ; Mantry P.S.; Mutimer D.; Reddy K.R.; Tran T.T.; Hu Y.B.; Gulati A.; Krishnan P.; Dumas E.O.; Porcalla A.; Shulman N.S.; Liu W.; Samanta S.; Trinh R.; Forns X.Hepatology91
4052018Significance of definitions of relapse after discontinuation of oral antivirals in HBeAg-negative chronic hepatitis BPapatheodoridis G.V.; Manolakopoulos S.; Su T.-H.; Siakavellas S.; Liu C.-J.; Kourikou A.; Yang H.-C.; JIA-HORNG KAO Hepatology26
4062018Quantification of serum hepatitis B core antibody to predict off-entecavir relapse in patients with chronic hepatitis BTseng C.-H.; Hsu Y.-C.; Chang C.-Y.; Tseng T.-C.; Wu M.-S.; Lin J.-T.; JIA-HORNG KAO Journal of the Formosan Medical Association13
4072018One-year weight management lowers lipopolysaccharide-binding protein and its implication in metainflammation and liver fibrosisNien H.-C.; Sheu J.-C.; Chi Y.-C.; Chen C.-L.; JIA-HORNG KAO ; Yang W.-S.PLoS ONE2
4082018Hepatitis B: From control to cureJIA-HORNG KAO Journal of the Formosan Medical Association13
4092018HighlightsJIA-HORNG KAO Journal of the Formosan Medical Association0
4102018HighlightsJIA-HORNG KAO Journal of the Formosan Medical Association0
4112018HighlightsJIA-HORNG KAO Journal of the Formosan Medical Association0
4122018HighlightsJIA-HORNG KAO Journal of the Formosan Medical Association0
4132018Boceprevir-based triple therapy to rescue HCV genotype 1/HBV dually infected patients refractory to peginterferon plus ribavirin combination therapy in TaiwanHsieh M.-H.; Yeh M.-L.; Su T.-H.; Liu T.-W.; Huang C.-F.; Huang C.-I.; Wang S.-C.; Huang J.-F.; Dai C.-Y.; JIA-HORNG KAO ; Chuang W.-L.; Chen P.-J.; Liu C.-J.; Yu M.-L.Journal of the Formosan Medical Association4
4142018Real-world effectiveness and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with or without ribavirin for patients with chronic hepatitis C virus genotype 1b infection in TaiwanLiu C.-H.; Liu C.-J.; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO Journal of Gastroenterology and Hepatology (Australia)19
4152018Distinct Relapse Rates and Risk Predictors after Discontinuing Tenofovir and Entecavir TherapySu T.-H.; Yang H.-C.; Tseng T.-C.; Liou J.-M.; Liu C.-H.; Chen C.-L.; Chen P.-J.; Chen D.-S.; Liu C.-J.; JIA-HORNG KAO Journal of Infectious Diseases32
4162018HCC risk in patients with HBV-related cirrhosis receiving nucleos(t)ide analogues therapy: Is HCC prevented or delayed?Su T.-H.; Tseng T.-C.; JIA-HORNG KAO Hepatology8
4172018Prevention of mother-to-child transmission: the key of hepatitis B virus eliminationLin C.-L.; JIA-HORNG KAO Hepatology International4
4182018HighlightsJIA-HORNG KAO Journal of the Formosan Medical Association0
4192018HighlightsJIA-HORNG KAO Journal of the Formosan Medical Association0
4202018HighlightsJIA-HORNG KAO Journal of the Formosan Medical Association0
4212018HighlightsJIA-HORNG KAO Journal of the Formosan Medical Association0
4222017PARP1 controls KLF4-mediated telomerase expression in stem cells and cancer cellsHsieh, Meng-Hsun; Chen, Yi-Ting; You-Tzung Chen; Lee, Yi-Hsuan; Lu, Jean; CHUNG-LIANG CHIEN; HSIN-FU CHEN ; HONG-NERNG HO; Yu, Chia-Jung; Wang, Zhao-Qi; SHU-CHUN TENG Nucleic acids research 1920
4232017Genetic modifiers of progression-free survival in never-smoking lung adenocarcinoma patients treated with first-line tyrosine kinase inhibitorsChang I.-S.; PAN-CHYR YANG et al. American Journal of Respiratory and Critical Care Medicine810
4242017Phosphoproteomics Reveals HMGA1, a CK2 Substrate, as a Drug-Resistant Target in Non-Small Cell Lung CancerWang Y.-T.; PAN-CHYR YANG et al. Scientific Reports1616
4252017Final results of the large-scale multinational trial PROFILE 1005: Efficacy and safety of crizotinib in previously treated patients with advanced/metastatic ALK-positive non-small-cell lung cancerBlackhall F.; PAN-CHYR YANG et al. ESMO Open37
4262017Corrigendum: Daxx inhibits hypoxia-induced lung cancer cell metastasis by suppressing the HIF-1α/HDAC1/Slug axisLin C.-W.; PAN-CHYR YANG et al. Nature communications01
4272017Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2CChang T.-H.; PAN-CHYR YANG et al. Cancer Letters3431
4282017Gene expression of MAGE-A3 and PRAME tumor antigens and EGFR mutational status in Taiwanese non–small cell lung cancer patientsPan S.-H.; PAN-CHYR YANG et al. Asia-Pacific Journal of Clinical Oncology46
4292017Association between GWAS-identified lung adenocarcinoma susceptibility loci and EGFR mutations in never-smoking Asian women, and comparison with findings from Western populationsSeow W.J.; PAN-CHYR YANG et al. Human Molecular Genetics3540
4302017Broad Consent and Single Institutional Review Board(IRB) in Recent US Common Rule AmendmentKai-Jung Yuan; Yu-Chen Juang; Hsiang Chao; Tsung-Fu Chen; DANIEL FU-CHANG TSAI Formosan Journal of Medicine00
4312017Mobilizing transit-amplifying cell-derived ectopic progenitors prevents hair loss from chemotherapy or radiation therapyHuang W.-Y.; Lai S.-F.; Chiu H.-Y.; Chang M.; Plikus M.V.; Chan C.-C.; YOU-TZUNG CHEN ; Tsao P.-N.; Yang T.-L.; Lee H.-S.; Chi P.; Lin S.-J.Cancer Research1717
4322017Combining MAD and CPAP as an effective strategy for treating patients with severe sleep apnea intolerant to high-pressure PAP and unresponsive to MADLiu, Hsiang-Wen; Chen, Yunn-Jy; Lai, Yi-Chun; Huang, Ching-Yi; Huang, Ya-Ling; Lin, Ming-Tzer; Han, Sung-Ying; CHI-LING CHEN ; Chong-Jen Yu; Lee, Pei-LinPloS one1113
4332017Astrocyte-elevated gene-1 confers resistance to pemetrexed in non-small cell lung cancer by upregulating thymidylate synthase expressionChen C.-Y.; Chen Y.-Y.; Chen J.J.W.; Chen K.-Y.; Ho C.-C.; Shih J.-Y.; Chang Y.-L.; Yu C.-J.; PAN-CHYR YANG Oncotarget6
4342017Subcellular localization of survivin determines its function in cardiomyocytesTsang T.-J.; Hsueh Y.-C.; Wei E.I.; Lundy D.J.; Cheng B.; YOU-TZUNG CHEN ; Wang S.-S.; Hsieh P.C.H.Theranostics57
4352017A CTLA-4 Antagonizing DNA Aptamer with Antitumor EffectHuang B.-T.; Lai W.-Y.; Chang Y.-C.; Wang J.-W.; Yeh S.-D.; Lin E.P.-Y.; PAN-CHYR YANG Molecular Therapy - Nucleic Acids18
4362017Turning diversity toward precisionLin P.-Y.; Chen H.-Y.; Yu S.-L.; PAN-CHYR YANG Journal of the National Cancer Institute00
4372017PARP1 controls KLF4-mediated telomerase expression in stem cells and cancer cellsHsieh M.-H.; YOU-TZUNG CHEN ; YOU-TZUNG CHEN ; Lee Y.-H.; Lu J.; Chien C.-L.; Chen H.-F.; Ho H.-N.; Yu C.-J.; Wang Z.-Q.; Teng S.-C.Nucleic Acids Research1922
4382017Combining MAD and CPAP as an effective strategy for treating patients with severe sleep apnea intolerant to high-pressure PAP and unresponsive to MADLiu, Hsiang-Wen; Chen, Yunn-Jy; Lai, Yi-Chun; Huang, Ching-Yi; Huang, Ya-Ling; Lin, Ming-Tzer; Han, Sung-Ying; CHI-LING CHEN ; Chong-Jen Yu; PEI-LIN LEEPloS one1113
4392017AtlA Mediates Extracellular DNA Release, Which Contributes to Streptococcus mutans Biofilm Formation in an Experimental Rat Model of Infective EndocarditisJung, Chiau-Jing; RON-BIN HSU; CHIA-TUNG SHUN; Hsu, Chih-Chieh; JEAN-SAN CHIA Infection and immunity1716
4402017High PD-L1 expression is associated with stage IV disease and poorer overall survival in 186 cases of small cell lung cancersChang Y.-L.; Yang C.-Y.; Huang Y.-L.; Wu C.-T.; PAN-CHYR YANG Oncotarget3836
4412017Single-Stage Cartilage Repair Using Platelet-Rich Fibrin Scaffolds With Autologous Cartilaginous GraftsWong C.-C.; Chen C.-H.; Chan W.P.; Chiu L.-H.; Ho W.-P.; Hsieh F.-J.; YOU-TZUNG CHEN ; Yang T.-L.American Journal of Sports Medicine2221
4422017The data of establishing a three-dimensional culture system for in vitro recapitulation and mechanism exploration of tumor satellite formation during cancer cell transitionChen C.-N.; YOU-TZUNG CHEN ; Yang T.-L.Data in Brief2
4432017Comparative global immune-related gene profiling of somatic cells, human pluripotent stem cells and their derivatives: implication for human lymphocyte proliferationWu, Chia-Eng; Yu, Chen-Wei; Chang, Kai-Wei; Chou, Wen-Hsi; Lu, Chen-Yu; Ghelfi, Elisa; Wu, Fang-Chun; Jan, Pey-Shynan; Huang, Mei-Chi; Allard, Patrick; SHAU-PING LIN; HONG-NERNG HO; HSIN-FU CHEN Experimental & molecular medicine 33
4442017Risk of new-onset diabetes mellitus in primary aldosteronism: A population study over 5 yearsWu V.-C.; Chueh S.-C.J.; Chen L.; Chang C.-H.; Hu Y.-H.; Lin Y.-H.; Wu K.-D.; WEI-SHIUNG YANG Journal of Hypertension60
4452017Human serum RNase-L level is inversely associated with metabolic syndrome and ageWang Y.-T.; Tseng P.-H.; Chen C.-L.; Han D.-S.; Chi Y.-C.; Tseng F.-Y.; WEI-SHIUNG YANG Cardiovascular Diabetology3
4462017High serum lipopolysaccharide-binding protein level in chronic hepatitis C viral infection is reduced by anti-viral treatmentsNien H.-C.; Hsu S.-J.; Su T.-H.; Yang P.-J.; Sheu J.-C.; Wang J.-T.; Chow L.-P.; Chen C.-L.; Kao J.-H.; WEI-SHIUNG YANG PLoS ONE9
4472017Longitudinal evaluation of myocardial glucose metabolism and contractile function in obese type 2 diabetic db/db mice using small-animal dynamic 18F-FDG PET and echocardiographyKo K.-Y.; Wu Y.-W.; Liu C.-W.; Cheng M.-F.; Yen R.-F.; WEI-SHIUNG YANG Oncotarget4
4482017Cerebrospinal fluid high mobility group box 1 is associated with neuronal death in subarachnoid hemorrhageWang K.-C.; Tang S.-C.; Lee J.-E.; Li Y.-I.; Huang Y.-S.; WEI-SHIUNG YANG ; Jeng J.-S.; Arumugam T.V.; Tu Y.-K.Journal of Cerebral Blood Flow and Metabolism19
4492017Serum reference value of two potential doping candidates-myostatin and insulin-like growth factor-I in the healthy young maleHan D.-S.; Huang C.-H.; Chen S.-Y.; WEI-SHIUNG YANG Journal of the International Society of Sports Nutrition5
4502017Relation between serum myokines and phase II cardiac rehabilitationHan D.-S.; Hsiao M.-Y.; Wang T.-G.; Chen S.-Y.; WEI-SHIUNG YANG Medicine (United States)5
4512017Dexamethasone treatment at the myoblast stage enhanced C2C12 myocyte differentiationHan D.-S.; WEI-SHIUNG YANG ; Kao T.-W.International Journal of Medical Sciences16
4522017Effects of tumor necrosis factor blocker on salicylate-induced tinnitus in miceHwang J.-H.; Huang D.C.-W.; Lu Y.-C.; WEI-SHIUNG YANG ; Liu T.-C.International Tinnitus Journal0
4532017The present and future disease burden of hepatitis C virus infections with today's treatment paradigm: Volume 4Chan H.L.Y.; Chen C.J.; Omede O.; Al Qamish J.; Al Naamani K.; Bane A.; Tan S.S.; Simonova M.; Cardenas I.; Derbala M.; Akin O.; Phillips R.O.; Abdelmageed M.K.; Abdulla M.; Adda D.; Al Baqali A.; Al Dweik N.; Al Ejji K.; Al ghazzawi I.; Al Kaabi S.; Al Sadadi M.; Al Salman J.; AlBadri M.; Al-Busafi S.A.; Al-Romaihi H.E.; Ampofo W.; Antonov K.; Anyaike C.; Arome F.; Blach S.; Borodo M.M.; Brandon S.M.; Bright B.; Butt M.T.; Chen D.S.; PEI-JER CHEN ; Chien R.N.; Chuang W.L.; Cuellar D.; Elbardiny A.A.; Estes C.; Farag E.; Fung J.; Gamkrelidze I.; Garcia V.; Genov J.; Ghandour Z.; Ghuloom M.; Gomez B.; Gunter J.; Habeeb J.; Hajelssedig O.; Hamoudi W.; Himatt S.M.; Hrstic I.; Hu C.C.; Huang C.F.; Hui Y.T.; Jahis R.; Jelev D.; John A.K.; Kaliaskarova K.S.; Kamel Y.; Kao J.H.; Khamis J.; Khattabi H.; Khoudri I.; Konysbekova A.; Kotzev I.; Lai M.S.; Lao W.C.; Layden J.; Lee M.H.; Lesi O.; Li M.; Lo A.; Loo C.K.; Luk?i? B.; Maaroufi A.; Malu A.O.; Mateva L.; Mitova R.; Mohamed R.; Morovi? M.; Murphy K.; Mustapha B.; Nersesov A.; Ngige E.; Njouom R.; Njoya O.; Nonkovi? D.; Obekpa S.; Oguche S.; Okolo E.E.; Omuemu C.; Ondoa P.; Opare-Sem O.; Owusu-Ofori S.; Prokopenko Y.N.; Razavi H.; Razavi-Shearer D.; Razavi-Shearer K.; Redae B.; Reic T.; Rinke de Wit T.; Rios C.; Robbins S.; Roberts L.R.; Sanad S.J.; Schmelzer J.D.; Sharma M.; Su T.H.; Sultan K.; Tchernev K.; Tsang O.T.Y.; Tsang S.; Tzeuton C.; Ugoeze S.; Uzochukwu B.; Vi R.; Vince A.; Wani H.U.; Wong V.W.S.; Workneh A.; Yacoub R.; Yesmembetov K.I.; Youbi M.; Yuen M.F.; Nde H.Journal of Viral Hepatitis19
4542017Historical epidemiology of hepatitis C virus in select countries—volume 4Maaroufi A.; Vince A.; Himatt S.M.; Mohamed R.; Fung J.; Opare-Sem O.; Workneh A.; Njouom R.; Al ghazzawi I.; Abdulla M.; Kaliaskarova K.S.; Owusu-Ofori S.; Abdelmageed M.K.; Adda D.; Akin O.; Al Baqali A.; Al Dweik N.; Al Ejji K.; Al Kaabi S.; Al Naamani K.; Al Qamish J.; Al Sadadi M.; Al Salman J.; AlBadri M.; Al-Busafi S.A.; Al-Romaihi H.E.; Ampofo W.; Antonov K.; Anyaike C.; Arome F.; Bane A.; Blach S.; Borodo M.M.; Brandon S.M.; Bright B.; Butt M.T.; Cardenas I.; Chan H.L.Y.; Chen C.J.; Chen D.S.; PEI-JER CHEN ; Chien R.N.; Chuang W.L.; Cuellar D.; Derbala M.; Elbardiny A.A.; Estes C.; Farag E.; Gamkrelidze I.; Garcia V.; Genov J.; Ghandour Z.; Ghuloom M.; Gomez B.; Gunter J.; Habeeb J.; Hajelssedig O.; Hamoudi W.; Hrstic I.; Hu C.C.; Huang C.F.; Hui Y.T.; Jahis R.; Jelev D.; John A.K.; Kamel Y.; Kao J.H.; Khamis J.; Khattabi H.; Khoudri I.; Konysbekova A.; Kotzev I.; Lai M.S.; Lao W.C.; Layden J.; Lee M.H.; Lesi O.; Li M.; Lo A.; Loo C.K.; Luk?i? B.; Malu A.O.; Mateva L.; Mitova R.; Morovi? M.; Murphy K.; Mustapha B.; Nde H.; Nersesov A.; Ngige E.; Njoya O.; Nonkovi? D.; Obekpa S.; Oguche S.; Okolo E.E.; Omede O.; Omuemu C.; Ondoa P.; Phillips R.O.; Prokopenko Y.N.; Razavi H.; Razavi-Shearer D.; Redae B.; Reic T.; Rinke de Wit T.; Rios C.; Robbins S.; Roberts L.R.; Sanad S.J.; Schmelzer J.D.; Sharma M.; Simonova M.; Su T.H.; Sultan K.; Tan S.S.; Tchernev K.; Tsang O.T.Y.; Tsang S.; Tzeuton C.; Ugoeze S.; Uzochukwu B.; Vi R.; Wani H.U.; Wong V.W.S.; Yacoub R.; Yesmembetov K.I.; Youbi M.; Yuen M.F.; Razavi-Shearer K.Journal of Viral Hepatitis20
4552017Strategies to manage hepatitis C virus infection disease burden—Volume 4Chen D.S.; Hamoudi W.; Mustapha B.; Layden J.; Nersesov A.; Reic T.; Garcia V.; Rios C.; Mateva L.; Njoya O.; Al-Busafi S.A.; Abdelmageed M.K.; Abdulla M.; Adda D.; Akin O.; Al Baqali A.; Al Dweik N.; Al Ejji K.; Al ghazzawi I.; Al Kaabi S.; Al Naamani K.; Al Qamish J.; Al Sadadi M.; Al Salman J.; AlBadri M.; Al-Romaihi H.E.; Ampofo W.; Antonov K.; Anyaike C.; Arome F.; Bane A.; Blach S.; Borodo M.M.; Brandon S.M.; Bright B.; Butt M.T.; Cardenas I.; Chan H.L.Y.; Chen C.J.; PEI-JER CHEN ; Chien R.N.; Chuang W.L.; Cuellar D.; Derbala M.; Elbardiny A.A.; Estes C.; Farag E.; Fung J.; Gamkrelidze I.; Genov J.; Ghandour Z.; Ghuloom M.; Gomez B.; Gunter J.; Habeeb J.; Hajelssedig O.; Himatt S.M.; Hrstic I.; Hu C.C.; Huang C.F.; Hui Y.T.; Jahis R.; Jelev D.; John A.K.; Kaliaskarova K.S.; Kamel Y.; Kao J.H.; Khamis J.; Khattabi H.; Khoudri I.; Konysbekova A.; Kotzev I.; Lai M.S.; Lao W.C.; Lee M.H.; Lesi O.; Li M.; Lo A.; Loo C.K.; Luk?i? B.; Maaroufi A.; Malu A.O.; Mitova R.; Mohamed R.; Morovi? M.; Murphy K.; Nde H.; Ngige E.; Njouom R.; Nonkovi? D.; Obekpa S.; Oguche S.; Okolo E.E.; Omede O.; Omuemu C.; Ondoa P.; Opare-Sem O.; Owusu-Ofori S.; Phillips R.O.; Prokopenko Y.N.; Razavi H.; Razavi-Shearer D.; Razavi-Shearer K.; Redae B.; Rinke de Wit T.; Robbins S.; Roberts L.R.; Sanad S.J.; Sharma M.; Simonova M.; Su T.H.; Sultan K.; Tan S.S.; Tchernev K.; Tsang O.T.Y.; Tsang S.; Tzeuton C.; Ugoeze S.; Uzochukwu B.; Vi R.; Vince A.; Wani H.U.; Wong V.W.S.; Workneh A.; Yacoub R.; Yesmembetov K.I.; Youbi M.; Yuen M.F.; Schmelzer J.D.Journal of Viral Hepatitis11
4562017Src-homology protein tyrosine phosphatase-1 agonist, SC-43, reduces liver fibrosisSu T.-H.; Shiau C.-W.; Jao P.; Yang N.-J.; Tai W.-T.; Liu C.-J.; Tseng T.-C.; Yang H.-C.; Liu C.-H.; Huang K.-W.; Hu T.-C.; Huang Y.-J.; Wu Y.-M.; Chen L.-J.; PEI-JER CHEN ; Chen D.-S.; Chen K.-F.; Kao J.-H.Scientific Reports4
4572017Fibrosis-4 Index Helps Identify HBV Carriers with the Lowest Risk of Hepatocellular CarcinomaTseng T.-C.; Liu C.-J.; Su T.-H.; Yang W.-T.; Chen C.-L.; Yang H.-C.; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; PEI-JER CHEN ; Chen D.-S.; Kao J.-H.American Journal of Gastroenterology27
4582017Hepatitis B virus reactivation in patients receiving interferon-free direct-acting antiviral agents for chronic hepatitis C virus infectionLiu C.-H.; Liu C.-J.; Su T.-H.; Fang Y.-J.; Yang H.-C.; PEI-JER CHEN ; Chen D.-S.; Kao J.-H.Open Forum Infectious Diseases30
4592017Impact of occult hepatitis B on the clinical outcomes of patients with chronic hepatitis C virus infection: A 10-year follow-upChen H.-Y.; Su T.-H.; Tseng T.-C.; Yang W.-T.; Chen T.-C.; PEI-JER CHEN ; Chen D.-S.; Kao J.-H.; Liu C.-J.Journal of the Formosan Medical Association8
4602017Genome-wide association analysis identifies a GLUL haplotype for familial hepatitis B virus-related hepatocellular carcinomaLin Y.-Y.; Yu M.-W.; Lin S.-M.; Lee S.-D.; Chen C.-L.; Chen D.-S.; PEI-JER CHEN Cancer10
4612017Peg-interferon lambda treatment induces robust innate and adaptive immunity in chronic hepatitis B patientsPhillips S.; Mistry S.; Riva A.; Cooksley H.; Hadzhiolova-Lebeau T.; Plavova S.; Katzarov K.; Simonova M.; Zeuzem S.; Woffendin C.; PEI-JER CHEN ; Peng C.-Y.; Chang T.-T.; Lueth S.; Knegt R.D.; Choi M.-S.; Wedemeyer H.; Dao M.; Kim C.-W.; Chu H.-C.; Wind-Rotolo M.; Williams R.; Cooney E.; Chokshi S.Frontiers in Immunology24
4622017A phase I/II multicenter study of single-agent foretinib as first-line therapy in patients with advanced hepatocellular carcinomaYau T.C.C.; Lencioni R.; Sukeepaisarnjaroen W.; Chao Y.; Yen C.-J.; Lausoontornsiri W.; PEI-JER CHEN ; Sanpajit T.; Camp A.; Cox D.S.; Gagnon R.C.; Liu Y.; Raffensperger K.E.; Kulkarni D.A.; Kallender H.; Ottesen L.H.; Poon R.T.P.; Bottaro D.P.Clinical Cancer Research27
4632017Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 updateOmata M.; Cheng A.-L.; Kokudo N.; Kudo M.; Lee J.M.; Jia J.; Tateishi R.; Han K.-H.; Chawla Y.K.; Shiina S.; Jafri W.; Payawal D.A.; Ohki T.; Ogasawara S.; PEI-JER CHEN ; Lesmana C.R.A.; Lesmana L.A.; Gani R.A.; Obi S.; Dokmeci A.K.; Sarin S.K.Hepatology International747
4642017Corrigendum to “Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma” (Journal of Hepatology (2017) 66(3) (666–668) (S0168827816307127) (10.1016/j.jhep.2016.12.007))Tai W.-T.; Cheng A.-L.; Shiau C.-W.; Huang H.-P.; Huang J.-W.; PEI-JER CHEN ; Chen K.-F.Journal of Hepatology1
4652017Chronologic changes in serum hepatitis B virus DNA, genotypes, surface antigen mutants and reverse transcriptase mutants during 25-year nationwide immunization in TaiwanHsu H.-Y.; Chang M.-H.; Ni Y.-H.; Chiang C.-L.; Wu J.-F.; Chen H.-L.; PEI-JER CHEN ; Chen D.-S.Journal of Viral Hepatitis6
4662017De novo assembly of highly polymorphic metagenomic data using in situ generated reference sequences and a novel BLAST-based assembly pipelineLin Y.-Y.; Hsieh C.-H.; Chen J.-H.; Lu X.; Kao J.-H.; PEI-JER CHEN ; Chen D.-S.; Wang H.-Y.BMC Bioinformatics9
4672017One-Pot Two-Nanoprobe Assay Uncovers Targeted Glycoprotein BiosignatureChen Y.-J.; Dela Rosa M.A.C.; Chen W.-C.; Chen Y.-J.; Obena R.P.; Chang C.-H.; Capangpangan R.Y.; Su T.-H.; Chen C.-L.; PEI-JER CHEN Analytical Chemistry17
4682017Prescription patterns of sorafenib and outcomes of patients with advanced hepatocellular carcinoma: A national population studyLu L.-C.; PEI-JER CHEN ; Yeh Y.-C.; Hsu C.-H.; Chen H.-M.; Lai M.-S.; Shao Y.-Y.; Cheng A.-L.Anticancer Research13
4692017Addition of ribavirin to daclatasvir plus asunaprevir for chronic hepatitis C 1b patients with baseline NS5A resistance-associated variants improved responseHong C.-M.; Liu C.-J.; Yeh S.-H.; PEI-JER CHEN Journal of the Formosan Medical Association3
4702017Corrigendum to “Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma” (Journal of Hepatology (2011) 55(5) (1041–1048)(S0168827811001917)(10.1016/j.jhep.2011.01.047))Tai W.-T.; Cheng A.-L.; Shiau C.-W.; Huang H.-P.; Huang J.-W.; PEI-JER CHEN ; Chen K.-F.Journal of Hepatology1
4712017Genome-wide identification of blood DNA methylation patterns associated with early-onset hepatocellular carcinoma development in hepatitis B carriersKao W.-Y.; Yang S.-H.; Liu W.-J.; Yeh M.-Y.; Lin C.-L.; Liu C.-J.; Huang C.-J.; Lin S.-M.; Lee S.-D.; PEI-JER CHEN ; Yu M.-W.Molecular Carcinogenesis12
4722017Management of hepatitis C virus infection in the Asia-Pacific region: an updateLim S.G.; Aghemo A.; PEI-JER CHEN ; Dan Y.Y.; Gane E.; Gani R.; Gish R.G.; Guan R.; Jia J.D.; Lim K.; Piratvisuth T.; Shah S.; Shiffman M.L.; Tacke F.; Tan S.S.; Tanwandee T.; Win K.M.; Yurdaydin C.The Lancet Gastroenterology and Hepatology39
4732017A novel toolbox for the in vitro assay of hepatitis D virus infectionZhao J.-H.; Zhang Y.-L.; Zhang T.-Y.; Yuan L.-Z.; Cheng T.; PEI-JER CHEN ; Yuan Q.; Xia N.-S.Scientific Reports3
4742017Hydrodynamic HBV transfection mouse modelWu L.-L.; Wang H.-Y.; PEI-JER CHEN Methods in Molecular Biology0
4752017Early measurement of IL-10 predicts the outcomes of patients with acute respiratory distress syndrome receiving extracorporeal membrane oxygenation /631/250/127 /692/53/2422 /13 /13/21 /13/31 /45/23 articleLiu C.-H.; Kuo S.-W.; Ko W.-J.; Tsai P.-R.; Wu S.-W.; Lai C.-H.; Wang C.-H.; Chen Y.-S.; PEI-LUNG CHEN ; Liu T.-T.; Huang S.-C.; Jou T.-S.Scientific Reports12
4762017A novel missense variant in the nuclear localization signal of POU4F3 causes autosomal dominant non-syndromic hearing lossLin Y.-H.; Lin Y.-H.; Lu Y.-C.; Liu T.-C.; Chen C.-Y.; Hsu C.-J.; PEI-LUNG CHEN ; Wu C.-C.Scientific Reports12
4772017Identification of VPS35 p.D620N mutation-related Parkinson's disease in a Taiwanese family with successful bilateral subthalamic nucleus deep brain stimulation: A case report and literature reviewChen Y.-F.; Chang Y.-Y.; Lan M.-Y.; PEI-LUNG CHEN ; Lin C.-H.BMC Neurology8
4782017Intrafamilial phenotypic heterogeneity in a Taiwanese family with a MAPT p.R5H mutation: A case report and literature reviewLin H.-C.; Lin C.-H.; PEI-LUNG CHEN ; Cheng S.-J.; Chen P.-H.BMC Neurology9
4792017Identification of a novel HLA-B allele, HLA-B*40:238, in a Taiwanese individualLee H.-L.; Lai S.-K.; PEI-LUNG CHEN ; Chu C.-C.HLA1
4802017Irreversible Electroporation: A Novel Ultrasound-guided Modality for Non-thermal Tumor AblationHsiao C.-Y.; KAI-WEN HUANG Journal of Medical Ultrasound711
4812017Aptamer-Drug Conjugates of Active Metabolites of Nucleoside Analogs and Cytotoxic Agents Inhibit Pancreatic Tumor Cell GrowthYoon S.; KAI-WEN HUANG ; Reebye V.; Spalding D.; Przytycka T.M.; Wang Y.; Swiderski P.; Li L.; Armstrong B.; Reccia I.; Zacharoulis D.; Dimas K.; Kusano T.; Shively J.; Habib N.; Rossi J.J.Molecular Therapy - Nucleic Acids3238
4822017The Legal Issues of the Applications of Big Data on Medical ResearchTsung-Fu Chen; DANIEL FU-CHANG TSAI Formosan Journal of Medicine00
4832017The Ethical Perspectives on Big Data and Medical ResearchDANIEL FU-CHANG TSAI ; Mei-Fen TsaiFormosan Journal of Medicine00
4842017The Ethical Perspectives and Practical Challenge of Patient Self Determination ActDANIEL FU-CHANG TSAI ; Hui-Hsin KuoFormosan Journal of Medicine00
4852017Special Topic: Big Data and Its Medical Applications(II)DANIEL FU-CHANG TSAI ; Mei-Shu LaiFormosan Journal of Medicine
4862017The Clinical Guidelines and Ethical Issues in the Care of Motor Neuron Diseases (ALS)DANIEL FU-CHANG TSAI ; Li-You Huang; Chih-Chao YangFormosan Journal of Medicine00
4872017Ultrasound-Induced Magnetic Imaging of Tumors Targeted by Biofunctional Magnetic NanoparticlesKAI-WEN HUANG ; Chieh J.-J.; Yeh C.-K.; Liao S.-H.; Lee Y.-Y.; Hsiao P.-Y.; Wei W.-C.; Yang H.-C.; Horng H.-E.ACS Nano1112
4882017Impact of cavitron ultrasonic surgical aspirator (CUSA) and bipolar radiofrequency device (Habib-4X) based hepatectomy for hepatocellular carcinoma on tumour recurrence and diseasefree survivalKAI-WEN HUANG ; Lee P.-H.; Kusano T.; Reccia I.; Jayant K.; Habib N.Oncotarget88
4892017Noninvasive prenatal diagnosis of fetal aneuploidy by circulating fetal nucleated red blood cells and extravillous trophoblasts using silicon-based nanostructured microfluidicsHuang, Chung-Er; Ma, Gwo-Chin; Jou, Hei-Jen; Lin, Wen-Hsiang; Lee, Dong-Jay; Lin, Yi-Shing; Ginsberg, Norman A; HSIN-FU CHEN ; Chang, Frank Mau-Chung; Chen, MingMolecular cytogenetics 2018
4902017Src-homology protein tyrosine phosphatase-1 agonist, SC-43, reduces liver fibrosisSu T.-H.; Shiau C.-W.; Jao P.; Yang N.-J.; Tai W.-T.; Liu C.-J.; Tseng T.-C.; Yang H.-C.; Liu C.-H.; KAI-WEN HUANG ; Hu T.-C.; Huang Y.-J.; Wu Y.-M.; Chen L.-J.; Chen P.-J.; Chen D.-S.; Chen K.-F.; Kao J.-H.Scientific Reports34
4912017Keratin/chitosan UV-crosslinked composites promote the osteogenic differentiation of human adipose derived stem cellsLin Y.-H.; KAI-WEN HUANG ; Chen S.-Y.; Cheng N.-C.; Yu J.Journal of Materials Chemistry B1617
4922017Characterizations of anti-alpha-fetoprotein- conjugated magnetic nanoparticles associated with alpha-fetoprotein for biomedical applicationsLiao S.-H.; Huang H.-S.; Chieh J.-J.; Su Y.-K.; Tong Y.-F.; KAI-WEN HUANG Sensors (Switzerland)31
4932017The Ethical Issues Arising from Direct-to-Consumer (DTC) Genetic TestingDANIEL FU-CHANG TSAI ; Chia-Ju Chen; Yu-Jen HsuFormosan Journal of Medicine00
4942017The outcomes and controversies of transplant tourism-Lessons of an 11-year retrospective cohort study from TaiwanDANIEL FU-CHANG TSAI ; Huang S.-W.; Holm S.; Lin Y.-P.; Chang Y.-K.; Hsu C.-C.PLoS ONE33
4952017Emotional Learning and Identity Development in Medicine: A Cross-Cultural Qualitative Study Comparing Taiwanese and Dutch Medical UndergraduatesHelmich E.; Yeh H.-M.; Yeh C.-C.; De Vries J.; DANIEL FU-CHANG TSAI ; Dornan T.Academic Medicine811
4962017De novo assembly of highly polymorphic metagenomic data using in situ generated reference sequences and a novel BLAST-based assembly pipelineLin Y.-Y.; Hsieh C.-H.; Chen J.-H.; Lu X.; Kao J.-H.; Chen P.-J.; Chen D.-S.; HURNG-YI WANG BMC Bioinformatics89
4972017Hydrodynamic HBV transfection mouse modelWu L.-L.; HURNG-YI WANG ; Chen P.-J.Methods in Molecular Biology20
4982017Early measurement of IL-10 predicts the outcomes of patients with acute respiratory distress syndrome receiving extracorporeal membrane oxygenation /631/250/127 /692/53/2422 /13 /13/21 /13/31 /45/23 articleLiu C.-H.; Kuo S.-W.; Ko W.-J.; Tsai P.-R.; Wu S.-W.; Lai C.-H.; Wang C.-H.; Chen Y.-S.; Chen P.-L.; Liu T.-T.; Huang S.-C.; TZUU-SHUH JOU Scientific Reports12
4992017Galectin-8 regulates targeting of Gp135/podocalyxin and lumen formation at the apical surface of renal epithelial cellsLim H.; Yu C.-Y.; TZUU-SHUH JOU FASEB Journal6
5002017De novo assembly of highly polymorphic metagenomic data using in situ generated reference sequences and a novel BLAST-based assembly pipelineLin Y.-Y.; Hsieh C.-H.; Chen J.-H.; Lu X.; JIA-HORNG KAO ; Chen P.-J.; Chen D.-S.; Wang H.-Y.BMC Bioinformatics9
5012017Treatment of de novo hepatitis C virus-related fibrosing cholestatic hepatitis after orthotopic heart transplantation by ledipasvir and sofosbuvirLiu C.-H.; Chen Y.-S.; Wang S.-S.; JIA-HORNG KAO Journal of the Formosan Medical Association5
5022017Urgency to treat patients with chronic hepatitis C in AsiaJIA-HORNG KAO ; Ahn S.H.; Chien R.-N.; Cho M.; Chuang W.-L.; Jeong S.-H.; Liu C.-H.; Paik S.-W.Journal of Gastroenterology and Hepatology (Australia)14
5032017Surveillance of hepatocellular carcinoma by magnetic resonance imaging with liver-specific contrastSu T.-H.; JIA-HORNG KAO JAMA Oncology1
5042017Natural history of acute and chronic hepatitis B: The role of HBV genotypes and mutantsLin C.-L.; JIA-HORNG KAO Best Practice and Research: Clinical Gastroenterology65
5052017Hepatitis B virus infection and decreased risk of nonalcoholic fatty liver disease: A cohort studyWang C.-C.; JIA-HORNG KAO Hepatology5
5062017Letter: the influence of direct acting agents for hepatitis C, on hepatitis B reactivationWang C.-C.; JIA-HORNG KAO Alimentary Pharmacology and Therapeutics0
5072017More viral mutants, less HBsAg clearance? One size may not fit allTseng T.-C.; Yang H.-C.; JIA-HORNG KAO Gut1
5082017HBV markers for HCC prediction: Three heads are better than two?Tseng T.-C.; JIA-HORNG KAO Journal of Hepatology3
5092017Global prevalence and genotype distribution of hepatitis C virus infection in 2015: A modelling studyBlach S.; Zeuzem S.; Manns M.; Altraif I.; Duberg A.-S.; Muljono D.H.; Waked I.; Alavian S.M.; Lee M.-H.; Negro F.; Abaalkhail F.; Abdou A.; Abdulla M.; Abou Rached A.; Aho I.; Akarca U.; Al Ghazzawi I.; Al Kaabi S.; Al Lawati F.; Al Namaani K.; Al Serkal Y.; Al-Busafi S.A.; Al-Dabal L.; Aleman S.; Alghamdi A.S.; Aljumah A.A.; Al-Romaihi H.E.; Andersson M.I.; Arendt V.; Arkkila P.; Assiri A.M.; Baatarkhuu O.; Bane A.; Ben-Ari Z.; Bergin C.; Bessone F.; Bihl F.; Bizri A.R.; Blachier M.; Blasco A.J.; Brandao Mello C.E.; Bruggmann P.; Brunton C.R.; Calinas F.; Chan H.L.Y.; Chaudhry A.; Cheinquer H.; Chen C.-J.; Chien R.-N.; Choi M.S.; Christensen P.B.; Chuang W.-L.; Chulanov V.; Cisneros L.; Clausen M.R.; Cramp M.E.; Craxi A.; Croes E.A.; Dalgard O.; Daruich J.R.; De Ledinghen V.; Dore G.J.; El-Sayed M.H.; Ergor G.; Esmat G.; Estes C.; Falconer K.; Farag E.; Ferraz M.L.G.; Ferreira P.R.; Flisiak R.; Frankova S.; Gamkrelidze I.; Gane E.; Garcia-Samaniego J.; Khan A.G.; Gountas I.; Goldis A.; Gottfredsson M.; Grebely J.; Gschwantler M.; Guimaraes Pessoa M.; Gunter J.; Hajarizadeh B.; Hajelssedig O.; Hamid S.; Hamoudi W.; Hatzakis A.; Himatt S.M.; Hofer H.; Hrstic I.; Hui Y.-T.; Hunyady B.; Idilman R.; Jafri W.; Jahis R.; Janjua N.Z.; Jar?u?ka P.; Jeruma A.; Jonasson J.G.; Kamel Y.; JIA-HORNG KAO ; Kaymakoglu S.; Kershenobich D.; Khamis J.; Kim Y.S.; Kondili L.; Koutoubi Z.; Krajden M.; Krarup H.; Lai M.-S.; Laleman W.; Lao W.-C.; Lavanchy D.; Lazaro P.; Leleu H.; Lesi O.; Lesmana L.A.; Li M.; Liakina V.; Lim Y.-S.; Luksic B.; Mahomed A.; Maimets M.; Makara M.; Malu A.O.; Marinho R.T.; Marotta P.; Mauss S.; Memon M.S.; Mendes Correa M.C.; Mendez-Sanchez N.; Merat S.; Metwally A.M.; Mohamed R.; Moreno C.; Mourad F.H.; Mullhaupt B.; Murphy K.; Nde H.; Njouom R.; Nonkovic D.; Norris S.; Obekpa S.; Oguche S.; Olafsson S.; Oltman M.; Omede O.; Omuemu C.; Opare-Sem O.; Ovrehus A.L.H.; Owusu-Ofori S.; Oyunsuren T.S.; Papatheodoridis G.; Pasini K.; Peltekian K.M.; Phillips R.O.; Pimenov N.; Poustchi H.; Prabdial-Sing N.; Qureshi H.; Ramji A.; Razavi-Shearer D.; Razavi-Shearer K.; Redae B.; Reesink H.W.; Ridruejo E.; Robbins S.; Roberts L.R.; Roberts S.K.; Rosenberg W.M.; Roudot-Thoraval F.; Ryder S.D.; Safadi R.; Sagalova O.; Salupere R.; Sanai F.M.; Sanchez Avila J.F.; Saraswat V.; Sarmento-Castro R.; Sarrazin C.; Schmelzer J.D.; Schreter I.; Seguin-Devaux C.; Shah S.R.; Sharara A.I.; Sharma M.; Shevaldin A.; Shiha G.E.; Sievert W.; Sonderup M.; Souliotis K.; Speiciene D.; Sperl J.; Starkel P.; Stauber R.E.; Stedman C.; Struck D.; Su T.-H.; Sypsa V.; Tan S.-S.; Tanaka J.; Thompson A.J.; Tolmane I.; Tomasiewicz K.; Valantinas J.; Van Damme P.; Van Der Meer A.J.; Van Thiel I.; Van Vlierberghe H.; Vince A.; Vogel W.; Wedemeyer H.; Weis N.; Wong V.W.S.; Yaghi C.; Yosry A.; Yuen M.-F.; Yunihastuti E.; Yusuf A.; Zuckerman E.; Razavi H.; The Polaris Observatory HCV CollaboratorsThe Lancet Gastroenterology and Hepatology1055
5102017High serum lipopolysaccharide-binding protein level in chronic hepatitis C viral infection is reduced by anti-viral treatmentsNien H.-C.; Hsu S.-J.; Su T.-H.; Yang P.-J.; Sheu J.-C.; Wang J.-T.; Chow L.-P.; Chen C.-L.; JIA-HORNG KAO ; Yang W.-S.PLoS ONE9
5112017Targeting SHP-1-STAT3 signaling: A promising therapeutic approach for the treatment of cholangiocarcinomaHu M.-H.; Chen L.-J.; Chen Y.-L.; Tsai M.-S.; Shiau C.-W.; Chao T.-I.; Liu C.-Y.; JIA-HORNG KAO ; Chen K.-F.Oncotarget10
5122017Response to Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in?chronic hepatitis B patientsSu T.-H.; JIA-HORNG KAO Liver International2
5132017Benefits of long-term therapy with nucleos(t)ide analogues in treatment-na?ve patients with chronic hepatitis BWei L.; JIA-HORNG KAO Current Medical Research and Opinion9
5142017Letter: HBsAg kinetics-guided interferon therapy for chronic hepatitis DKao C.-N.; Su T.-H.; JIA-HORNG KAO Alimentary Pharmacology and Therapeutics1
5152017NOhep: Toward Global Control of Hepatitis B Virus Infection - An IntroductionLiu C.-J.; JIA-HORNG KAO Journal of Infectious Diseases3
5162017Unmet Needs in Clinical and Basic Hepatitis B Virus ResearchSu T.-H.; JIA-HORNG KAO Journal of Infectious Diseases14
5172017Elimination of Hepatitis B: Is It a Mission Possible?Tseng T.-C.; JIA-HORNG KAO BMC Medicine18
5182017Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C PatientsLee M.-H.; Huang C.-F.; Lai H.-C.; Lin C.-Y.; Dai C.-Y.; Liu C.-J.; Wang J.-H.; Huang J.-F.; Su W.-P.; Yang H.-C.; Kee K.-M.; Yeh M.-L.; Chuang P.-H.; Hsu S.-J.; Huang C.-I.; JIA-HORNG KAO ; Chen C.-C.; Chen S.-H.; Jeng W.-J.; Yang H.-I.; Yuan Y.; Lu S.-N.; Sheen I.-S.; Liu C.-H.; Peng C.-Y.; JIA-HORNG KAO ; Yu M.-L.; Chuang W.-L.; Chen C.-J.Scientific Reports12
5192017Daclatasvir/asunaprevir/beclabuvir, all-oral, fixed-dose combination for patients with chronic hepatitis C virus genotype 1JIA-HORNG KAO ; Yu M.-L.; Peng C.-Y.; Heo J.; Chu C.-J.; Chang T.-T.; Lee Y.-J.; Hu T.-H.; Yoon K.T.; Paik S.W.; Lim Y.S.; Ahn S.H.; Isakov V.; McPhee F.; Hu W.; Scott Swenson E.; Yin P.D.; Treitel M.Journal of Gastroenterology and Hepatology (Australia)12
5202017Time-varying serum gradient of hepatitis B surface antigen predicts risk of relapses after off-NA therapyChien N.-H.; Huang Y.-T.; Wu C.-Y.; Chang C.-Y.; Wu M.-S.; JIA-HORNG KAO ; Mo L.-R.; Tai C.-M.; Lin C.-W.; Yang T.-H.; Lin J.-T.; Hsu Y.-C.BMC Gastroenterology2
5212017The present and future disease burden of hepatitis C virus infections with today's treatment paradigm: Volume 4Chan H.L.Y.; Chen C.J.; Omede O.; Al Qamish J.; Al Naamani K.; Bane A.; Tan S.S.; Simonova M.; Cardenas I.; Derbala M.; Akin O.; Phillips R.O.; Abdelmageed M.K.; Abdulla M.; Adda D.; Al Baqali A.; Al Dweik N.; Al Ejji K.; Al ghazzawi I.; Al Kaabi S.; Al Sadadi M.; Al Salman J.; AlBadri M.; Al-Busafi S.A.; Al-Romaihi H.E.; Ampofo W.; Antonov K.; Anyaike C.; Arome F.; Blach S.; Borodo M.M.; Brandon S.M.; Bright B.; Butt M.T.; Chen D.S.; Chen P.J.; Chien R.N.; Chuang W.L.; Cuellar D.; Elbardiny A.A.; Estes C.; Farag E.; Fung J.; Gamkrelidze I.; Garcia V.; Genov J.; Ghandour Z.; Ghuloom M.; Gomez B.; Gunter J.; Habeeb J.; Hajelssedig O.; Hamoudi W.; Himatt S.M.; Hrstic I.; Hu C.C.; Huang C.F.; Hui Y.T.; Jahis R.; Jelev D.; John A.K.; Kaliaskarova K.S.; Kamel Y.; JIA-HORNG KAO ; Khamis J.; Khattabi H.; Khoudri I.; Konysbekova A.; Kotzev I.; Lai M.S.; Lao W.C.; Layden J.; Lee M.H.; Lesi O.; Li M.; Lo A.; Loo C.K.; Luk?i? B.; Maaroufi A.; Malu A.O.; Mateva L.; Mitova R.; Mohamed R.; Morovi? M.; Murphy K.; Mustapha B.; Nersesov A.; Ngige E.; Njouom R.; Njoya O.; Nonkovi? D.; Obekpa S.; Oguche S.; Okolo E.E.; Omuemu C.; Ondoa P.; Opare-Sem O.; Owusu-Ofori S.; Prokopenko Y.N.; Razavi H.; Razavi-Shearer D.; Razavi-Shearer K.; Redae B.; Reic T.; Rinke de Wit T.; Rios C.; Robbins S.; Roberts L.R.; Sanad S.J.; Schmelzer J.D.; Sharma M.; Su T.H.; Sultan K.; Tchernev K.; Tsang O.T.Y.; Tsang S.; Tzeuton C.; Ugoeze S.; Uzochukwu B.; Vi R.; Vince A.; Wani H.U.; Wong V.W.S.; Workneh A.; Yacoub R.; Yesmembetov K.I.; Youbi M.; Yuen M.F.; Nde H.Journal of Viral Hepatitis19
5222017Historical epidemiology of hepatitis C virus in select countries—volume 4Maaroufi A.; Vince A.; Himatt S.M.; Mohamed R.; Fung J.; Opare-Sem O.; Workneh A.; Njouom R.; Al ghazzawi I.; Abdulla M.; Kaliaskarova K.S.; Owusu-Ofori S.; Abdelmageed M.K.; Adda D.; Akin O.; Al Baqali A.; Al Dweik N.; Al Ejji K.; Al Kaabi S.; Al Naamani K.; Al Qamish J.; Al Sadadi M.; Al Salman J.; AlBadri M.; Al-Busafi S.A.; Al-Romaihi H.E.; Ampofo W.; Antonov K.; Anyaike C.; Arome F.; Bane A.; Blach S.; Borodo M.M.; Brandon S.M.; Bright B.; Butt M.T.; Cardenas I.; Chan H.L.Y.; Chen C.J.; Chen D.S.; Chen P.J.; Chien R.N.; Chuang W.L.; Cuellar D.; Derbala M.; Elbardiny A.A.; Estes C.; Farag E.; Gamkrelidze I.; Garcia V.; Genov J.; Ghandour Z.; Ghuloom M.; Gomez B.; Gunter J.; Habeeb J.; Hajelssedig O.; Hamoudi W.; Hrstic I.; Hu C.C.; Huang C.F.; Hui Y.T.; Jahis R.; Jelev D.; John A.K.; Kamel Y.; JIA-HORNG KAO ; Khamis J.; Khattabi H.; Khoudri I.; Konysbekova A.; Kotzev I.; Lai M.S.; Lao W.C.; Layden J.; Lee M.H.; Lesi O.; Li M.; Lo A.; Loo C.K.; Luk?i? B.; Malu A.O.; Mateva L.; Mitova R.; Morovi? M.; Murphy K.; Mustapha B.; Nde H.; Nersesov A.; Ngige E.; Njoya O.; Nonkovi? D.; Obekpa S.; Oguche S.; Okolo E.E.; Omede O.; Omuemu C.; Ondoa P.; Phillips R.O.; Prokopenko Y.N.; Razavi H.; Razavi-Shearer D.; Redae B.; Reic T.; Rinke de Wit T.; Rios C.; Robbins S.; Roberts L.R.; Sanad S.J.; Schmelzer J.D.; Sharma M.; Simonova M.; Su T.H.; Sultan K.; Tan S.S.; Tchernev K.; Tsang O.T.Y.; Tsang S.; Tzeuton C.; Ugoeze S.; Uzochukwu B.; Vi R.; Wani H.U.; Wong V.W.S.; Yacoub R.; Yesmembetov K.I.; Youbi M.; Yuen M.F.; Razavi-Shearer K.Journal of Viral Hepatitis20
5232017Strategies to manage hepatitis C virus infection disease burden—Volume 4Chen D.S.; Hamoudi W.; Mustapha B.; Layden J.; Nersesov A.; Reic T.; Garcia V.; Rios C.; Mateva L.; Njoya O.; Al-Busafi S.A.; Abdelmageed M.K.; Abdulla M.; Adda D.; Akin O.; Al Baqali A.; Al Dweik N.; Al Ejji K.; Al ghazzawi I.; Al Kaabi S.; Al Naamani K.; Al Qamish J.; Al Sadadi M.; Al Salman J.; AlBadri M.; Al-Romaihi H.E.; Ampofo W.; Antonov K.; Anyaike C.; Arome F.; Bane A.; Blach S.; Borodo M.M.; Brandon S.M.; Bright B.; Butt M.T.; Cardenas I.; Chan H.L.Y.; Chen C.J.; Chen P.J.; Chien R.N.; Chuang W.L.; Cuellar D.; Derbala M.; Elbardiny A.A.; Estes C.; Farag E.; Fung J.; Gamkrelidze I.; Genov J.; Ghandour Z.; Ghuloom M.; Gomez B.; Gunter J.; Habeeb J.; Hajelssedig O.; Himatt S.M.; Hrstic I.; Hu C.C.; Huang C.F.; Hui Y.T.; Jahis R.; Jelev D.; John A.K.; Kaliaskarova K.S.; Kamel Y.; JIA-HORNG KAO ; Khamis J.; Khattabi H.; Khoudri I.; Konysbekova A.; Kotzev I.; Lai M.S.; Lao W.C.; Lee M.H.; Lesi O.; Li M.; Lo A.; Loo C.K.; Luk?i? B.; Maaroufi A.; Malu A.O.; Mitova R.; Mohamed R.; Morovi? M.; Murphy K.; Nde H.; Ngige E.; Njouom R.; Nonkovi? D.; Obekpa S.; Oguche S.; Okolo E.E.; Omede O.; Omuemu C.; Ondoa P.; Opare-Sem O.; Owusu-Ofori S.; Phillips R.O.; Prokopenko Y.N.; Razavi H.; Razavi-Shearer D.; Razavi-Shearer K.; Redae B.; Rinke de Wit T.; Robbins S.; Roberts L.R.; Sanad S.J.; Sharma M.; Simonova M.; Su T.H.; Sultan K.; Tan S.S.; Tchernev K.; Tsang O.T.Y.; Tsang S.; Tzeuton C.; Ugoeze S.; Uzochukwu B.; Vi R.; Vince A.; Wani H.U.; Wong V.W.S.; Workneh A.; Yacoub R.; Yesmembetov K.I.; Youbi M.; Yuen M.F.; Schmelzer J.D.Journal of Viral Hepatitis11
5242017Src-homology protein tyrosine phosphatase-1 agonist, SC-43, reduces liver fibrosisSu T.-H.; Shiau C.-W.; Jao P.; Yang N.-J.; Tai W.-T.; Liu C.-J.; Tseng T.-C.; Yang H.-C.; Liu C.-H.; Huang K.-W.; Hu T.-C.; Huang Y.-J.; Wu Y.-M.; Chen L.-J.; Chen P.-J.; Chen D.-S.; Chen K.-F.; JIA-HORNG KAO Scientific Reports4
5252017Serum viral load at the virological relapse predicts subsequent clinical flares in chronic hepatitis B patients off entecavir therapyHsu Y.-C.; Mo L.-R.; Chang C.-Y.; Wu M.-S.; Yang T.-H.; JIA-HORNG KAO ; Chen C.-C.; Tseng C.-H.; Tai C.-M.; Lin C.-W.; Wu C.-Y.; Lin J.-T.Journal of Gastroenterology and Hepatology (Australia)4
5262017Fibrosis-4 Index Helps Identify HBV Carriers with the Lowest Risk of Hepatocellular CarcinomaTseng T.-C.; Liu C.-J.; Su T.-H.; Yang W.-T.; Chen C.-L.; Yang H.-C.; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO American Journal of Gastroenterology27
5272017Hepatitis B virus reactivation in patients receiving interferon-free direct-acting antiviral agents for chronic hepatitis C virus infectionLiu C.-H.; Liu C.-J.; Su T.-H.; Fang Y.-J.; Yang H.-C.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO Open Forum Infectious Diseases30
5282017Impact of occult hepatitis B on the clinical outcomes of patients with chronic hepatitis C virus infection: A 10-year follow-upChen H.-Y.; Su T.-H.; Tseng T.-C.; Yang W.-T.; Chen T.-C.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO ; Liu C.-J.Journal of the Formosan Medical Association8
5292017An update on non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in AsiaHsu C.S.; JIA-HORNG KAO Expert Review of Gastroenterology and Hepatology8
5302017Telbivudine therapy for chronic hepatitis B: A journey to identify super-responders and to optimize treatment using the roadmap modelJIA-HORNG KAO ; Asselah T.; Dou X.-G.; Hamed K.Journal of Gastroenterology and Hepatology (Australia)6
5312017Hepatitis B reactivation in patients receiving immunosuppressive therapy: a hidden menaceLin C.-L.; JIA-HORNG KAO Hepatology International2
5322016簡評「病人自主權利法」及其影響吳振吉 ; 蔡甫昌 醫院雙月刊
5332016HLJ1 is an endogenous Src inhibitor suppressing cancer progression through dual mechanismsChen C.-H.; PAN-CHYR YANG et al. Oncogene78
5342016SPANXA suppresses EMT by inhibiting c-JUN/SNAI2 signaling in lung adenocarcinomaHsiao Y.-J.; PAN-CHYR YANG et al. Oncotarget1920
5352016Acquisition of tumorigenic potential and enhancement of angiogenesis in pulmonary stem/progenitor cells through Oct-4 hyperexpressionGu S.-Y.; PAN-CHYR YANG et al. Oncotarget32
5362016MDA-9/Syntenin-Slug transcriptional complex promote epithelial-mesenchymal transition and invasion/metastasis in lung adenocarcinomaWang L.-K.; PAN-CHYR YANG et al. Oncotarget1818
5372016Female chromosome X mosaicism is age-related and preferentially affects the inactivated X chromosomeMacHiela M.J.; PAN-CHYR YANG et al. Nature Communications4541
5382016Small molecule T315 promotes casitas b-lineage lymphoma dependent degradation of epidermal growth factor receptor via Y1045 autophosphorylationHuang K.-Y.; PAN-CHYR YANG et al. American Journal of Respiratory and Critical Care Medicine1313
5392016Coexistence of EGFR T790M mutation and common activating mutations in pretreatment non-small cell lung cancer: A systematic review and meta-analysisChen L.-Y.; PAN-CHYR YANG et al. Lung Cancer4543
5402016Higher frequency but random distribution of EGFR mutation subtypes in familial lung cancer patientsHsu K.-H.; PAN-CHYR YANG et al. Oncotarget44
5412016Fanconi anemia genes in lung adenocarcinoma - A pathway-wide study on cancer susceptibilityYang S.-Y.; PAN-CHYR YANG et al. Journal of Biomedical Science1212
5422016Randomized phase II trial of gefitinib with and without pemetrexed as first-line therapy in patients with advanced nonsquamous non-small-cell lung cancer with activating epidermal growth factor receptor mutationsCheng Y.; PAN-CHYR YANG et al. Journal of Clinical Oncology10997
5432016Daxx inhibits hypoxia-induced lung cancer cell metastasis by suppressing the HIF-1α/HDAC1/Slug axisLin C.-W.; PAN-CHYR YANG et al. Nature Communications4852
5442016Safety and immunogenicity of the M72/AS01E candidate tuberculosis vaccine in adults with tuberculosis: A phase II randomised studyGillard P.; PAN-CHYR YANG et al. Tuberculosis4338
5452016Purine-Type Compounds Induce Microtubule Fragmentation and Lung Cancer Cell Death through Interaction with KataninKuo T.-C.; PAN-CHYR YANG et al. Journal of Medicinal Chemistry1617
5462016Immunogenicity of AS03-adjuvanted and non-adjuvanted trivalent inactivated influenza vaccines in elderly adults: A Phase 3, randomized trial and post-hoc correlate of protection analysisRuiz-Palacios G.M.; PAN-CHYR YANG et al. Human Vaccines and Immunotherapeutics33
5472016Meta-analysis of genome-wide association studies identifies multiple lung cancer susceptibility loci in never-smoking Asian womenWang Z.; PAN-CHYR YANG et al. Human Molecular Genetics2623
5482016EGFR-activating mutations, DNA copy number abundance of ErbB family, and prognosis in lung adenocarcinomaChen H.-Y.; PAN-CHYR YANG et al. Oncotarget1213
5492016The Ecology and Evolution of Cancer: The Ultra-Microevolutionary ProcessWu C.-I.; HURNG-YI WANG ; Ling S.; Lu X.Annual Review of Genetics4043
5502016The effect of three-dimensional conformal radiotherapy on locally recurrent nasopharyngeal carcinoma and on the expression of succinate dehydrogenase BLiu C.-X.; HURNG-YI WANG ; Qian X.-M.; Lu F.-X.; Zhuang S.-F.; Yang M.-X.; Wang F.-L.; Wang Y.-T.European review for medical and pharmacological sciences58
5512016Pathology and molecular detection of rabies virus in ferret badgers associated with a rabies outbreak in TaiwanChiou H.-Y.; Jeng C.-R.; HURNG-YI WANG ; Inoue S.; Chan F.-T.; Liao J.-W.; Chiou M.-T.; Pang V.F.Journal of Wildlife Diseases76
5522016Cost-effectiveness analysis of population-based screening of hepatocellular carcinoma: Comparing ultrasonography with two-stage screeningKuo, Ming-Jeng; HSIU-HSI CHEN ; Chen, Hsiu-Hsi ; Chen, Chi-Ling ; Fann, Jean Ching-Yuan; Chen, Sam Li-Sheng; Chiu, Sherry Yueh-Hsia; Lin, Yu-Min; Liao, Chao-Sheng; Liao, Chao-Sheng; Chang, Hung-Chuen; Lin, Yueh-Shih; Lin, Yueh-Shih; Yen, Amy Ming-FangWorld Journal of Gastroenterology 77
5532016Making good death more accessible: end-of-life care in the intensive care unitHo A.; DANIEL FU-CHANG TSAI Intensive Care Medicine810
5542016Increased rate of DNR status in hospitalized end-of-life patients in TaiwanCheng M.-T.; Hsih F.-Y.; Tsai C.-L.; Tsai H.-B.; DANIEL FU-CHANG TSAI ; Fang C.-C.Intensive Care Medicine77
5552016Ethical Issues in Pre-Implantation Embryonic Genetic DiagnosisYu-Ying Huang; DANIEL FU-CHANG TSAI Formosan Journal of Medicine00
5562016Brief commentaries on the Patient Autonomy Act and its influencesChen-Chi Wu; DANIEL FU-CHANG TSAI HOSPITAL = 醫院雙月刊
5572016Taiwan guideline for the management of gout andhyperuricemia - updated 2016DANIEL FU-CHANG TSAI Formosan Journal of Rheumatology00
5582016Mesenchymal Transitions in Development and DiseaseMedici D.; Mu?oz-C?noves P.; PAN-CHYR YANG ; Brunelli S.Stem Cells International0
5592016Noncoding RNAs in Tumor Epithelial-to-Mesenchymal TransitionLin C.-W.; Lin P.-Y.; PAN-CHYR YANG Stem Cells International25
5602016The Ethical Consideration and Challenge of Health Technology Assessment (HTA)DANIEL FU-CHANG TSAI ; Chang-Yun KuFormosan Journal of Medicine00
5612016MicroRNA and pathogenesis of enterovirus infectionHo B.-C.; PAN-CHYR YANG ; Yu S.-L.Viruses2526
5622016The World Medical Association Declaration of Taipei on Ethical Considerations Regarding Health Databases and BiobanksDANIEL FU-CHANG TSAI ; Tai-Yuan ChiuFormosan Journal of Medicine00
5632016Special Topic: Big Data and Its Medical Applications(I)DANIEL FU-CHANG TSAI Formosan Journal of Medicine
5642016Rapid and quantitative discrimination of tumour cells on tissue slicesKAI-WEN HUANG ; Chieh J.-J.; Liao S.-H.; Wei W.-C.; Hsiao P.-Y.; Yang H.-C.; Horng H.-E.Nanotechnology21
5652016The Ethical Issues Surrounding Vaccine Development and A Reflection on Vaccine Policies in TaiwanDANIEL FU-CHANG TSAI ; Bo-Yu ChenCheng Ching Medical Journa = 澄清醫護管理雜誌
5662016Targeted Delivery of C/EBPα -saRNA by Pancreatic Ductal Adenocarcinoma-specific RNA Aptamers Inhibits Tumor Growth in VivoYoon S.; KAI-WEN HUANG ; Reebye V.; Mintz P.; Tien Y.-W.; Lai H.-S.; S?trom P.; Reccia I.; Swiderski P.; Armstrong B.; Jozwiak A.; Spalding D.; Jiao L.; Habib N.; Rossi J.J.Molecular Therapy3738
5672016Immunomagnetic reduction assay on des-gamma-carboxy prothrombin for screening of hepatocellular carcinomaChieh J.-J.; KAI-WEN HUANG ; Chuang C.P.; Wei W.C.; Dong J.J.; Lee Y.Y.IEEE Transactions on Biomedical Engineering55
5682016The Ethical Issues of Genetic Testing and Counseling for DementiaDANIEL FU-CHANG TSAI ; Yu-Ren Hsu; Chin-Ying Chen; Tzung-Jeng Hwang; Ming-Jang ChiuFormosan Journal of Medicine00
5692016Local Control by Radiofrequency Thermal Ablation Increased Overall Survival in Patients with Refractory Liver Metastases of Colorectal CancerYang P.-C.; Lin B.-R.; Chen Y.-C.; Lin Y.-L.; Lai H.-S.; KAI-WEN HUANG ; Liang J.-T.Medicine (United States)45
5702016Joint Ethics Review Mechanism for Multi-Center Clinical Trials: The International Trend and Taiwan ProgressDANIEL FU-CHANG TSAI ; Chih-Chung Yao; Chih-Liu Lin; Tseng-Fu Chen; Pan-Chyr YangFormosan Journal of Medicine00
5712016Irreversible electroporation in locally advanced pancreatic cancer: A call for standardization of energy deliveryMartin R.C.G.; II, Durham A.N.; Besselink M.G.; Iannitti D.; Weiss M.J.; Wolfgang C.L.; KAI-WEN HUANG Journal of Surgical Oncology4746
5722016Factors in association between Parkinson disease and risk of cancer in Taiwan - ReplyLin P.-Y.; Lin C.-H.; PAN-CHYR YANG JAMA Oncology11
5732016A pilot proof-of-principle study to compare fresh and vitrified cycle preimplantation genetic screening by chromosome microarray and next generation sequencingMa, Gwo-Chin; MING CHEN ; HSIN-FU CHEN ; YU-SHIH YANG; Lin, Wen-Hsiang; Tsai, Feng-Po; Lin, Chi-Fang; Chiu, ChiMolecular Cytogenetics 1111
5742016Programmed cell death-ligand 1 expression is associated with a favourable immune microenvironment and better overall survival in stage i pulmonary squamous cell carcinomaYang C.-Y.; Lin M.-W.; Chang Y.-L.; Wu C.-T.; PAN-CHYR YANG European Journal of Cancer9088
5752016Remote Control of Light-Triggered VirotherapyTseng S.-J.; Huang K.-Y.; Kempson I.M.; Kao S.-H.; Liu M.-C.; Yang S.-C.; Liao Z.-X.; PAN-CHYR YANG ACS Nano1919
5762016The Prognostic Significance of pSTAT1 and CD163 Expressions in Surgically Resected Stage 1 Pulmonary Squamous Cell CarcinomasLin M.-W.; Yang C.-Y.; Kuo S.-W.; Wu C.-T.; Chang Y.-L.; PAN-CHYR YANG Annals of Surgical Oncology33
5772016Association of BIM deletion polymorphism with intrinsic resistance to EGFR tyrosine kinase inhibitors in patients with lung adenocarcinomaWu S.-G.; Liu Y.-N.; Yu C.-J.; PAN-CHYR YANG ; Shih J.-Y.JAMA Oncology1513
5782016Remote Control of Light-Triggered VirotherapyS.-Ja Tseng; Kuo-Yen Huang; Ivan M. Kempson; Shih-Han Kao; Meng-Chia Liu; Shuenn-Chen Yang; Zi-Xian Liao; PAN-CHYR YANG {ACS} Nano19
5792016Efficacy of pemetrexed-based chemotherapy in patients with ROS1 fusion-positive lung adenocarcinoma compared with in patients harboring other driver mutations in East Asian populationsChen Y.-F.; Hsieh M.-S.; Wu S.-G.; Chang Y.-L.; Yu C.-J.; Yang J.C.-H.; PAN-CHYR YANG ; Shih J.-Y.Journal of Thoracic Oncology3736
5802016The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patientsWu S-G.; Liu Y.-N.; Tsai M.-F.; Chang Y.-L.; Yu C.-J.; PAN-CHYR YANG ; Yang J.C.-H.; Wen Y.-F.; Shih J.-Y.Oncotarget148146
5812016Uncovering synthetic lethal interactions for therapeutic targets and predictive markers in lung adenocarcinomaChang J.-G.; Chen C.-C.; Wu Y.-Y.; Che T.-F.; Huang Y.-S.; Yeh K.-T.; Shieh G.S.; PAN-CHYR YANG Oncotarget46
5822016Kinesin-5 Contributes to Spindle-length Scaling in the Evolution of Cancer toward MetastasisYang C.-F.; Tsai W.-Y.; Chen W.-A.; Liang K.-W.; Pan C.-J.; Lai P.-L.; PAN-CHYR YANG ; Huang H.-C.Scientific Reports1010
5832016Heterogeneous nuclear ribonucleoproteins A1 and A2 modulate expression of Tid1 isoforms and EGFR signaling in non-small cell lung cancerChen C.-Y.; Jan C.-I.; Pi W.-C.; Wang W.-L.; PAN-CHYR YANG ; Wang T.-H.; Karni R.; Wang T.-C.V.Oncotarget1012
5842016The prevalence of expression of MAGE-A3 and PRAME tumor antigens in East and South East Asian non-small cell lung cancer patientsThongprasert S.; PAN-CHYR YANG ; Lee J.S.; Soo R.; Gruselle O.; Myo A.; Louahed J.; Lehmann F.F.; Brichard V.G.; Coche T.Lung Cancer88
5852016High co-expression of PD-L1 and HIF-1α correlates with tumour necrosis in pulmonary pleomorphic carcinomaChang Y.-L.; Yang C.-Y.; Lin M.-W.; Wu C.-T.; PAN-CHYR YANG European Journal of Cancer5959
5862016The GlnR Regulon in Streptococcus mutans Is Differentially Regulated by GlnR and PmrAChen, Yi-Ywan M; Chen, Yueh-Ying; Hung, Jui-Lung; Chen, Pei-Min; JEAN-SAN CHIA PloS one44
5872016The role of PIK3CA mutations among lung adenocarcinoma patients with primary and acquired resistance to EGFR tyrosine kinase inhibitionWu S.-G.; Chang Y.-L.; Yu C.-J.; PAN-CHYR YANG ; Shih J.-Y.Scientific Reports2120
5882016A Novel PD-L1-targeting Antagonistic DNA Aptamer With Antitumor EffectsLai W.-Y.; Huang B.-T.; Wang J.-W.; Lin P.-Y.; PAN-CHYR YANG Molecular Therapy - Nucleic Acids39
589201678P LCRMP-1 associated aptamers inhibit tumor metastasisHung P.-F.; Chang Y.-C.; Hong T.-M.; PAN-CHYR YANG ; Pan S.-H.Journal of Thoracic Oncology0
5902016Does a rifamycin-containing preventive regimen increase rifampicin resistance? An unresolved concernWang J.-Y.; PAN-CHYR YANG International Journal of Tuberculosis and Lung Disease1
5912016Characterization of metastatic tumor antigen 1 and its interaction with hepatitis B virus X protein in NF-κB signaling and tumor progression in a woodchuck hepatocellular carcinoma modelLi Y.-T.; Liu C.-J.; Su T.-H.; Cheng H.-R.; Jeng Y.-M.; Lin H.-L.; Wang C.-C.; Kao J.-H.; PEI-JER CHEN ; Chen D.-S.; Wu H.-L.Oncotarget4
5922016Skeletal muscle mass adjusted by height correlated better with muscular functions than that adjusted by body weight in defining sarcopeniaHan D.-S.; Chang K.-V.; Li C.-M.; Lin Y.-H.; Kao T.-W.; Tsai K.-S.; Wang T.-G.; WEI-SHIUNG YANG Scientific Reports53
5932016Serum Spot 14 concentration is negatively associated with thyroid-stimulating hormone levelChen Y.-T.; Tseng F.-Y.; PEI-LUNG CHEN ; Chi Y.-C.; Han D.-S.; Yang W.-S.Medicine (United States)2
5942016KCNN2 polymorphisms and cardiac tachyarrhythmiasYu C.-C.; Chia-Ti T.; Chen P.-L.; Wu C.-K.; Chiu F.-C.; Chiang F.-T.; Chen P.-S.; Chen C.-L.; Lin L.-Y.; Juang J.-M.; Ho L.-T.; La L.-P.; WEI-SHIUNG YANG ; Lin J.-L.Medicine (United States)8
5952016Health-related quality of life in thrombocytopenic patients with chronic hepatitis C with or without cirrhosis in the ENABLE-1 and ENABLE-2 studiesGrotzinger K.M.; Younossi Z.M.; Giannini E.G.; PEI-JER CHEN ; Rendas-Baum R.; Theodore D.Health and Quality of Life Outcomes2
5962016Clinical heterogeneity of LRRK2 p.I2012T mutationFan T.-S.; Wu R.-M.; PEI-LUNG CHEN ; Chen T.-F.; Li H.-Y.; Lin Y.-H.; Chen C.-Y.; Chen M.-L.; Tai C.-H.; Lin H.-I.; Lin C.-H.Parkinsonism and Related Disorders9
5972016Prolonged suppression of HBV in mice by a novel antibody that targets a unique epitope on hepatitis B surface antigenZhang T.-Y.; Yuan Q.; Zhao J.-H.; Zhang Y.-L.; Yuan L.-Z.; Lan Y.; Lo Y.-C.; Sun C.-P.; Wu C.-R.; Zhang J.-F.; Zhang Y.; Cao J.-L.; Guo X.-R.; Liu X.; Mo X.-B.; Luo W.-X.; Cheng T.; Chen Y.-X.; Tao M.-H.; Shih J.W.K.; Zhao Q.-J.; Zhang J.; PEI-JER CHEN ; Yuan Y.A.; Xia N.-S.Gut62
5982016Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 updateSarin S.K.; Kumar M.; Lau G.K.; Abbas Z.; Chan H.L.Y.; Chen C.J.; Chen D.S.; Chen H.L.; PEI-JER CHEN ; Chien R.N.; Dokmeci A.K.; Gane E.; Hou J.L.; Jafri W.; Jia J.; Kim J.H.; Lai C.L.; Lee H.C.; Lim S.G.; Liu C.J.; Locarnini S.; Al Mahtab M.; Mohamed R.; Omata M.; Park J.; Piratvisuth T.; Sharma B.C.; Sollano J.; Wang F.S.; Wei L.; Yuen M.F.; Zheng S.S.; Kao J.H.Hepatology International1108
5992016Peginterferon lambda for the treatment of HBeAg-positive chronic hepatitis B: A randomized phase 2b study (LIRA-B)Chan H.L.Y.; Ahn S.H.; Chang T.-T.; Peng C.-Y.; Wong D.; Coffin C.S.; Lim S.G.; PEI-JER CHEN ; Janssen H.L.A.; Marcellin P.; Serfaty L.; Zeuzem S.; Cohen D.; Critelli L.; Xu D.; Wind-Rotolo M.; Cooney E.; LIRA-B Study TeamJournal of Hepatology44
6002016Next generation sequencing yields the complete mitochondrial genome of the flathead mullet, Mugil cephalus cryptic species NWP2 (Teleostei: Mugilidae)Shen K.-N.; Yen T.-C.; Chen C.-H.; Li H.-Y.; PEI-LUNG CHEN ; Hsiao C.-D.Mitochondrial DNA. Part A, DNA mapping, sequencing, and analysis31
6012016Serum Spot 14 concentration is negatively associated with thyroid-stimulating hormone levelChen Y.-T.; Tseng F.-Y.; Chen P.-L.; Chi Y.-C.; Han D.-S.; WEI-SHIUNG YANG Medicine (United States)2
6022016Downregulation of angiotensin type 1 receptor and nuclear factor-κ B by sirtuin 1 contributes to renoprotection in unilateral ureteral obstructionYang S.-Y.; Lin S.-L.; Chen Y.-M.; Wu V.-C.; WEI-SHIUNG YANG ; Wu K.-D.Scientific Reports6
6032016Increased follistatin associated with decreased gait speed among old adultsLiaw F.-Y.; Kao T.-W.; Fang W.-H.; Han D.-S.; Chi Y.-C.; WEI-SHIUNG YANG European Journal of Clinical Investigation5
6042016Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancerLin P.-H.; Kuo W.-H.; Huang A.-C.; Lu Y.-S.; Lin C.-H.; Kuo S.-H.; Wang M.-Y.; Liu C.-Y.; Cheng F.T.-F.; Yeh M.-H.; Li H.-Y.; Yang Y.-H.; Hsu Y.-H.; Fan S.-C.; Li L.-Y.; Yu S.-L.; Chang K.-J.; PEI-LUNG CHEN ; Ni Y.-H.; Huang C.-S.Oncotarget45
6052016First step towards precision medicine for antithyroid drug-induced agranulocytosisChen P.-L.; Fann C.S.-J.; Shih S.-R.; WEI-SHIUNG YANG ; Chang T.-C.The Lancet Diabetes and Endocrinology1
6062016Follicular thyroid carcinoma with NRAS Q61K and GNAS R201H mutations that had a good 131I treatment responseLu J.-Y.; Hung P.-J.; PEI-LUNG CHEN ; Yen R.-F.; Kuo K.-T.; Yang T.-L.; Wang C.-Y.; Chang T.-C.; Huang T.-S.; Chang C.-C.Endocrinology, Diabetes and Metabolism Case Reports6
6072016Prevalence and clinical implications of IL28B genotypes in Taiwanese patients with chronic hepatitis CMah Y.-H.; Liu C.-H.; Chen C.-L.; Tseng T.-C.; Liu C.-J.; PEI-JER CHEN ; Chen D.-S.; Kao J.-H.Journal of the Formosan Medical Association7
6082016Examining how p16 INK4a expression levels are linked to handgrip strength in the elderlyKao T.-W.; Chen W.-L.; Han D.-S.; Huang Y.-H.; Chen C.-L.; WEI-SHIUNG YANG Scientific Reports3
6092016Duodenojejunal Bypass Leads to Altered Gut Microbiota and Strengthened Epithelial Barriers in RatsYang P.-J.; WEI-SHIUNG YANG ; Nien H.-C.; Chen C.-N.; Lee P.-H.; Yu L.C.-H.; Lin M.-T.Obesity Surgery16
6102016A link between adipogenesis and innate immunity: RNase-L promotes 3T3-L1 adipogenesis by destabilizing Pref-1 mRNAWang Y.-T.; Chiang H.-H.; Huang Y.-S.; Hsu C.-L.; Yang P.-J.; Juan H.-F.; WEI-SHIUNG YANG Cell Death and Disease6
6112016Associations between lower urinary tract dysfunction and glycemic control in women with type 2 diabetes: A cross-sectional studyTai H.-C.; Tai T.-Y.; WEI-SHIUNG YANG ; Wang S.-W.; Yu H.-J.Journal of Diabetes and its Complications3
6122016Cleaved but not endogenous secretory RAGE is associated with outcome in acute ischemic strokeTang S.-C.; Yeh S.-J.; Tsai L.-K.; Hu C.-J.; Lien L.-M.; Peng G.-S.; WEI-SHIUNG YANG ; Chiou H.-Y.; Jeng J.-S.Neurology15
6132016Hypoxia-activated cytotoxic agent tirapazamine enhances hepatic artery ligation-induced killing of liver tumor in HBx transgenic miceLin W.-H.; Yeh S.-H.; Yeh K.-H.; Chen K.-W.; Cheng Y.-W.; Su T.-H.; Jao P.; Ni L.-C.; PEI-JER CHEN ; Chen D.-S.Proceedings of the National Academy of Sciences of the United States of America19
6142016Association of serum myokines and aerobic exercise training in patients with spinal cord injury: An observational studyHan D.-S.; Hsiao M.-Y.; Wang T.-G.; Chen S.-Y.; WEI-SHIUNG YANG BMC Neurology9
6152016A low-salt diet increases the expression of renal sirtuin 1 through activation of the ghrelin receptor in ratsYang S.-Y.; Lin S.-L.; Chen Y.-M.; Wu V.-C.; WEI-SHIUNG YANG ; Wu K.-D.Scientific Reports7
6162016The Hepatitis Viral Status in Patients with Hepatocellular Carcinoma: A Study of 3843 Patients from Taiwan Liver Cancer NetworkChang I.-C.; Huang S.-F.; PEI-JER CHEN ; Chen C.-L.; Chen C.-L.; Wu C.-C.; Tsai C.-C.; Lee P.-H.; Chen M.-F.; Lee C.-M.; Yu H.-C.; Lo G.-H.; Yeh C.-T.; Hong C.-C.; Eng H.-L.; Wang J.; Tseng H.-H.; Hsiao C.-H.; Wu H.-D.I.; Yen T.-C.; Liaw Y.-F.Medicine (United States)28
6172016Progressive accumulation of mutations in the hepatitis B virus genome and its impact on time to diagnosis of hepatocellular carcinomaSung F.-Y.; Lan C.-Y.; Huang C.-J.; Lin C.-L.; Liu C.-J.; PEI-JER CHEN ; Lin S.-M.; Yu M.-W.Hepatology10
6182016Chronic Hepatitis B virus infectionYuen M.-F.; Ahn S.H.; Chen D.-S.; PEI-JER CHEN ; Dusheiko G.M.; Hou J.-L.; Maddrey W.C.; Mizokami M.; Seto W.-K.; Zoulim F.; Lai C.-L.Journal of Clinical Gastroenterology36
6192016Perspectives on dual hepatitis B and C infection in TaiwanLiu C.-J.; PEI-JER CHEN ; Chen D.-S.; Tseng T.-C.; Kao J.-H.Journal of the Formosan Medical Association8
6202016KCNN2 polymorphisms and cardiac tachyarrhythmiasYu C.-C.; Chia-Ti T.; PEI-LUNG CHEN ; Wu C.-K.; Chiu F.-C.; Chiang F.-T.; Chen P.-S.; Chen C.-L.; Lin L.-Y.; Juang J.-M.; Ho L.-T.; La L.-P.; Yang W.-S.; Lin J.-L.Medicine (United States)8
6212016Serum levels of follistatin are positively associated with serum-free thyroxine levels in patients with hyperthyroidism or euthyroidismTseng F.-Y.; Chen Y.-T.; Chi Y.-C.; Chen P.-L.; WEI-SHIUNG YANG Medicine (United States)4
6222016First step towards precision medicine for antithyroid drug-induced agranulocytosisPEI-LUNG CHEN ; Fann C.S.-J.; Shih S.-R.; Yang W.-S.; Chang T.-C.The Lancet Diabetes and Endocrinology1
6232016Astaxanthin inhibits expression of retinal oxidative stress and inflammatory mediators in streptozotocin-induced diabetic ratsYeh P.-T.; Huang H.-W.; Yang C.-M.; WEI-SHIUNG YANG ; Yang C.-H.PLoS ONE63
6242016Liver gene expression profiles correlate with virus infection and response to interferon therapy in chronic hepatitis B patientsWu H.-L.; Hsiao T.-H.; PEI-JER CHEN ; Wong S.-H.; Kao J.-H.; Chen D.-S.; Lu J.-Y.; Lu T.-P.; Chen Y.; Chuang E.Y.; Tu H.-C.; Liu C.-J.Scientific Reports16
6252016Hepatocellular carcinoma and hepatitis C virusWang S.-H.; Yeh S.-H.; PEI-JER CHEN Hepatitis C Virus II: Infection and Disease0
6262016Hepatitis C viral infection increases the risk of lymphoid-neoplasms: A population-based cohort studySu T.-H.; Liu C.-J.; Tseng T.-C.; Chou S.-W.; Liu C.-H.; Yang H.-C.; Wu S.-J.; PEI-JER CHEN ; Chen D.-S.; Chen C.-L.; Kao J.-H.Hepatology27
6272016Serum levels of follistatin are positively associated with serum-free thyroxine levels in patients with hyperthyroidism or euthyroidismTseng F.-Y.; Chen Y.-T.; Chi Y.-C.; PEI-LUNG CHEN ; Yang W.-S.Medicine (United States)4
6282016Hepatitis B surface antigen loss and hepatocellular carcinoma development in patients with dual hepatitis B and C infectionYang W.-T.; Wu L.-W.; Tseng T.-C.; Chen C.-L.; Yang H.-C.; Su T.-H.; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; PEI-JER CHEN ; Chen D.-S.; Liu C.-J.; Kao J.-H.Medicine (United States)9
6292016In vitro and in vivo models to study corneal endothelial-mesenchymal transitionHo W.-T.; Su C.-C.; Chang J.-S.; Chang S.-W.; Hu F.-R.; TZUU-SHUH JOU ; Wang I.-J.Journal of Visualized Experiments2
6302016Peroxiredoxin 1 induces inflammatory cytokine response and predicts outcome of cardiogenic shock patients necessitating extracorporeal membrane oxygenation: An observational cohort study and translational approachLiu C.-H.; Kuo S.-W.; Hsu L.-M.; Huang S.-C.; Wang C.-H.; Tsai P.-R.; Chen Y.-S.; TZUU-SHUH JOU ; Ko W.-J.Journal of Translational Medicine23
6312016Ras-activated RSK1 phosphorylates EBP50 to regulate its nuclear localization and promote cell proliferationLim H.; TZUU-SHUH JOU Oncotarget9
6322016Faldaprevir, pegylated interferon, and ribavirin for treatment-na?ve HCV genotype-1: Pooled analysis of two phase 3 trialsJensen D.M.; Asselah T.; Dieterich D.; Foster G.R.; Sulkowski M.S.; Zeuzem S.; Mantry P.; Yoshida E.M.; Moreno C.; Ouzan D.; Wright M.; Morano L.E.; Buynak R.; Bourli?re M.; Hassanein T.; Nishiguchi S.; JIA-HORNG KAO ; Omata M.; Paik S.W.; Wong D.K.; Tam E.; Kaita K.; Victor Feinman S.; Stern J.O.; Scherer J.; Quinson A.-M.; Voss F.; Gallivan J.-P.; B?cher W.O.; Ferenci P.Annals of Hepatology0
6332016Ledipasvir/sofosbuvir fixed-dose combination tablet in Taiwanese patients with chronic genotype 1 hepatitis C virusChuang W.-L.; Chien R.-N.; Peng C.-Y.; Chang T.-T.; Lo G.-H.; Sheen I.-S.; Wang H.-Y.; Chen J.-J.; Yang J.C.; Knox S.J.; Gao B.; Garrison K.L.; Mo H.; Pang P.S.; Hsu Y.-C.; Hu T.-H.; Chu C.-J.; JIA-HORNG KAO Journal of Gastroenterology and Hepatology (Australia)19
6342016Daclatasvir plus asunaprevir for HCV genotype 1b infection in patients with or without compensated cirrhosis: a pooled analysisJIA-HORNG KAO ; Jensen D.M.; Manns M.P.; Jacobson I.; Kumada H.; Toyota J.; Heo J.; Yoffe B.; Sievert W.; Bessone F.; Peng C.-Y.; Roberts S.K.; Lee Y.-J.; Bhore R.; Mendez P.; Hughes E.; Noviello S.Liver International11
6352016Hepatitis B surface antigen loss and hepatocellular carcinoma development in patients with dual hepatitis B and C infectionYang W.-T.; Wu L.-W.; Tseng T.-C.; Chen C.-L.; Yang H.-C.; Su T.-H.; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Liu C.-J.; JIA-HORNG KAO Medicine (United States)9
6362016Efficacy of entecavir therapy for hepatitis B e-antigen positive chronic hepatitis B patients with prior exposure to interferon or nucleoside/nucleotide analoguesTseng K.-C.; Tseng C.-W.; Hsieh T.-Y.; Peng C.-Y.; Lin C.-L.; Su T.-H.; Tseng T.-C.; Lin H.H.; Wang C.-C.; JIA-HORNG KAO Hepatology Research0
6372016How have the recent advances in antiviral therapy impacted the management of virus-related hepatocellular carcinoma?Wang C.-C.; JIA-HORNG KAO Expert Opinion on Pharmacotherapy9
6382016Perspectives on dual hepatitis B and C infection in TaiwanLiu C.-J.; Chen P.-J.; Chen D.-S.; Tseng T.-C.; JIA-HORNG KAO Journal of the Formosan Medical Association8
6392016Review article: novel therapies for hepatitis B virus cure – advances and perspectivesLin C.-L.; JIA-HORNG KAO Alimentary Pharmacology and Therapeutics35
6402016Management of hepatitis C patients with decompensated liver diseaseHsu C.-S.; JIA-HORNG KAO Expert Review of Gastroenterology and Hepatology4
6412016Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 updateSarin S.K.; Kumar M.; Lau G.K.; Abbas Z.; Chan H.L.Y.; Chen C.J.; Chen D.S.; Chen H.L.; Chen P.J.; Chien R.N.; Dokmeci A.K.; Gane E.; Hou J.L.; Jafri W.; Jia J.; Kim J.H.; Lai C.L.; Lee H.C.; Lim S.G.; Liu C.J.; Locarnini S.; Al Mahtab M.; Mohamed R.; Omata M.; Park J.; Piratvisuth T.; Sharma B.C.; Sollano J.; Wang F.S.; Wei L.; Yuen M.F.; Zheng S.S.; JIA-HORNG KAO Hepatology International1108
6422016Characterization of metastatic tumor antigen 1 and its interaction with hepatitis B virus X protein in NF-κB signaling and tumor progression in a woodchuck hepatocellular carcinoma modelLi Y.-T.; Liu C.-J.; Su T.-H.; Cheng H.-R.; Jeng Y.-M.; Lin H.-L.; Wang C.-C.; JIA-HORNG KAO ; Chen P.-J.; Chen D.-S.; Wu H.-L.Oncotarget4
6432016Efficacy and resistance to telbivudine treatment in chronic hepatitis B patients with favorable predictors: a multicenter study in TaiwanWang C.-C.; Lin C.-L.; Hsieh T.-Y.; Tseng K.-C.; Peng C.-Y.; Su T.-H.; Yang S.-S.; Hsu Y.-C.; Chen T.-M.; JIA-HORNG KAO Hepatology International2
6442016Hepatitis C viral infection increases the risk of lymphoid-neoplasms: A population-based cohort studySu T.-H.; Liu C.-J.; Tseng T.-C.; Chou S.-W.; Liu C.-H.; Yang H.-C.; Wu S.-J.; Chen P.-J.; Chen D.-S.; Chen C.-L.; JIA-HORNG KAO Hepatology27
6452016Hepatocellular carcinoma recurrence after interferon-free direct acting antiviral treatment for chronic hepatitis C virus infection: Fact or fiction?Liu C.-H.; JIA-HORNG KAO Translational Cancer Research3
6462016Daclatasvir-containing all-oral regimens for the treatment of hepatitis C virus infectionYang S.-S.; JIA-HORNG KAO Hepatology International7
6472016New perspectives of biomarkers for the management of chronic hepatitis BLin C.-L.; JIA-HORNG KAO Clinical and Molecular Hepatology39
6482016Hepatitis C virus infection in Taiwan: Past, present, and futureJIA-HORNG KAO Journal of the Formosan Medical Association51
6492016HIV/HCV coinfection in TaiwanHsu C.-S.; JIA-HORNG KAO AIDS Reviews2
6502016APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testingOmata M.; Kanda T.; Wei L.; Yu M.-L.; Chuang W.-L.; Ibrahim A.; Lesmana C.R.A.; Sollano J.; Kumar M.; Jindal A.; Sharma B.C.; Hamid S.S.; Dokmeci A.K.; Al-Mahtab M.; McCaughan G.W.; Wasim J.; Crawford D.H.G.; JIA-HORNG KAO ; Yokosuka O.; Lau G.K.K.; Sarin S.K.Hepatology International58
6512016A phase 3b study of sofosbuvir plus ribavirin in Taiwanese patients with chronic genotype 2 hepatitis C virus infectionJIA-HORNG KAO ; Chien R.-N.; Chang T.-T.; Peng C.-Y.; Hu T.-H.; Lo G.-H.; Wang H.-Y.; Chen J.-J.; Yang J.C.; Knox S.J.; Han L.; Mo H.; Mathias A.; Brainard D.M.; Sheen I.-S.; Hsu Y.-C.; Chu C.-J.; Chuang W.-L.Liver International23
6522016Association Between Serum Level of Hepatitis B Surface Antigen at End of Entecavir Therapy and Risk of Relapse in E Antigen–Negative PatientsHsu Y.-C.; Mo L.-R.; Chang C.-Y.; Wu M.-S.; JIA-HORNG KAO ; Wang W.-L.; Yang T.-H.; Wang C.-S.; Chiang M.-F.; Chen C.-C.; Fang Y.-J.; Hung H.-W.; Wu C.-Y.; Lin J.-T.Clinical Gastroenterology and Hepatology24
6532016APASL consensus statements and recommendation on treatment of hepatitis COmata M.; Kanda T.; Wei L.; Yu M.-L.; Chuang W.-L.; Ibrahim A.; Lesmana C.R.A.; Sollano J.; Kumar M.; Jindal A.; Sharma B.C.; Hamid S.S.; Dokmeci A.K.; Mamun-Al-Mahtab, McCaughan G.W.; Wasim J.; Crawford D.H.G.; JIA-HORNG KAO ; Yokosuka O.; Lau G.K.K.; Sarin S.K.Hepatology International137
6542016Ritonavir-boosted danoprevir plus peginterferon alfa-2a and ribavirin in Asian chronic hepatitis C patients with or without cirrhosisJIA-HORNG KAO ; Tung S.-Y.; Lee Y.; Thongsawat S.; Tanwandee T.; Sheen I.-S.; Wu J.J.; Li H.; Brennan B.J.; Zhou J.; Le Pogam S.; Najera I.; Thommes J.A.; Hill G.Journal of Gastroenterology and Hepatology (Australia)7
6552016All-oral daclatasvir plus asunaprevir for chronic hepatitis C virus (HCV) genotype 1b infection: a sub-analysis in Asian patients from the HALLMARK DUAL studyJIA-HORNG KAO ; Lee Y.-J.; Heo J.; Ahn S.-H.; Lim Y.-S.; Peng C.-Y.; Chang T.-T.; Torbeyns A.; Hughes E.; Bhore R.; Noviello S.Liver International23
6562016Liver gene expression profiles correlate with virus infection and response to interferon therapy in chronic hepatitis B patientsWu H.-L.; Hsiao T.-H.; Chen P.-J.; Wong S.-H.; JIA-HORNG KAO ; Chen D.-S.; Lu J.-Y.; Lu T.-P.; Chen Y.; Chuang E.Y.; Tu H.-C.; Liu C.-J.Scientific Reports16
6572016Association of SCARB1 Gene Polymorphisms with Virological Response in Chronic Hepatitis C Patients Receiving Pegylated Interferon plus Ribavirin TherapyHsu C.-S.; Hsu S.-J.; Liu W.-L.; Chen D.-S.; JIA-HORNG KAO Scientific Reports9
6582016Assessing the Durability of Entecavir-Treated Hepatitis B Using Quantitative HBsAgWang C.-C.; Tseng K.-C.; Hsieh T.-Y.; Tseng T.-C.; Lin H.H.; JIA-HORNG KAO American Journal of Gastroenterology42
6592016Incorporating Serum Level of Hepatitis B Surface Antigen or Omitting Level of Hepatitis B Virus DNA Does not Affect Calculation of Risk for Hepatocellular Carcinoma in Patients Without CirrhosisYang H.-I.; Tseng T.-C.; Liu J.; Lee M.-H.; Liu C.-J.; Su T.-H.; Batrla-Utermann R.; Chan H.L.Y.; JIA-HORNG KAO ; Chen C.-J.Clinical Gastroenterology and Hepatology15
6602016Looking into the crystal ball: biomarkers for outcomes of HBV infectionYang H.-C.; JIA-HORNG KAO Hepatology International10
6612016Hepatitis B virus: New therapeutic perspectivesLin C.-L.; Yang H.-C.; JIA-HORNG KAO Liver International31
6622016Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patientsSu T.-H.; Hu T.-H.; Chen C.-Y.; Huang Y.-H.; Chuang W.-L.; Lin C.-C.; Wang C.-C.; Su W.-W.; Chen M.-Y.; Peng C.-Y.; Chien R.-N.; Huang Y.-W.; Wang H.-Y.; Lin C.-L.; Yang S.-S.; Chen T.-M.; Mo L.-R.; Hsu S.-J.; Tseng K.-C.; Hsieh T.-Y.; Suk F.-M.; Hu C.-T.; Bair M.-J.; Liang C.-C.; Lei Y.-C.; Tseng T.-C.; Chen C.-L.; JIA-HORNG KAO ; the C-TEAM study group; the Taiwan Liver Diseases ConsortiumLiver International103
6632016Peginterferon Lambda-1a/ribavirin with daclatasvir or peginterferon alfa-2a/ribavirin with telaprevir for chronic hepatitis c genotype 1bFlisiak R.; Kawazoe S.; Znoyko O.; Assy N.; Gadano A.; JIA-HORNG KAO ; Lee K.-S.; Zwirtes R.; Portsmouth S.; Dong Y.; Xu D.; Kumada H.; Srinivasan S.Journal of Interferon and Cytokine Research6
6642016No Evidence of Reactivation of Hepatitis B Virus among Patients Treated with Ledipasvir-Sofosbuvir for Hepatitis C Virus InfectionSulkowski M.S.; Chuang W.-L.; JIA-HORNG KAO ; Yang J.C.; Gao B.; Brainard D.M.; Han K.-H.; Gane E.Clinical Infectious Diseases51
6652016Prevalence and clinical implications of IL28B genotypes in Taiwanese patients with chronic hepatitis CMah Y.-H.; Liu C.-H.; Chen C.-L.; Tseng T.-C.; Liu C.-J.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO Journal of the Formosan Medical Association7
6662016Pegylated IFN-α suppresses hepatitis C virus by promoting the DAPK-mTOR pathwayLiu W.-L.; Yang H.-C.; Hsu C.-S.; Wang C.-C.; Wang T.-S.; JIA-HORNG KAO ; Chen D.-S.Proceedings of the National Academy of Sciences of the United States of America7
6672016Associated factors and clinical implications of serum aminotransferase elevation in scrub typhusSu T.-H.; Liu C.-J.; Shu P.-Y.; Fu Y.-H.; Chang C.-H.; Jao P.; JIA-HORNG KAO Journal of Microbiology, Immunology and Infection2
6682016ReplySu T.-H.; Chen C.-L.; JIA-HORNG KAO Hepatology0
6692015Clinical outcome affected by tumor morcellation in unexpected early uterine leiomyosarcoma.Lin, Kuan-Hung; PAO-LING TORNG; Torng, Pao-Ling; Torng, Pao-Ling; Tsai, Ko-Hsin; Tsai, Ko-Hsin; Shih, Ho-Jun; Shih, Ho-Jun; Chen, Chi-Ling 89
6702015Interactions between household air pollution and GWAS-identified lung cancer susceptibility markers in the Female Lung Cancer Consortium in Asia (FLCCA)Hosgood H.D.; PAN-CHYR YANG et al. Human Genetics2524
6712015Identification of Five Driver Gene Mutations in Patients with Treatment-Na?ve Lung Adenocarcinoma in TaiwanHsu K.-H.; PAN-CHYR YANG et al. PLoS ONE56
6722015Estrogen receptor gene polymorphisms and lung adenocarcinoma risk in never-smoking womenChen K.-Y.; PAN-CHYR YANG et al. Journal of Thoracic Oncology117
6732015Opposite Effects of M1 and M2 Macrophage Subtypes on Lung Cancer ProgressionYuan A.; PAN-CHYR YANG et al. Scientific Reports163156
6742015Novel curcumin analogs to overcome EGFR-TKI lung adenocarcinoma drug resistance and reduce EGFR-TKI-induced GI adverse effectsWada K.; PAN-CHYR YANG et al. Bioorganic and Medicinal Chemistry2023
6752015Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer typesSampson J.N.; PAN-CHYR YANG et al. Journal of the National Cancer Institute84
6762015Characterization of large structural genetic mosaicism in human autosomesMachiela M.J.; PAN-CHYR YANG et al. American Journal of Human Genetics6663
6772015Slug is temporally regulated by cyclin e in cell cycle and controls genome stabilityWang W.-L.; PAN-CHYR YANG et al. Oncogene2222
6782015Genetic variants associated with longer telomere length are associated with increased lung cancer risk among never-smoking women in Asia: A report from the female lung cancer consortium in AsiaMachiela M.J.; PAN-CHYR YANG et al. International Journal of Cancer6151
6792015Severe Lymphopenia Is Associated with Elevated Plasma Interleukin-15 Levels and Increased Mortality during Severe SepsisChung K.-P.; PAN-CHYR YANG et al. Shock3535
6802015Highly specific in vivo gene delivery for p53-mediated apoptosis and genetic photodynamic therapies of tumourTseng S.-J.; PAN-CHYR YANG et al. Nature Communications7068
6812015Heparin co-factor II enhances cell motility and promotes metastasis in non-small cell lung cancerLiao W.-Y.; PAN-CHYR YANG et al. Journal of Pathology1816
68220152015年美國糖尿病學會臨床治療指引摘要WEI-SHIUNG YANG 台北市醫師公會會刊 
6832015Gender-Dimorphic Impact of PXR Genotype and Haplotype on Hepatotoxicity During Antituberculosis TreatmentWang J.Y.; Tsai C.H.; Lee Y.L.; Lee L.N.; Hsu C.L.; Chang H.C.; Chen J.M.; Hsu C.A.; Yu C.J.; PAN-CHYR YANG Medicine1211
6842015EGFR-L858R mutant enhances lung adenocarcinoma cell invasive ability and promotes malignant pleural effusion formation through activation of the CXCL12-CXCR4 pathwayTsai M.-F.; Chang T.-H.; Wu S.-G.; Yang H.-Y.; Hsu Y.-C.; PAN-CHYR YANG ; Shih J.-Y.Scientific Reports2828
6852015Estimated creatinine clearance rate is associated with the treatment effectiveness and toxicity of pemetrexed as continuation maintenance therapy for advanced nonsquamous non-small-cell lung cancerChen C.-Y.; Lin J.-W.; Huang J.-W.; Chen K.-Y.; Shih J.-Y.; Yu C.-J.; PAN-CHYR YANG Clinical Lung Cancer66
6862015Functional and structural deficits of the dentate gyrus network coincide with emerging spontaneous seizures in an Scn1a mutant dravet syndrome model during developmentTsai M.-S.; Lee M.-L.; Chang C.-Y.; Fan H.-H.; Yu I.-S.; YOU-TZUNG CHEN ; You J.-Y.; Chen C.-Y.; Chang F.-C.; Hsiao J.H.; Khorkova O.; Liou H.-H.; Yanagawa Y.; Lee L.-J.; Lin S.-W.Neurobiology of Disease2223
6872015Pathway-based gene signatures predicting clinical outcome of lung adenocarcinomaChang Y.-H.; Chen C.-M.; Chen H.-Y.; PAN-CHYR YANG Scientific Reports2923
6882015Association between Parkinson disease and risk of cancer in TaiwanLin P.-Y.; Chang S.-N.; Hsiao T.-H.; Huang B.-T.; Lin C.-H.; PAN-CHYR YANG JAMA Oncology4143
6892015PD-L1 is highly expressed in lung lymphoepithelioma-like carcinoma: A potential rationale for immunotherapyChang Y.-L.; Yang C.-Y.; Lin M.-W.; Wu C.-T.; PAN-CHYR YANG Lung Cancer4847
6902015Mitochondrial translocation of EGFR regulates mitochondria dynamics and promotes metastasis in NSCLCChe T.-F.; Lin C.-W.; Wu Y.-Y.; Chen Y.-J.; Han C.-L.; Chang Y.; Wu C.-T.; Hsiao T.-H.; Hong T.-M.; PAN-CHYR YANG Oncotarget3841
6912015miR-146a and miR-370 coordinate enterovirus 71-induced cell apoptosis through targeting SOS1 and GADD45βChang Y.-L.; Ho B.-C.; Sher S.; Yu S.-L.; PAN-CHYR YANG Cellular Microbiology2022
6922015Advanced non-small cell lung cancer in the elderly: The impact of age and comorbidities on treatment modalities and patient prognosisHsu C.-L.; Chen J.-H.; Chen K.-Y.; Shih J.-Y.; Yang J.C.H.; Yu C.-J.; PAN-CHYR YANG Journal of Geriatric Oncology2527
6932015Effect of sialylation on EGFR phosphorylation and resistance to tyrosine kinase inhibitionYen H.-Y.; Liu Y.-C.; Chen N.-Y.; Tsai C.-F.; Wang Y.-T.; Chen Y.-J.; Hsu T.-L.; PAN-CHYR YANG ; Wong C.-H.Proceedings of the National Academy of Sciences of the United States of America5563
6942015Non-tuberculous mycobacterial lung disease and copdHuang C.-T.; Lee M.-R.; Shu C.-C.; Wang J.-Y.; PAN-CHYR YANG ERS Monograph0
6952015Loss of non-coding RNA expression from the DLK1-DIO3 imprinted locus correlates with reduced neural differentiation potential in human embryonic stem cell linesHONG-NERNG HO; HSIN-FU CHEN Stem Cell Research and Therapy 3638
6962015Fluorescence-guided probes of aptamer-targeted gold nanoparticles with computed tomography imaging accesses for in vivo tumor resectionLi C.-H.; Kuo T.-R.; Su H.-J.; Lai W.-Y.; PAN-CHYR YANG ; Chen J.-S.; Wang D.-Y.; Wu Y.-C.; Chen C.-C.Scientific Reports4844
6972015Signal analysis and liver tumor discrimination by using a high-Tc SQUID-based low-field NMR system in hospitalLiao S.-H.; Chieh J.-J.; Chou Y.-T.; Wang M.-W.; Chen H.-H.; KAI-WEN HUANG ; Yang H.-C.; Horng H.-E.IEEE Transactions on Applied Superconductivity00
6982015Micromachining NiTi tubes for use in medical devices by using a femtosecond laserHung C.-H.; Chang F.-Y.; Chang T.-L.; Chang Y.-T.; KAI-WEN HUANG ; Liang P.-C.Optics and Lasers in Engineering2330
6992015Hepatoesophageal fistula after radiofrequency ablation for hepatic metastasisYang S.-M.; KAI-WEN HUANG ; Huang P.-M.Annals of Thoracic Surgery00
7002015Novel Noxipoint Therapy versus Conventional Physical Therapy for Chronic Neck and Shoulder Pain: Multicentre Randomised Controlled TrialsKoo C.C.; Lin R.S.; Wang T.-G.; Tsauo J.-Y.; PAN-CHYR YANG ; Yen C.-T.; Biswal S.Scientific Reports34
7012015Sub-tesla-field magnetization of vibrated magnetic nanoreagents for screening tumor markersChieh J.-J.; KAI-WEN HUANG ; Shi J.-C.Applied Physics Letters99
7022015Novel Integration of an Ultrasound Probe and a Rotational-Scanning SQUID Biosusceptometer for Diagnosing Liver TumorsChieh J.J.; Lee Y.Y.; Wei W.C.; Hsiao P.Y.; KAI-WEN HUANG IEEE Transactions on Applied Superconductivity00
7032015Evaluation of the medicinal herb Graptopetalum paraguayense as a treatment for liver cancerHsu W.-H.; Chang C.-C.; KAI-WEN HUANG ; Chen Y.-C.; Hsu S.-L.; Wu L.-C.; Tsou A.-P.; Lai J.-M.; Huang C.-Y.F.PLoS ONE1311
7042015Dual-imaging model of SQUID biosusceptometry for locating tumors targeted using magnetic nanoparticlesChieh J.-J.; KAI-WEN HUANG ; Lee Y.-Y.; Wei W.-C.Journal of Nanobiotechnology109
7052015Assaying Carcinoembryonic Antigens by Normalized Saturation MagnetizationKAI-WEN HUANG ; Chieh J.-J.; Shi J.-C.; Chiang M.-H.Nanoscale Research Letters21
7062015Initial institutional experience of uncooled single-antenna microwave ablation for large hepatocellular carcinomaLiang P.-C.; Lai H.-S.; Shih T.T.-F.; Wu C.-H.; KAI-WEN HUANG Clinical Radiology80
7072015Beneficial effect of continuous positive airway pressure on lipid profiles in obstructive sleep apnea: a meta-analysisLin, Ming-Tzer; PEI-LIN LEE; HSIEN-HO LIN ; Lin, Hsien-Ho ; Lee, Pei-Lin; Lee, Pei-Lin; Weng, Pei-Hsuan; Weng, Pei-Hsuan; Lee, Chang-Chun; Lee, Chang-Chun; Lai, Ting-Chun; Lai, Ting-Chun; Liu, Wei; Chen, Chi-Ling Sleep and Breathing 2527
7082015Instability of succinate dehydrogenase in SDHD polymorphism connects reactive oxygen species production to nuclear and mitochondrial genomic mutations in yeastChang Y.-L.; Hsieh M.-H.; Chang W.-W.; HURNG-YI WANG ; Lin M.-C.; Wang C.-P.; Lou P.-J.; Teng S.-C.Antioxidants and Redox Signaling77
7092015New insights into the evolutionary rate of hepatitis B virus at different biological scalesLin Y.-Y.; Liu C.; Chien W.-H.; Wu L.-L.; Tao Y.; Wu D.; Lu X.; Hsieh C.-H.; Chen P.-J.; HURNG-YI WANG ; Kao J.-H.; Chen D.-S.Journal of Virology2224
7102015Mining missing membrane proteins by high-ph reverse-phase stagetip fractionation and multiple reaction monitoring mass spectrometryKitata R.B.; PAN-CHYR YANG et al. Journal of Proteome Research2120
7112015如何與C肝說再見?!全口服藥物治療JIA-HORNG KAO 健康世界 
7122015Ethical Issues in the Treatment and Care for Dementia PatientsDANIEL FU-CHANG TSAI ; Yu-Ren Hsu; Tzung-Jeng Hwang; Chin-Ying Chen; Ming-Jang ChiuFormosan Journal of Medicine00
7132015Age-related immune clearance of hepatitis B virus infection requires the establishment of gut microbiotaChou H.-H.; Chien W.-H.; Wu L.-L.; Cheng C.-H.; Chung C.-H.; Horng J.-H.; Ni Y.-H.; Tseng H.-T.; Wu D.; Lu X.; HURNG-YI WANG ; Chen P.-J.; Chen D.-S.Proceedings of the National Academy of Sciences of the United States of America93105
7142015如何與C肝說再見?!還沒有能治療所有基因型的全口服C肝藥物JIA-HORNG KAO 健康世界 
7152015Micro-evolution of the hepatitis B virus genome in hepatitis B e-antigen-positive carriers: Comparison of genotypes B and C at various immune stagesLiu C.-J.; Chen T.-C.; Chen P.-J.; HURNG-YI WANG ; Tseng T.-C.; Cheng H.-R.; Liu C.-H.; Chen D.-S.; Kao J.-H.Journal of Gastroenterology and Hepatology (Australia)11
7162015EGFR mutation and lobar location of lung adenocarcinomaTseng C.-H.; PAN-CHYR YANG et al. Carcinogenesis66
7172015Functional microarray analysis of differentially expressed genes in granulosa cells from women with polycystic ovary syndrome related to MAPK/ERK signalingHONG-NERNG HO; Lan, Chen-Wei; MEI-JOU CHEN; Chen, Mei-Jou; HSIN-FU CHEN ; Tai, Kang-Yu; Yu, Danny C. W.; Yang, Yu-Chieh; Jan, Pey-Shynan; Yang, Yu-Shih; Chen, Hsin-Fu ; Ho, Hong-NerngScientific Reports 3338
7182015罹患了急性肝炎以支持療法為主JIA-HORNG KAO 健康世界 
7192015病毒性肝炎概論(上)什麼是過客病毒?JIA-HORNG KAO 健康世界 
7202015Preimplantation genetic screening of blastocysts by multiplex qPCR followed by fresh embryo transfer: Validation and verificationMING CHEN ; HSIN-FU CHEN Molecular Cytogenetics 78
7212015肝炎病毒以A型、B型、C型、D型、E型5種為主JIA-HORNG KAO 健康世界 
7222015The Ethical Issues of Medical Emergency in the Color Dust Explosion EventsTeng-Wei Su; Da-Wei Jou; Cheng-Chung Fang; DANIEL FU-CHANG TSAI Formosan Journal of Medicine00
7232015Rapid High-pH Reverse Phase StageTip for Sensitive Small-Scale Membrane Proteomic ProfilingDimayacyac-Esleta B.R.T.; PAN-CHYR YANG et al. Analytical Chemistry2426
7242015R331W missense mutation of oncogene YAP1 is a germline risk allele for lung adenocarcinoma with medical actionabilityChen H.-Y.; PAN-CHYR YANG et al. Journal of Clinical Oncology5759
7252015Granulosa cell-derived induced pluripotent stem cells exhibit pro-Trophoblastic differentiation potentialChuang, Ching-Yu; HONG-NERNG HO; Chuang, Ching-Yu; LI-HUI TSENG ; Huang, Mei-Chi; Huang, Mei-Chi; Chen, Hsin-Fu ; HSIANG-PO HUANG; HSIN-FU CHEN ; Tseng, Li-Hui ; Yu, Chun-Ying; Stone, Lee; Stone, Lee; Huang, Hsiang-Po; Huang, Hsiang-Po; Ho, Hong-Nerng; Kuo, Hung-ChihStem Cell Research and Therapy 33
7262015Perspectives of Transplant Professionals on the Values, Ethics, and Challenges of Living Kidney Donor Evaluation in AsiaTong A.; Chapman J.R.; Kee T.; Li P.K.T.; DANIEL FU-CHANG TSAI ; Wong G.; Craig J.C.Transplantation35
7272015The effect of androgens on ovarian follicle maturation: Dihydrotestosterone suppress FSH-stimulated granulosa cell proliferation by upregulating PPAR? 3-dependent PTEN expression.Chen M.-J.; Chou C.-H.; Chen S.-U.; WEI-SHIUNG YANG ; Yang Y.-S.; Ho H.-N.Scientific Reports35
7282015Iron stores and obesity are negatively associated with ovarian volume and anti-M?llerian hormone levels in women with polycystic ovary syndromeYang J.-H.; Chou C.-H.; WEI-SHIUNG YANG ; Ho H.-N.; Yang Y.-S.; Chen M.-J.Taiwanese Journal of Obstetrics and Gynecology10
7292015Diabetes Associated Markers After Bariatric Surgery: Fetuin-A, but Not Matrix Metalloproteinase-7, Is ReducedYang P.-J.; Ser K.-H.; Lin M.-T.; Nien H.-C.; Chen C.-N.; WEI-SHIUNG YANG ; Lee W.-J.Obesity Surgery11
7302015Associations of circulating gut hormone and adipocytokine levels with the spectrum of gastroesophageal reflux diseaseTseng P.-H.; WEI-SHIUNG YANG ; Liou J.-M.; Lee Y.-C.; Wang H.-P.; Lin J.-T.; Wu M.-S.PLoS ONE12
7312015Serum angiopoietin-like protein 2 concentrations are independently associated with heart failureHuang C.-L.; Wu Y.-W.; Wu C.-C.; Hwang J.-J.; WEI-SHIUNG YANG PLoS ONE17
7322015Genetic determinants of antithyroid drug-induced agranulocytosis by human leukocyte antigen genotyping and genome-wide association studyChen P.-L.; Shih S.-R.; Wang P.-W.; Lin Y.-C.; Chu C.-C.; Lin J.-H.; Chen S.-C.; Chang C.-C.; Huang T.-S.; Tsai K.S.; Tseng F.-Y.; Wang C.-Y.; Lu J.-Y.; Chiu W.-Y.; Chang C.-C.; Chen Y.-H.; Chen Y.-T.; Fann C.S.-J.; WEI-SHIUNG YANG ; Chang T.-C.Nature Communications54
7332015Concurrent exome-targeted next-generation sequencing and single nucleotide polymorphism array to identify the causative genetic aberrations of isolated Mayer-Rokitansky-K?ster-Hauser syndromeChen M.-J.; Wei S.-Y.; WEI-SHIUNG YANG ; Wu T.-T.; Li H.-Y.; Ho H.-N.; Yang Y.-S.; Chen P.-L.Human Reproduction12
7342015Contribution of adiponectin and its type 1 receptor to age-related hearing impairmentWu C.-C.; Tsai C.-H.; Lu Y.-C.; Lin H.-C.; Hwang J.-H.; Lin Y.-H.; WEI-SHIUNG YANG ; Chen P.-J.; Liao W.-C.; Lee Y.L.; Liu T.-C.; Hsu C.-J.Neurobiology of Aging9
7352015Nonalcoholic Fatty Liver Disease Is Associated With QT Prolongation in the General PopulationHung C.-S.; Tseng P.-H.; Tu C.-H.; Chen C.-C.; Liao W.-C.; Lee Y.-C.; Chiu H.-M.; Lin H.-J.; Ho Y.-L.; WEI-SHIUNG YANG ; Wu M.-S.; Chen M.-F.Journal of the American Heart Association43
7362015Dimerized plasmin fragment D as a potential biomarker to predict successful catheter-directed thrombolysis therapy in acute deep vein thrombosisLuo C.-M.; Wu I.-H.; Chan C.-Y.; Chen Y.-S.; WEI-SHIUNG YANG ; Wang S.-S.Phlebology3
7372015Serum Triglyceride Levels Independently Contribute to the Estimation of Visceral Fat Amount among Nondiabetic Obese AdultsHuang C.-Y.; Huang H.-L.; Yang K.-C.; Lee L.-T.; WEI-SHIUNG YANG ; Huang K.-C.; Tseng F.-Y.Medicine (United States)15
7382015Association between serum levels of adipocyte fatty acid-binding protein and free thyroxineTseng F.-Y.; Chen P.-L.; Chen Y.-T.; Chi Y.-C.; Shih S.-R.; Wang C.-Y.; Chen C.-L.; WEI-SHIUNG YANG Medicine (United States)5
7392015Higher blood aldosterone level in metabolic syndrome is independently related to adiposity and fasting plasma glucoseChiang J.-K.; Chen C.-L.; Tseng F.-Y.; Chi Y.-C.; Huang K.-C.; WEI-SHIUNG YANG Cardiovascular Diabetology3
7402015No association between plasma adiponectin levels and central auditory function in adultsHwang J.-H.; Tseng F.-Y.; Liu T.-C.; WEI-SHIUNG YANG Metabolic Brain Disease2
7412015Improvement of cerebral glucose metabolism in symptomatic patients with carotid artery stenosis after stentingKao H.-L.; Lin M.-S.; Wu W.-C.; Tseng W.-Y.I.; Su M.-Y.; Chen Y.-F.; Chiu M.-J.; Wang S.-Y.; WEI-SHIUNG YANG ; Tzen K.-Y.; Wu Y.-W.; Chen M.-F.Clinical Nuclear Medicine3
7422015Association of plasma thrombospondin-1 level with cardiovascular disease and mortality in hemodialysis patientsHuang C.-L.; Jong Y.-S.; Wu Y.-W.; Wang W.-J.; Hsieh A.-R.; Chao C.-L.; Chen W.-J.; WEI-SHIUNG YANG Acta Cardiologica Sinica9
7432015Identifying children with poor cochlear implantation outcomes using massively parallel sequencingWu C.-C.; Lin Y.-H.; Liu T.-C.; Lin K.-N.; WEI-SHIUNG YANG ; Hsu C.-J.; Chen P.-L.; Wu C.-M.Medicine (United States)25
7442015Use of HLA-B?58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: National prospective cohort studyKo T.-M.; Tsai C.-Y.; Chen S.-Y.; Chen K.-S.; Yu K.-H.; Chu C.-S.; Huang C.-M.; Wang C.-R.; Weng C.-T.; Yu C.-L.; Hsieh S.-C.; Tsai J.-C.; Lai W.-T.; Tsai W.-C.; Yin G.-D.; Ou T.-T.; Cheng K.-H.; Yen J.-H.; Liou T.-L.; Lin T.-H.; Chen D.-Y.; Hsiao P.-J.; Weng M.-Y.; Chen Y.-M.; Chen C.-H.; Liu M.-F.; Yen H.-W.; Lee J.-J.; Kuo M.-C.; Wu C.-C.; Hung S.-Y.; Luo S.-F.; Yang Y.-H.; Chuang H.-P.; Chou Y.-C.; Liao H.-T.; Wang C.-W.; Huang C.-L.; Chang C.-S.; Lee M.-T.M.; PEI-JER CHEN ; Wong C.-S.; Chen C.-H.; Wu J.-Y.; Chen Y.-T.; Shen C.-Y.BMJ (Online)111
7452015Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Na?ve Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized TrialLiu C.-H.; Huang C.-F.; Liu C.-J.; Dai C.-Y.; Huang J.-F.; Lin J.-W.; Liang C.-C.; Yang S.-S.; Lin C.-L.; Su T.-H.; Yang H.-C.; PEI-JER CHEN ; Chen D.-S.; Chuang W.-L.; Kao J.-H.; Yu M.-L.Scientific Reports8
7462015Linifanib versus sorafenib in patients with advanced hepatocellular carcinoma: Results of a randomized phase III trialCainap C.; Qin S.; Huang W.-T.; Chung I.J.; Pan H.; Cheng Y.; Kudo M.; Kang Y.-K.; PEI-JER CHEN ; Toh H.-C.; Gorbunova V.; Eskens F.A.L.M.; Qian J.; McKee M.D.; Ricker J.L.; Carlson D.M.; El-Nowiem S.Journal of Clinical Oncology364
7472015Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naive Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort StudyLiu C.-H.; Sheng W.-H.; Sun H.-Y.; Hsieh S.-M.; Lo Y.-C.; Liu C.-J.; Su T.-H.; Yang H.-C.; Liu W.-C.; PEI-JER CHEN ; Chen D.-S.; Hung C.-C.; Kao J.-H.Scientific Reports9
7482015Sorafenib Action in Hepatitis B Virus X-Activated Oncogenic Androgen Pathway in Liver Through SHP-1Wang S.-H.; Yeh S.-H.; Shiau C.-W.; Chen K.-F.; Lin W.-H.; Tsai T.-F.; Teng Y.-C.; Chen D.-S.; PEI-JER CHEN Journal of the National Cancer Institute14
7492015Global patterns of hepatocellular carcinoma management from diagnosis to death: The BRIDGE StudyPark J.-W.; Chen M.; Colombo M.; Roberts L.R.; Schwartz M.; PEI-JER CHEN ; Kudo M.; Johnson P.; Wagner S.; Orsini L.S.; Sherman M.Liver International417
7502015Treatment of liver cancerLiu C.-Y.; Chen K.-F.; PEI-JER CHEN Cold Spring Harbor Perspectives in Medicine96
7512015Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: A randomised trialLiu C.-H.; Liu C.-J.; Huang C.-F.; Lin J.-W.; Dai C.-Y.; Liang C.-C.; Huang J.-F.; Hung P.-H.; Tsai H.-B.; Tsai M.-K.; Lee C.-Y.; Chen S.-I.; Yang S.-S.; Su T.-H.; Yang H.-C.; PEI-JER CHEN ; Chen D.-S.; Chuang W.-L.; Yu M.-L.; Kao J.-H.Gut23
7522015Peginterferon plus weight-based ribavirin for treatment-na?ve hepatitis C virus genotype 2 patients not achieving rapid virologic response: A randomized trialLiu C.-H.; Huang C.-F.; Liu C.-J.; Dai C.-Y.; Huang J.-F.; Lin J.-W.; Liang C.-C.; Yang S.-S.; Lin C.-L.; Su T.-H.; Yang H.-C.; PEI-JER CHEN ; Chen D.-S.; Chuang W.-L.; Kao J.-H.; Yu M.-L.Scientific Reports7
7532015Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibitionSu T.-H.; Shiau C.-W.; Jao P.; Liu C.-H.; Liu C.-J.; Tai W.-T.; Jeng Y.-M.; Yang H.-C.; Tseng T.-C.; Huang H.-P.; Cheng H.-R.; PEI-JER CHEN ; Chen K.-F.; Kao J.-H.; Chen D.-S.Proceedings of the National Academy of Sciences of the United States of America45
7542015Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriersTseng T.-C.; Liu C.-J.; Yang H.-C.; Chen C.-L.; Yang W.-T.; Tsai C.-S.; Kuo S.F.-T.; Verbree F.C.; Su T.-H.; Wang C.-C.; Liu C.-H.; PEI-JER CHEN ; Chen D.-S.; Kao J.-H.Gut72
7552015Feedback regulation of IFN-α/β signaling by Axl receptor tyrosine kinase modulates HBV immunityHuang M.-T.; Liu W.-L.; Lu C.-W.; Huang J.-J.; Chuang H.-L.; Huang Y.-T.; Horng J.-H.; Liu P.; Han D.-S.; Chiang B.-L.; Shih C.; PEI-JER CHEN ; Chen D.-S.European Journal of Immunology6
7562015Rapid fluorescent lateral-flow immunoassay for hepatitis B virus genotypingSong L.-W.; Wang Y.-B.; Fang L.-L.; Wu Y.; Yang L.; Chen J.-Y.; Ge S.-X.; Zhang J.; Xiong Y.-Z.; Deng X.-M.; Min X.-P.; Zhang J.; PEI-JER CHEN ; Yuan Q.; Xia N.-S.Analytical Chemistry34
7572015Contribution of adiponectin and its type 1 receptor to age-related hearing impairmentWu C.-C.; Tsai C.-H.; Lu Y.-C.; Lin H.-C.; Hwang J.-H.; Lin Y.-H.; Yang W.-S.; PEI-JER CHEN ; Liao W.-C.; Lee Y.L.; Liu T.-C.; Hsu C.-J.Neurobiology of Aging9
7582015Development of risk scoring system for stratifying population for hepatocellular carcinoma screeningHung Y.-C.; Lin C.-L.; Liu C.-J.; Hung H.; Lin S.-M.; Lee S.-D.; PEI-JER CHEN ; Chuang S.-C.; Yu M.-W.Hepatology27
7592015Gender disparity in chronic hepatitis B: Mechanisms of sex hormonesWang S.-H.; PEI-JER CHEN ; Yeh S.-H.Journal of Gastroenterology and Hepatology (Australia)45
7602015Advanced hepatic fibrosis and steatosis are associated with persistent alanine aminotransferase elevation in chronic hepatitis C patients negative for hepatitis C virus RNA during pegylated interferon plus ribavirin therapyLiang C.-C.; Liu C.-H.; Chung C.-S.; Lin C.-K.; Su T.-H.; Yang H.-C.; Liu C.-J.; PEI-JER CHEN ; Chen D.-S.; Kao J.-H.Journal of Infectious Diseases6
7612015Predicting hepatitis B virus (HBV) surface antigen seroclearance in HBV e antigen-negative patients with chronic hepatitis B: External validation of a scoring systemLiu J.; Tseng T.-C.; Yang H.-I.; Lee M.-H.; Batrla-Utermann R.; Jen C.-L.; Lu S.-N.; Wang L.-Y.; You S.-L.; PEI-JER CHEN ; Chen C.-J.; Kao J.-H.Journal of Infectious Diseases8
7622015Quantitative hepatitis B core antibody levels in the natural history of hepatitis B virus infectionSong L.-W.; Liu P.-G.; Liu C.-J.; Zhang T.-Y.; Cheng X.-D.; Wu H.-L.; Yang H.-C.; Hao X.-K.; Yuan Q.; Zhang J.; Kao J.-H.; Chen D.-S.; PEI-JER CHEN ; Xia N.-S.Clinical Microbiology and Infection61
7632015Age-related immune clearance of hepatitis B virus infection requires the establishment of gut microbiotaChou H.-H.; Chien W.-H.; Wu L.-L.; Cheng C.-H.; Chung C.-H.; Horng J.-H.; Ni Y.-H.; Tseng H.-T.; Wu D.; Lu X.; Wang H.-Y.; PEI-JER CHEN ; Chen D.-S.Proceedings of the National Academy of Sciences of the United States of America105
7642015Higher lifetime chance of spontaneous surface antigen loss in hepatitis B carriers with genotype C infectionTseng T.-C.; Liu C.-J.; Chen C.-L.; Yang W.-T.; Yang H.-C.; Su T.-H.; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; PEI-JER CHEN ; Chen D.-S.; Kao J.-H.Alimentary Pharmacology and Therapeutics34
7652015Tumor necrosis factor-alpha blockage therapy impairs hepatitis B viral clearance and enhances T-cell exhaustion in a mouse modelChyuan I.-T.; Tsai H.-F.; Tzeng H.-T.; Sung C.-C.; Wu C.-S.; PEI-JER CHEN ; Hsu P.-N.Cellular and Molecular Immunology14
7662015Comparison of abbott realtime HCV genotype II with versant line probe assay 2.0 for hepatitis C virus genotypingLiu C.-H.; Liang C.-C.; Liu C.-J.; Lin C.-L.; Su T.-H.; Yang H.-C.; PEI-JER CHEN ; Chen D.-S.; Kao J.-H.Journal of Clinical Microbiology46
7672015New insights into the evolutionary rate of hepatitis B virus at different biological scalesLin Y.-Y.; Liu C.; Chien W.-H.; Wu L.-L.; Tao Y.; Wu D.; Lu X.; Hsieh C.-H.; PEI-JER CHEN ; Wang H.-Y.; Kao J.-H.; Chen D.-S.Journal of Virology24
7682015Elevated p53 promotes the processing of miR-18a to decrease estrogen receptor-α in female hepatocellular carcinomaLi C.-L.; Yeh K.-H.; Liu W.-H.; Chen C.-L.; Chen D.-S.; PEI-JER CHEN ; Yeh S.-H.International Journal of Cancer29
7692015Randomized, controlled pharmacokinetic and pharmacodynamic evaluation of albinterferon in patients with chronic hepatitis B infectionColvin R.A.; Tanwandee T.; Piratvisuth T.; Thongsawat S.; Hui A.J.; Zhang H.; Ren H.; PEI-JER CHEN ; Chuang W.-L.; Sobhonslidsuk A.; Li R.; Qi Y.; Praestgaard J.; Han Y.; Xu J.; Stein D.S.; Chien R.-N.; Flisiak R.; Jablkowski M.; Liaw Y.-F.; Sung J.J.-Y.Journal of Gastroenterology and Hepatology (Australia)5
7702015Micro-evolution of the hepatitis B virus genome in hepatitis B e-antigen-positive carriers: Comparison of genotypes B and C at various immune stagesLiu C.-J.; Chen T.-C.; PEI-JER CHEN ; Wang H.-Y.; Tseng T.-C.; Cheng H.-R.; Liu C.-H.; Chen D.-S.; Kao J.-H.Journal of Gastroenterology and Hepatology (Australia)1
7712015Slow decline of hepatitis B burden in general population: Results from a population-based survey and longitudinal follow-up study in TaiwanChen C.-L.; Yang J.-Y.; Lin S.-F.; Sun C.-A.; Bai C.-H.; You S.-L.; Chen C.-J.; Kao J.-H.; PEI-JER CHEN ; Chen D.-S.Journal of Hepatology43
7722015Clinical significance of circulating miR-122 in patients with dual chronic hepatitis B and C virus infectionCheng H.-R.; Kao J.-H.; Wu H.-L.; Tseng T.-C.; Liu C.-H.; Yang H.-C.; Su T.-H.; PEI-JER CHEN ; Chen D.-S.; Liu C.-J.Hepatology International10
7732015Genetic determinants of antithyroid drug-induced agranulocytosis by human leukocyte antigen genotyping and genome-wide association studyPEI-LUNG CHEN ; Shih S.-R.; Wang P.-W.; Lin Y.-C.; Chu C.-C.; Lin J.-H.; Chen S.-C.; Chang C.-C.; Huang T.-S.; Tsai K.S.; Tseng F.-Y.; Wang C.-Y.; Lu J.-Y.; Chiu W.-Y.; Chang C.-C.; Chen Y.-H.; Chen Y.-T.; Fann C.S.-J.; Yang W.-S.; Chang T.-C.Nature Communications54
7742015Functional variants in DPYSL2 sequence increase risk of schizophrenia and suggest a link to mTOR signalingLiu Y.; Pham X.; Zhang L.; PEI-LUNG CHEN ; Burzynski G.; McGaughey D.M.; He S.; McGrath J.A.; Wolyniec P.; Fallin M.D.; Pierce M.S.; McCallion A.S.; Pulver A.E.; Avramopoulos D.; Valle D.G3: Genes, Genomes, Genetics25
7752015Concurrent exome-targeted next-generation sequencing and single nucleotide polymorphism array to identify the causative genetic aberrations of isolated Mayer-Rokitansky-K?ster-Hauser syndromeChen M.-J.; Wei S.-Y.; Yang W.-S.; Wu T.-T.; Li H.-Y.; Ho H.-N.; Yang Y.-S.; PEI-LUNG CHEN Human Reproduction12
7762015Association between serum levels of adipocyte fatty acid-binding protein and free thyroxineTseng F.-Y.; PEI-LUNG CHEN ; Chen Y.-T.; Chi Y.-C.; Shih S.-R.; Wang C.-Y.; Chen C.-L.; Yang W.-S.Medicine (United States)5
7772015Identifying children with poor cochlear implantation outcomes using massively parallel sequencingWu C.-C.; Lin Y.-H.; Liu T.-C.; Lin K.-N.; Yang W.-S.; Hsu C.-J.; PEI-LUNG CHEN ; Wu C.-M.Medicine (United States)25
7782015An isodicentric X chromosome with gonadal dysgenesis in a lady without prominent somatic features of Turner's syndrome. A case reportYu T.-Y.; Lin H.-S.; PEI-LUNG CHEN ; Huang T.-S.Journal of the Formosan Medical Association2
7792015Long-term cochlear implant outcomes in children with GJB2 and SLC26A4 mutationsWu C.-M.; Ko H.-C.; Tsou Y.-T.; Lin Y.-H.; Lin J.-L.; Chen C.-K.; PEI-LUNG CHEN ; Wu C.-C.PLoS ONE24
7802015Identification of a novel GATA3 mutation in a deaf Taiwanese family by massively parallel sequencingLin Y.-H.; Wu C.-C.; Hsu T.-Y.; Chiu W.-Y.; Hsu C.-J.; PEI-LUNG CHEN Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis11
7812015Inhibition of Rho-associated kinase relieves C5a-induced proteinuria in murine nephrotic syndromeTsai I.-J.; Chou C.-H.; Yang Y.-H.; Lin W.-C.; Lin Y.-H.; Chow L.-P.; Lee H.-H.; Kao P.-G.; Liau W.-T.; TZUU-SHUH JOU ; Tsau Y.-K.Cellular and Molecular Life Sciences4
7822015Inhibition of Matrix Metalloproteinase Activity Reverses Corneal Endothelial-Mesenchymal TransitionHo W.-T.; Chang J.-S.; Su C.-C.; Chang S.-W.; Hu F.-R.; TZUU-SHUH JOU ; Wang I.-J.American Journal of Pathology17
7832015Advanced hepatic fibrosis and steatosis are associated with persistent alanine aminotransferase elevation in chronic hepatitis C patients negative for hepatitis C virus RNA during pegylated interferon plus ribavirin therapyLiang C.-C.; Liu C.-H.; Chung C.-S.; Lin C.-K.; Su T.-H.; Yang H.-C.; Liu C.-J.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO Journal of Infectious Diseases6
7842015Quantitative hepatitis B core antibody levels in the natural history of hepatitis B virus infectionSong L.-W.; Liu P.-G.; Liu C.-J.; Zhang T.-Y.; Cheng X.-D.; Wu H.-L.; Yang H.-C.; Hao X.-K.; Yuan Q.; Zhang J.; JIA-HORNG KAO ; Chen D.-S.; Chen P.-J.; Xia N.-S.Clinical Microbiology and Infection61
7852015Higher lifetime chance of spontaneous surface antigen loss in hepatitis B carriers with genotype C infectionTseng T.-C.; Liu C.-J.; Chen C.-L.; Yang W.-T.; Yang H.-C.; Su T.-H.; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO Alimentary Pharmacology and Therapeutics34
7862015HBV-DNA level at 6 months of entecavir treatment predicts HBeAg loss in HBeAg-positive chronic hepatitis B patientsPeng C.-Y.; Hsieh T.-C.; Hsieh T.-Y.; Tseng K.-C.; Lin C.-L.; Su T.-H.; Tseng T.-C.; Lin H.H.; Wang C.-C.; JIA-HORNG KAO Journal of the Formosan Medical Association8
7872015Clinical significance of circulating miR-122 in patients with dual chronic hepatitis B and C virus infectionCheng H.-R.; JIA-HORNG KAO ; Wu H.-L.; Tseng T.-C.; Liu C.-H.; Yang H.-C.; Su T.-H.; Chen P.-J.; Chen D.-S.; Liu C.-J.Hepatology International10
7882015New insights into the evolutionary rate of hepatitis B virus at different biological scalesLin Y.-Y.; Liu C.; Chien W.-H.; Wu L.-L.; Tao Y.; Wu D.; Lu X.; Hsieh C.-H.; Chen P.-J.; Wang H.-Y.; JIA-HORNG KAO ; Chen D.-S.Journal of Virology24
7892015Adipocytokines and liver fibrosis stages in patients with chronic hepatitis B virus infectionHsu C.-S.; Liu W.-L.; Chao Y.-C.; Lin H.H.; Tseng T.-C.; Wang C.-C.; Chen D.-S.; JIA-HORNG KAO Hepatology International22
7902015Improving clinical outcomes of chronic hepatitis B virus infectionSu T.-H.; JIA-HORNG KAO Expert Review of Gastroenterology and Hepatology19
7912015Treating Immune-tolerant Hepatitis BTseng, T.-C.; JIA-HORNG KAO Journal of viral hepatitis23
7922015Reimbursement policies in the Asia-Pacific for chronic hepatitis BLim S.G.; Amarapurkar D.N.; Chan H.L.-Y.; Crawford D.H.; Gane E.J.; Han K.-H.; Ahn S.H.; Jafri W.; Jia J.; JIA-HORNG KAO ; Lesmana L.A.; Lesmana C.R.A.; Mohamed R.; Phiet P.H.; Piratvisuth T.; Sarin S.K.; Sollarno J.D.; Eguchi Y.; Mahtab M.-A.; Lee K.H.Hepatology International16
7932015Micro-evolution of the hepatitis B virus genome in hepatitis B e-antigen-positive carriers: Comparison of genotypes B and C at various immune stagesLiu C.-J.; Chen T.-C.; Chen P.-J.; Wang H.-Y.; Tseng T.-C.; Cheng H.-R.; Liu C.-H.; Chen D.-S.; JIA-HORNG KAO Journal of Gastroenterology and Hepatology (Australia)1
7942015Asunaprevir-containing regimens for the treatment of hepatitis C virus infectionYang S.-S.; JIA-HORNG KAO Expert Review of Gastroenterology and Hepatology5
7952015Hepatitis B virus infection and metabolic syndrome: Fact or fiction?Wang C.-C.; Tseng T.-C.; JIA-HORNG KAO Journal of Gastroenterology and Hepatology (Australia)52
7962015Viral hepatitis: HBV cure-can we pin our hopes on immunotherapy?Yang H.-C.; JIA-HORNG KAO Nature Reviews Gastroenterology and Hepatology20
7972015What can we learn from hepatitis B virus clinical cohorts?Lin C.-L.; Tseng T.-C.; JIA-HORNG KAO Liver International9
7982015Treating immune-tolerant Hepatitis BTseng T.-C.; JIA-HORNG KAO Journal of Viral Hepatitis23
7992015Slow decline of hepatitis B burden in general population: Results from a population-based survey and longitudinal follow-up study in TaiwanChen C.-L.; Yang J.-Y.; Lin S.-F.; Sun C.-A.; Bai C.-H.; You S.-L.; Chen C.-J.; JIA-HORNG KAO ; Chen P.-J.; Chen D.-S.Journal of Hepatology43
8002015Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patientsWang C.-C.; Liu C.-H.; Lin C.-L.; Wang P.-C.; Tseng T.-C.; Lin H.H.; JIA-HORNG KAO Journal of the Formosan Medical Association17
8012015On-treatment low serum HBV RNA level predicts initial virological response in chronic hepatitis B patients receiving nucleoside analogue therapyHuang Y.-W.; Takahashi S.; Tsuge M.; Chen C.-L.; Wang T.-C.; Abe H.; Hu J.-T.; Chen D.-S.; Yang S.-S.; Chayama K.; JIA-HORNG KAO Antiviral Therapy42
8022015Serum biomarkers predictive of significant fibrosis and cirrhosis in chronic hepatitis BLin C.-L.; Liu C.-H.; Wang C.-C.; Liang C.-C.; Su T.-H.; Liu C.-J.; JIA-HORNG KAO Journal of Clinical Gastroenterology25
8032015Reply to: Modulation of Toll-like receptor 9 expression on monocytes of viral hepatitis patientsHuang Y.-W.; Yang S.-S.; JIA-HORNG KAO Antiviral Therapy0
8042015Successful treatment of chronic hepatitis B and D with pegylated-interferon plus entecavirChen G.-Y.; Su T.-H.; JIA-HORNG KAO Journal of the Formosan Medical Association6
8052015Perspectives and control of hepatitis B virus infection in TaiwanLin C.-L.; JIA-HORNG KAO Journal of the Formosan Medical Association53
8062015Hepatitis B virus genotypes and variantsLin C.-L.; JIA-HORNG KAO Cold Spring Harbor Perspectives in Medicine93
8072015Hepatitis B vaccination and prevention of hepatocellular carcinomaJIA-HORNG KAO Best Practice and Research: Clinical Gastroenterology43
8082015Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: A randomised trialLiu C.-H.; Liu C.-J.; Huang C.-F.; Lin J.-W.; Dai C.-Y.; Liang C.-C.; Huang J.-F.; Hung P.-H.; Tsai H.-B.; Tsai M.-K.; Lee C.-Y.; Chen S.-I.; Yang S.-S.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Yu M.-L.; JIA-HORNG KAO Gut23
8092015Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Na?ve Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized TrialLiu C.-H.; Huang C.-F.; Liu C.-J.; Dai C.-Y.; Huang J.-F.; Lin J.-W.; Liang C.-C.; Yang S.-S.; Lin C.-L.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; JIA-HORNG KAO ; Yu M.-L.Scientific Reports8
8102015Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naive Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort StudyLiu C.-H.; Sheng W.-H.; Sun H.-Y.; Hsieh S.-M.; Lo Y.-C.; Liu C.-J.; Su T.-H.; Yang H.-C.; Liu W.-C.; Chen P.-J.; Chen D.-S.; Hung C.-C.; JIA-HORNG KAO Scientific Reports9
8112015Increased risk of hepatocellular carcinoma in chronic hepatitis C patients with new onset diabetes: A nation-wide cohort studyHuang Y.-W.; Wang T.-C.; Yang S.-S.; Lin S.-Y.; Fu S.-C.; Hu J.-T.; Liu C.-J.; JIA-HORNG KAO ; Chen D.-S.Alimentary Pharmacology and Therapeutics17
8122015Artificial ascites is feasible and effective for difficult-to-ablate hepatocellular carcinomaWang C.-C.; JIA-HORNG KAO Hepatology International17
8132015Can noninvasive biomarkers replace liver biopsy for chronic hepatitis B?Lin C.-L.; JIA-HORNG KAO Hepatology (Baltimore, Md.)1
8142015Alisporivir with peginterferon/ribavirin in patients with chronic hepatitis C genotype 1 infection who failed to respond to or relapsed after prior interferon-based therapy: FUNDAMENTAL, a Phase II trialButi M.; Flisiak R.; JIA-HORNG KAO ; Chuang W.-L.; Streinu-Cercel A.; Tabak F.; Calistru P.; Goeser T.; Rasenack J.; Horban A.; Davis G.L.; Alberti A.; Mazzella G.; Pol S.; Orsenigo R.; Brass C.Journal of Viral Hepatitis16
8152015Towards an HBV cure: State-of-the-art and unresolved questions-report of the ANRS workshop on HBV cureZeisel M.B.; Lucifora J.; Mason W.S.; Sureau C.; Beck J.; Levrero M.; Kann M.; Knolle P.A.; Benkirane M.; Durantel D.; Michel M.-L.; Autran B.; Cosset F.-L.; Strick-Marchand H.; Tr?po C.; JIA-HORNG KAO ; Carrat F.; Lacombe K.; Schinazi R.F.; Barr?-Sinoussi F.; Delfraissy J.-F.; Zoulim F.Gut178
8162015Peginterferon plus weight-based ribavirin for treatment-na?ve hepatitis C virus genotype 2 patients not achieving rapid virologic response: A randomized trialLiu C.-H.; Huang C.-F.; Liu C.-J.; Dai C.-Y.; Huang J.-F.; Lin J.-W.; Liang C.-C.; Yang S.-S.; Lin C.-L.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; JIA-HORNG KAO ; Yu M.-L.Scientific Reports7
8172015Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibitionSu T.-H.; Shiau C.-W.; Jao P.; Liu C.-H.; Liu C.-J.; Tai W.-T.; Jeng Y.-M.; Yang H.-C.; Tseng T.-C.; Huang H.-P.; Cheng H.-R.; Chen P.-J.; Chen K.-F.; JIA-HORNG KAO ; Chen D.-S.Proceedings of the National Academy of Sciences of the United States of America45
8182015Predicting hepatitis B virus (HBV) surface antigen seroclearance in HBV e antigen-negative patients with chronic hepatitis B: External validation of a scoring systemLiu J.; Tseng T.-C.; Yang H.-I.; Lee M.-H.; Batrla-Utermann R.; Jen C.-L.; Lu S.-N.; Wang L.-Y.; You S.-L.; Chen P.-J.; Chen C.-J.; JIA-HORNG KAO Journal of Infectious Diseases8
8192015Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriersTseng T.-C.; Liu C.-J.; Yang H.-C.; Chen C.-L.; Yang W.-T.; Tsai C.-S.; Kuo S.F.-T.; Verbree F.C.; Su T.-H.; Wang C.-C.; Liu C.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO Gut72
8202015Comparison of abbott realtime HCV genotype II with versant line probe assay 2.0 for hepatitis C virus genotypingLiu C.-H.; Liang C.-C.; Liu C.-J.; Lin C.-L.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO Journal of Clinical Microbiology46
8212015A review of the burden of hepatitis C virus infection in China, Japan, South Korea and TaiwanBennett H.; Waser N.; Johnston K.; JIA-HORNG KAO ; Lim Y.-S.; Duan Z.-P.; Lee Y.-J.; Wei L.; Chen C.-J.; Sievert W.; Yuan Y.; Li H.Hepatology International58
8222015Systematic review: Impact of interferon-based therapy on HCV-related hepatocellular carcinomaHsu C.-S.; Chao Y.-C.; Lin H.H.; Chen D.-S.; JIA-HORNG KAO Scientific Reports35
82320142014年美國糖尿病學會臨床治療指引摘要WEI-SHIUNG YANG 台北市醫師公會會刊 
8242014Sorafenib relieves cell-intrinsic and cell-extrinsic inhibitions of effector T cells in tumor microenvironment to augment antitumor immunityChen M.-L.; Yan B.-S.; Lu W.-C.; Chen M.-H.; Yu S.-L.; PAN-CHYR YANG ; Cheng A.-L.International Journal of Cancer75
8252014Clinicopathologic characteristics and prognostic significance of EGFR and p53 mutations in surgically resected lung adenocarcinomas ?2 cm in maximal dimensionLin M.-W.; Wu C.-T.; Shih J.-Y.; Chang Y.-L.; PAN-CHYR YANG Journal of Surgical Oncology20
8262014Clinicopathology and genetic profile of synchronous multiple small adenocarcinomas: Implication for surgical treatment of an uncommon lung malignancyLin M.-W.; Wu C.-T.; Kuo S.-W.; Chang Y.-L.; PAN-CHYR YANG Annals of Surgical Oncology13
8272014The miRNAs and epithelial-mesenchymal transition in cancersLin C.-W.; Kao S.-H.; PAN-CHYR YANG Current Pharmaceutical Design11
8282014In responseShi Y.; PAN-CHYR YANG Journal of Thoracic Oncology0
8292014AS1411 aptamer-conjugated Gd2O3:Eu nanoparticles for target-specific computed tomography/magnetic resonance/fluorescence molecular imagingKuo T.; Lai W.; Li C.; Wun Y.; Chang H.; Chen J.; PAN-CHYR YANG ; Chen C.Nano Research25
8302014FOXF1 mediates mesenchymal stem cell fusion-induced reprogramming of lung cancer cellsWei H.-J.; Nickoloff J.A.; Chen W.-H.; Liu H.-Y.; Lo W.-C.; Chang Y.-T.; PAN-CHYR YANG ; Wu C.-W.; Williams D.F.; Gelovani J.G.; Deng W.-P.Oncotarget50
8312014Programmed cell death-ligand 1 expression in surgically resected stage i pulmonary adenocarcinoma and its correlation with driver mutations and clinical outcomesYang C.-Y.; Lin M.-W.; Chang Y.-L.; Wu C.-T.; PAN-CHYR YANG European Journal of Cancer234
8322014Intrapleural minocycline pleurodesis for the treatment of primary spontaneous pneumothoraxChen J.-S.; Chan W.-K.; PAN-CHYR YANG Current Opinion in Pulmonary Medicine10
8332014The antitumor agent PBT-1 directly targets HSP90 and hnRNP A2/B1 and inhibits lung adenocarcinoma growth and metastasisChen C.-Y.; Yang S.-C.; Lee K.-H.; Yang X.; Wei L.-Y.; Chow L.-P.; Wang T.-C.V.; Hong T.-M.; Lin J.-C.; Kuan C.; PAN-CHYR YANG Journal of Medicinal Chemistry19
8342014Overcoming EGFR T790M-based tyrosine kinase inhibitor resistance with an allele-specific DNAzymeLai W.-Y.; Chen C.-Y.; Yang S.-C.; Wu J.-Y.; Chang C.-J.; PAN-CHYR YANG ; Peck K.Molecular Therapy - Nucleic Acids5
8352014Shisa3 is associated with prolonged survival through promoting β-catenin degradation in lung cancerChen C.-C.; Chen H.-Y.; Su K.-Y.; Hong Q.-S.; Yan B.-S.; Chen C.-H.; Pan S.-H.; Chang Y.-L.; Wang C.-J.; Hung P.-F.; Yuan S.; Chang G.-C.; Chen J.J.W.; PAN-CHYR YANG ; Yang Y.-C.; Yu S.-L.American Journal of Respiratory and Critical Care Medicine27
8362014Bcl-2-like protein 11 deletion polymorphism predicts survival in advanced non-small-cell lung cancerLee J.-H.; Lin Y.-L.; Hsu W.-H.; Chen H.-Y.; Chang Y.-C.; Yu C.-J.; Shih J.-Y.; Lin C.-C.; Chen K.-Y.; Ho C.-C.; Laio W.-Y.; PAN-CHYR YANG ; Yang J.C.-H.Journal of Thoracic Oncology34
8372014Clinical and the prognostic characteristics of lung adenocarcinoma patients with ros1 fusion in comparison with other driver mutations in east asian populationsChen Y.-F.; Hsieh M.-S.; Wu S.-G.; Chang Y.-L.; Shih J.-Y.; Liu Y.-N.; Tsai M.-F.; Tsai T.-H.; Yu C.-J.; Yang J.C.-H.; PAN-CHYR YANG Journal of Thoracic Oncology51
8382014A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER)Shi Y.; Au J.S.-K.; Thongprasert S.; Srinivasan S.; Tsai C.-M.; Khoa M.T.; Heeroma K.; Itoh Y.; Cornelio G.; PAN-CHYR YANG Journal of Thoracic Oncology643
8392014Ethical Reflection and Management of Conflict of Interest in Medical ResearchDANIEL FU-CHANG TSAI Formosan Journal of Medicine00
8402014All-cause mortality in patients with type 2 diabetes in association with achieved hemoglobin A1c, systolic blood pressure, and low-density lipoprotein cholesterol levelsCHIH-YUAN WANG; Chiang, Hou-Hsien; FEN-YU TSENG; Tseng, Fen-Yu; Wang, Chih-Yuan; Chen, Chi-Ling ; Chen, Yi-Chun; See, Ting-Ting; Chen, Hua-FenPLoS ONE 1616
8412014Multilocus approach to clarify species status and the divergence history of the Bemisia tabaci (Hemiptera: Aleyrodidae) species complexHsieh C.-H.; Ko C.-C.; Chung C.-H.; HURNG-YI WANG Molecular Phylogenetics and Evolution1414
8422014Influence of gene flow on divergence dating - Implications for the speciation history of Takydromus grass lizardsTseng S.-P.; Li S.-H.; Hsieh C.-H.; HURNG-YI WANG ; Lin S.-M.Molecular Ecology1214
8432014Molecular characterization of cryptically circulating rabies virus from ferret badgers, TaiwanChiou H.-Y.; Hsieh C.-H.; Jeng C.-R.; Chan F.-T.; HURNG-YI WANG ; Pang V.F.Emerging Infectious Diseases2928
8442014The CRISPR/Cas9 system facilitates clearance of the intrahepatic HBV templates in vivoLin S.-R.; Yang H.-C.; Kuo Y.-T.; Liu C.-J.; Yang T.-Y.; Sung K.-C.; Lin Y.-Y.; HURNG-YI WANG ; Wang C.-C.; Shen Y.-C.; Wu F.-Y.; Kao J.-H.; Chen D.-S.; Chen P.-J.Molecular Therapy - Nucleic Acids236255
8452014Genetic analysis of CARD14 in non-familial pityriasis rubra pilaris: A case seriesHong J.-B.; Chen P.-L.; YOU-TZUNG CHEN ; Tsai T.-F.Acta Dermato-Venereologica107
8462014A nucleolus-predominant piggyBac transposase, NP-mPB, mediates elevated transposition efficiency in mammalian cellsHong J.-B.; Chou F.-J.; Ku A.T.; Fan H.-H.; Lee T.-L.; Huang Y.-H.; Yang T.-L.; Su I.-C.; Yu I.-S.; Lin S.-W.; Chien C.-L.; Ho H.-N.; YOU-TZUNG CHEN PLoS ONE33
8472014Synergistic inhibition of lung cancer cell invasion, tumor growth and angiogenesis using aptamer-siRNA chimerasLai W.-Y.; Wang W.-Y.; Chang Y.-C.; Chang C.-J.; PAN-CHYR YANG ; Peck K.Biomaterials4548
8482014Granulosa cells and retinoic acid co-treatment enrich potential germ cells from manually selected Oct4-EGFP expressing human embryonic stem cellsChen, Hsin-Fu ; HONG-NERNG HO; Jan, Pey-Shynan; CHUNG-LIANG CHIEN; Kuo, Hung-Chih; HSIN-FU CHEN ; Wu, Fang-Chun; Lan, Chen-Wei; Huang, Mei-Chi; Chien, Chung-Liang; Ho, Hong-NerngReproductive BioMedicine Online 108
8492014Cancer-associated fibroblasts regulate the plasticity of lung cancer stemness via paracrine signallingChen W.-J.; Ho C.-C.; Chang Y.-L.; Chen H.-Y.; Lin C.-A.; Ling T.-Y.; Yu S.-L.; Yuan S.-S.; Louisa Chen Y.-J.; Lin C.-Y.; Pan S.-H.; Elizabeth Chou H.-Y.; Chang G.-C.; Chu W.-C.; Lee Y.-M.; Lee J.-Y.; Lee P.-J.; Li K.-C.; Chen H.-W.; PAN-CHYR YANG Nature Communications199213
8502014Novel RNA oligonucleotide improves liver function and inhibits liver carcinogenesis in vivoReebye V.; S?trom P.; Mintz P.J.; KAI-WEN HUANG ; Swiderski P.; Peng L.; Liu C.; Liu X.; Lindk?r-Jensen S.; Zacharoulis D.; Kostomitsopoulos N.; Kasahara N.; Nicholls J.P.; Jiao L.R.; Pai M.; Spalding D.R.; Mizandari M.; Chikovani T.; Emara M.M.; Haoudi A.; Tomalia D.A.; Rossi J.J.; Habib N.A.Hepatology7269
8512014MicroRNA-133a suppresses multiple oncogenic membrane receptors and cell invasion in non-small cell lung carcinomaWang L.-K.; Hsiao T.-H.; Hong T.-M.; Chen H.-Y.; Kao S.-H.; Wang W.-L.; Yu S.-L.; Lin C.-W.; PAN-CHYR YANG PLoS ONE63150
8522014A legume product fermented by Saccharomyces cerevisiae modulates cutaneous atopic dermatitis-like inflammation in miceLI-FANG WANG ; Yeh, Chiou-Yueh; Jung, Chiau-Jing; Huang, Ching-Ning; Huang, Ying-Che; Lien, Huei-Ting; Wang, Won-Bo ; Wang, Li-Fang ; Chia, Jean-San BMC Complementary and Alternative Medicine 54
8532014Time-evolution contrast of target MRI using high-stability antibody functionalized magnetic nanoparticles: An animal modelKAI-WEN HUANG ; Yang S.Y.; Horng H.E.; Chieh J.J.; Chen H.H.; Wu C.C.; Chen J.H.; Lin I.T.; Yang C.C.; Yang H.C.Journal of Nanomaterials52
8542014Exploiting human CD34+ stem cell-conditioned medium for tissue repairMintz P.J.; KAI-WEN HUANG ; Reebye V.; Nteliopoulos G.; Lai H.-S.; S?trom P.; Kasahara N.; Jensen S.; Pai M.; Gordon M.Y.A.; Marley S.B.; Behan R.; Spalding D.R.; Haoudi A.; Emara M.M.; Nicholls J.; Rossi J.J.; Habib N.A.Molecular Therapy77
8552014Development of renal cysts after crizotinib treatment in advanced ALK-positive non-small-cell lung cancerLin Y.-T.; Wang Y.-F.; Yang J.C.-H.; Yu C.-J.; Wu S.-G.; Shih J.-Y.; PAN-CHYR YANG Journal of Thoracic Oncology3331
8562014Clinicopathological and prognostic significances of EGFR, KRAS and BRAF mutations in biliary tract carcinomas in TaiwanChang Y.-T.; Chang M.-C.; KAI-WEN HUANG ; Tung C.-C.; Hsu C.; Wong J.-M.Journal of Gastroenterology and Hepatology (Australia)1821
8572014Long-term booster schedules with AS03A-adjuvanted heterologous H5N1 vaccines induces rapid and broad immune responses in Asian adultsGillard P.; Chu D.W.S.; Hwang S.-J.; PAN-CHYR YANG ; Thongcharoen P.; Lim F.S.; Dram? M.; Walravens K.; Roman F.BMC Infectious Diseases1515
8582014The pilot experience upon surgical ablation of large liver tumor by microwave system with tissue permittivity feedback control mechanismLiang P.-C.; Lai H.-S.; Shih T.T.-F.; Wu C.-H.; KAI-WEN HUANG BMC Surgery87
8592014Theoretical and Experimental study of a circular imprint process for fabricating polylactide stentsTeng P.-T.; Chang F.-Y.; Lin M.-J.; Chang Y.-T.; Liang P.-C.; KAI-WEN HUANG Japanese Journal of Applied Physics00
8602014Virological, serological, and antiviral studies in an imported human case of avian influenza A(H7N9) virus in TaiwanLin P.-H.; Chao T.-L.; Kuo S.-W.; Wang J.-T.; Hung C.-C.; Lin H.-C.; Yang Z.-Y.; Ho S.-Y.; Chang C.-K.; Huang M.-S.; Chen H.-H.; Chen Y.-C.; Lai H.-S.; Chang S.-Y.; Chang S.-C.; PAN-CHYR YANG Clinical Infectious Diseases3537
8612014Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33Wang Z.; Zhu B.; Zhang M.; Parikh H.; Jia J.; Chung C.C.; Sampson J.N.; Hoskins J.W.; Hutchinson A.; Burdette L.; Ibrahim A.; Hautman C.; Raj P.S.; Abnet C.C.; Adjei A.A.; Ahlbom A.; Albanes D.; Allen N.E.; Ambrosone C.B.; Aldrich M.; Amiano P.; Amos C.; Andersson U.; Gerald Andriole G.A.; Jr.; Andrulis I.L.; Arici C.; Arslan A.A.; Austin M.A.; Baris D.; Barkauskas D.A.; Bassig B.A.; Freeman L.E.B.; Berg C.D.; Berndt S.I.; Bertazzi P.A.; Biritwum R.B.; Black A.; Blot W.; Boeing H.; Boffetta P.; Bolton K.; Boutron-Ruault M.-C.; Bracci P.M.; Brennan P.; Brinton L.A.; Brotzman M.; Bueno-de-Mesquita H.B.; Buring J.E.; Butler M.A.; Cai Q.; Cancel-Tassin G.; Canzian F.; Cao G.; Caporaso N.E.; Carrato A.; Carreon T.; Carta A.; Chang G.-C.; Chang I.-S.; Chang-Claude J.; Che X.; Chen C.-J.; Chen C.-Y.; Chen C.-H.; Chen C.; Chen K.-Y.; Chen Y.-M.; Chokkalingam A.P.; Chu L.W.; Clavel-Chapelon F.; Colditz G.A.; Colt J.S.; Conti D.; Cook M.B.; Cortessis V.K.; Crawford E.D.; Cussenot O.; Davis F.G.; De Vivo I.; Deng X.; Ding T.; Dinney C.P.; Di Stefano A.L.; Diver W.R.; Duell E.J.; Elena J.W.; Fan J.-H.; Feigelson H.S.; Feychting M.; Figueroa J.D.; Flanagan A.M.; Fraumeni J.F.; Jr.; Freedman N.D.; Fridley B.L.; Fuchs C.S.; Gago-Dominguez M.; Gallinger S.; Gao Y.-T.; Gapstur S.M.; Garcia-Closas M.; Garcia-Closas R.; Gastier-Foster J.M.; Gaziano J.M.; Gerhard D.S.; Giffen C.A.; Giles G.G.; Gillanders E.M.; Giovannucci E.L.; Goggins M.; Gokgoz N.; Goldstein A.M.; Gonzalez C.; Gorlick R.; Greene M.H.; Gross M.; Grossman H.B.; Grubb R.; III, Gu J.; Guan P.; Haiman C.A.; Hallmans G.; Hankinson S.E.; Harris C.C.; Hartge P.; Hattinger C.; Hayes R.B.; He Q.; Helman L.; Henderson B.E.; Henriksson R.; Hoffman-Bolton J.; Hohensee C.; Holly E.A.; Hong Y.-C.; Hoover R.N.; Dean Hosgood H.; Hsiao C.-F.; Hsing A.W.; Hsiung C.A.; Hu N.; Hu W.; Hu Z.; Huang M.-S.; Hunter D.J.; Inskip P.D.; Ito H.; Jacobs E.J.; Jacobs K.B.; Jenab M.; Ji B.-T.; Johansen C.; Johansson M.; Johnson A.; Kaaks R.; Kamat A.M.; Kamineni A.; Karagas M.; Khanna C.; Khaw K.-T.; Kim C.; Kim I.-S.; Kim J.H.; Kim Y.H.; Kim Y.-C.; Kim Y.T.; Kang C.H.; Jung Y.J.; Kitahara C.M.; Klein A.P.; Klein R.; Kogevinas M.; Koh W.-P.; Kohno T.; Kolonel L.N.; Kooperberg C.; Kratz C.P.; Krogh V.; Kunitoh H.; Kurtz R.C.; Kurucu N.; Lan Q.; Lathrop M.; Lau C.C.; Lecanda F.; Lee K.-M.; Lee M.P.; Marchand L.L.; Lerner S.P.; Li D.; Liao L.M.; Lim W.-Y.; Lin D.; Lin J.; Lindstrom S.; Linet M.S.; Lissowska J.; Liu J.; Ljungberg B.; Lloreta J.; Lu D.; Ma J.; Malats N.; Mannisto S.; Marina N.; Mastrangelo G.; Matsuo K.; McGlynn K.A.; McKean-Cowdin R.; McNeil L.H.; McWilliams R.R.; Melin B.S.; Meltzer P.S.; Mensah J.E.; Miao X.; Michaud D.S.; Mondul A.M.; Moore L.E.; Muir K.; Niwa S.; Olson S.H.; Orr N.; Panico S.; Park J.Y.; Patel A.V.; Patino-Garcia A.; Pavanello S.; Peeters P.H.M.; Peplonska B.; Peters U.; Petersen G.M.; Picci P.; Pike M.C.; Porru S.; Prescott J.; Pu X.; Purdue M.P.; Qiao Y.-L.; Rajaraman P.; Riboli E.; Risch H.A.; Rodabough R.J.; Rothman N.; Ruder A.M.; Ryu J.-S.; Sanson M.; Schned A.; Schumacher F.R.; Schwartz A.G.; Schwartz K.L.; Schwenn M.; Scotlandi K.; Seow A.; Serra C.; Serra M.; Sesso H.D.; Severi G.; Shen H.; Shen M.; Shete S.; Shiraishi K.; Shu X.-O.; Siddiq A.; Sierrasesumaga L.; Sierri S.; Sihoe A.D.L.; Silverman D.T.; Simon M.; Southey M.C.; Spector L.; Spitz M.; Stampfer M.; Stattin P.; Stern M.C.; Stevens V.L.; Stolzenberg-Solomon R.Z.; Stram D.O.; Strom S.S.; Su W.-C.; Sund M.; Sung S.W.; Swerdlow A.; Tan W.; Tanaka H.; Tang W.; Tang Z.-Z.; Tardon A.; Tay E.; Taylor P.R.; Tettey Y.; Thomas D.M.; Tirabosco R.; Tjonneland A.; Tobias G.S.; Toro J.R.; Travis R.C.; Trichopoulos D.; Troisi R.; Truelove A.; Tsai Y.-H.; Tucker M.A.; Tumino R.; Van Den Berg D.; Van Den Eeden S.K.; Vermeulen R.; Vineis P.; Visvanathan K.; Vogel U.; Wang C.; Wang C.; Wang J.; Wang S.S.; Weiderpass E.; Weinstein S.J.; Wentzensen N.; Wheeler W.; White E.; Wiencke J.K.; Wolk A.; Wolpin B.M.; Wong M.P.; Wrensch M.; Wu C.; Wu T.; Wu X.; Wu Y.-L.; Wunder J.S.; Xiang Y.-B.; Xu J.; Yang H.P.; PAN-CHYR YANG ; Yatabe Y.; Ye Y.; Yeboah E.D.; Yin Z.; Ying C.; Yu C.-J.; Yu K.; Yuan J.-M.; Zanetti K.A.; Zeleniuch-Jacquotte A.; Zheng W.; Zhou B.; Mirabello L.; Savage S.A.; Kraft P.; Chanock S.J.; Yeager M.; Landi M.T.; Shi J.; Chatterjee N.; Amundadottir L.T.Human Molecular Genetics69
8622014Chronic obstructive pulmonary disease treated with inhaled medium- or high-dose corticosteroids: A prospective and randomized study focusing on clinical efficacy and the risk of PneumoniaCcheng S.-L.; Su K.-C.; Wang H.-C.; Perng D.-W.; PAN-CHYR YANG Drug Design, Development and Therapy1513
8632014GSK3β controls epithelial-mesenchymal transition and tumor metastasis by CHIP-mediated degradation of slugKao S.-H.; Wang W.-L.; Chen C.-Y.; Chang Y.-L.; Wu Y.-Y.; Wang Y.-T.; Wang S.-P.; Nesvizhskii A.I.; Chen Y.-J.; Hong T.-M.; PAN-CHYR YANG Oncogene8484
8642014Micro cutting of biliary stent with nanosecond fiber laser systemTeng P.-T.; Chang F.-Y.; Chang Y.-T.; Liang P.-C.; KAI-WEN HUANG Advanced Materials Research10
8652014Quality of life and related factors in patients with newly diagnosed advanced lung cancer: A longitudinal studyLiao Y.-C.; Shun S.-C.; Liao W.-Y.; Yu C.-J.; PAN-CHYR YANG ; Lai Y.-H.Oncology Nursing Forum3330
8662014Development of antibody functionalized magnetic nanoparticles for the immunoassay of carcinoembryonic antigen: A feasibility study for clinical useYang C.-C.; Yang S.-Y.; Ho C.-S.; Chang J.-F.; Liu B.-H.; KAI-WEN HUANG Journal of Nanobiotechnology1111
8672014A peptide that inhibits function of Myristoylated Alanine-Rich C Kinase Substrate (MARCKS) reduces lung cancer metastasisChen C.-H.; Thai P.; Yoneda K.; Adler K.B.; PAN-CHYR YANG ; Wu R.Oncogene4247
8682014Erratum: Discriminating hepatocellular carcinoma in rats using a high-Tc SQUID detected nuclear resonance spectrometer in a magnetic shielding boxKAI-WEN HUANG ; Chen H.-H.; Yang H.-C.; Horng H.-E.; Liao S.-H.; Yang S.Y.; Chieh J.-J.; Wang L.-M.PLoS ONE10
8692014Inhibition of miR-146a prevents enterovirus-induced death by restoring the production of type i interferonHo B.-C.; Yu I.-S.; Lu L.-F.; Rudensky A.; Chen H.-Y.; Tsai C.-W.; Chang Y.-L.; Wu C.-T.; Chang L.-Y.; Shih S.-R.; Lin S.-W.; Lee C.-N.; PAN-CHYR YANG ; Yu S.-L.Nature Communications8995
8702014Suppression of the SOX2 neural effector gene by PRDM1 promotes human germ cell fate in embryonic stem cellsHONG-NERNG HO; Lin, I-Ying; Chiu, Feng-Lan; HSIN-FU CHEN ; Yeang, Chen-Hsiang; Chen, Hsin-Fu ; Chuang, Ching-Yu; Yang, Shii-Yi; Hou, Pei-Shan; Sintupisut, Nardnisa; Ho, Hong-Nerng; Kuo, Hung-Chih; Lin, Kuo-IStem Cell Reports 2834
8712014A prospective study of gynecological cancer risk in relation to adiposity factors: Cumulative incidence and association with plasma adipokine levelsCHI-AN CHEN; Wu, Meei-Maan; WEN-FANG CHENG; Chen, Hui-Chi; Chen, Hui-Chi; Chen, Chi-Ling ; You, San-Lin; Cheng, Wen-Fang; Cheng, Wen-Fang; Chen, Chi-An; Lee, Te-Chang; Chen, Chien-JenPLoS ONE 1512
8722014Impact of surgeon experience on the rate of blood transfusion in off-pump coronary artery bypassJENG-WEI CHEN; Chen, Jeng-Wei; Hsu, Ron-Bin; Chen, Chi-Ling Journal of the Formosan Medical Association 66
8732014ELSI practices in genomic research in East Asia: Implications for research collaboration and public participationYoshizawa G.; Ho C.W.L.; Zhu W.; Hu C.; Syukriani Y.; Lee I.; Kim H.; DANIEL FU-CHANG TSAI ; Minari J.; Kato K.Genome Medicine1114
8742014Predicting HLA genotypes using unphased and flanking single-nucleotide polymorphisms in Han Chinese populationHsieh A.-R.; Chang S.-W.; Chen P.-L.; Chu C.-C.; Hsiao C.-L.; WEI-SHIUNG YANG ; Chang C.-C.; Wu J.-Y.; Chen Y.-T.; Chang T.-C.; Fann C.S.J.BMC Genomics11
8752014Association of esophageal inflammation, obesity and gastroesophageal reflux disease: From FDG PET/CT perspectiveWu Y.-W.; Tseng P.-H.; Lee Y.-C.; Wang S.-Y.; Chiu H.-M.; Tu C.-H.; Wang H.-P.; Lin J.-T.; Wu M.-S.; WEI-SHIUNG YANG PLoS ONE16
8762014Association of lower extremity arterial calcification with amputation and mortality in patients with symptomatic peripheral artery diseaseHuang C.-L.; Wu I.-H.; Wu Y.-W.; Hwang J.-J.; Wang S.-S.; Chen W.-J.; Lee W.-J.; WEI-SHIUNG YANG PLoS ONE31
8772014Association between plasma levels of hyaluronic acid and functional outcome in acute stroke patientsTang S.-C.; Yeh S.-J.; Tsai L.-K.; Hu C.-J.; Lien L.-M.; Peng G.-S.; WEI-SHIUNG YANG ; Chiou H.-Y.; Jeng J.-S.Journal of Neuroinflammation8
8782014Bariatric surgery decreased the serum level of an endotoxin-Associated marker: Lipopolysaccharide-binding proteinYang P.-J.; Lee W.-J.; Tseng P.-H.; Lee P.-H.; Lin M.-T.; WEI-SHIUNG YANG Surgery for Obesity and Related Diseases34
8792014Serum myostatin is reduced in individuals with metabolic syndromeHan D.-S.; Yu C.-S.; Chiang C.-K.; Tseng F.-Y.; Tseng P.-H.; Chen C.-L.; Wu K.-D.; WEI-SHIUNG YANG PLoS ONE20
8802014Plasma adipokines and risk of hepatocellular carcinoma in chronic hepatitis B virus-infected carriers: A prospective study in TaiwanChen C.-L.; WEI-SHIUNG YANG ; Yang H.-I.; Chen C.-F.; You S.-L.; Wang L.-Y.; Lu S.-N.; Liu C.-J.; Kao J.-H.; Chen P.-J.; Chen D.-S.; Chen C.-J.Cancer Epidemiology Biomarkers and Prevention15
8812014Normal values and symptom correlation of a simplified oatmeal-based gastric emptying study in the Chinese populationTseng P.-H.; Wu Y.-W.; Lee Y.-C.; Cheng M.-F.; Tzen K.-Y.; Wang H.-P.; Lin J.-T.; Hsieh S.-T.; WEI-SHIUNG YANG ; Wu M.-S.Journal of Gastroenterology and Hepatology (Australia)8
8822014Opposite association between diabetes, dyslipidemia, and hepatocellular carcinoma mortality in the middle-aged and elderlyChiang C.-H.; Lee L.-T.; Hung S.-H.; Lin W.-Y.; Hung H.-F.; WEI-SHIUNG YANG ; Sung P.-K.; Huang K.-C.Hepatology33
8832014The risk of osteonecrosis of the jaws in taiwanese osteoporotic patients treated with oral alendronate or raloxifeneChiu W.-Y.; Chien J.-Y.; WEI-SHIUNG YANG ; Juang J.-M.J.; Lee J.-J.; Tsai K.-S.Journal of Clinical Endocrinology and Metabolism14
8842014Effects of fenofibrate on adiponectin expression in retinas of streptozotocin-induced diabetic ratsHsu Y.-J.; Wang L.-C.; WEI-SHIUNG YANG ; Yang C.-M.; Yang C.-H.Journal of Diabetes Research4
8852014A fault-tolerant method for HLA typing with PacBio dataChang C.-J.; Chen P.-L.; WEI-SHIUNG YANG ; Chao K.-M.BMC Bioinformatics12
8862014Circulating programmed death-1 as a marker for sustained high hepatitis b viral load and risk of hepatocellular carcinoma e95870Cheng H.-Y.; Kang P.-J.; Chuang Y.-H.; Wang Y.-H.; Jan M.-C.; Wu C.-F.; Lin C.-L.; Liu C.-J.; Liaw Y.-F.; Lin S.-M.; PEI-JER CHEN ; Lee S.-D.; Yu M.-W.PLoS ONE15
8872014Spontaneous seroclearance of hepatitis B seromarkers and subsequent risk of hepatocellular carcinomaLiu J.; Yang H.-I.; Lee M.-H.; Lu S.-N.; Jen C.-L.; Batrla-Utermann R.; Wang L.-Y.; You S.-L.; Hsiao C.K.; PEI-JER CHEN ; Chen C.-J.Gut96
8882014A Lego?-like swappable fluidic module for bio-chem applicationsHsieh Y.-F.; Yang A.-S.; Chen J.-W.; Liao S.-K.; Su T.-W.; Yeh S.-H.; PEI-JER CHEN ; Chen P.-H.Sensors and Actuators, B: Chemical16
8892014Nucleocapsid phosphorylation and RNA helicase DDX1 recruitment enables coronavirus transition from discontinuous to continuous transcriptionWu C.-H.; PEI-JER CHEN ; Yeh S.-H.Cell Host and Microbe65
8902014The driving circuit of HBx and androgen receptor in HBV-related hepatocarcinogenesisWang S.-H.; Yeh S.-H.; PEI-JER CHEN Gut12
8912014Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrenceLiu C.-J.; Chang J.; Lee P.-H.; Lin D.-Y.; Wu C.-C.; Jeng L.-B.; Lin Y.-J.; Mok K.-T.; Lee W.-C.; Yeh H.-Z.; Ho M.-C.; Yang S.-S.; Yang M.-D.; Yu M.-C.; Hu R.-H.; Peng C.-Y.; Lai K.-L.; Chang S.S.-C.; PEI-JER CHEN World Journal of Gastroenterology42
8922014Reduced toll-like receptor 9 expression on peripheral C D14+ monocytes of chronic hepatitis B patients and its restoration by effective therapyHuang Y.-W.; Hsu C.-K.; Lin S.-C.; Wei S.-C.; Hu J.-T.; Chang H.-Y.; Liang C.-W.; Chen D.-S.; PEI-JER CHEN ; Hsu P.-N.; Yang S.-S.; Kao J.-H.Antiviral Therapy14
8932014Erratum: Report from a Viral Hepatitis Policy Forum on implementing the WHO framework for global action on viral hepatitis in North Asia (Journal of Hepatology (2013) 59 (1073-1080))Chen D.-S.; Locarnini S.; Wait S.; Bae S.-H.; PEI-JER CHEN ; Fung J.Y.Y.; Kim H.S.; Lu S.-N.; Sung J.; Tanaka J.; Wakita T.; Ward J.; Wallace J.Journal of Hepatology0
8942014Association of adjuvant antiviral therapy with risk of cancer progression and deaths in patients with hepatitis-B-virus-related hepatocellular carcinoma following curative treatment: A nationwide cohort studyYeh Y.-C.; Liu C.-J.; Kuo R.N.; Lai C.-L.; Shau W.-Y.; PEI-JER CHEN ; Lai M.-S.PLoS ONE12
8952014The CRISPR/Cas9 system facilitates clearance of the intrahepatic HBV templates in vivoLin S.-R.; Yang H.-C.; Kuo Y.-T.; Liu C.-J.; Yang T.-Y.; Sung K.-C.; Lin Y.-Y.; Wang H.-Y.; Wang C.-C.; Shen Y.-C.; Wu F.-Y.; Kao J.-H.; Chen D.-S.; PEI-JER CHEN Molecular Therapy - Nucleic Acids260
8962014A procalcitonin-based algorithm to guide antibiotic therapy in secondary peritonitis following emergency surgery: A prospective study with propensity score matching analysisHuang T.-S.; Huang S.-S.; Shyu Y.-C.; Lee C.-H.; Jwo S.-C.; PEI-JER CHEN ; Chen H.-Y.PLoS ONE16
8972014Tumor necrosis factor-alpha induced by hepatitis B virus core mediating the immune response for hepatitis B viral clearance in mice modelTzeng H.-T.; Tsai H.-F.; Chyuan I.-T.; Liao H.-J.; Chen C.-J.; PEI-JER CHEN ; Hsu P.-N.PLoS ONE37
8982014Hepatitis B virus: Pathogenesis and host immune responseYang H.-C.; Yeh S.-H.; PEI-JER CHEN ; Chen D.-S.Viruses and Human Cancer0
8992014Anti-viral treatment and cancer controlShih W.-L.; Fang C.-T.; PEI-JER CHEN Recent Results in Cancer Research0
9002014Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: A prospective studyHsu C.; Tsou H.-H.; Lin S.-J.; Wang M.-C.; Yao M.; Hwang W.-L.; Kao W.-Y.; Chiu C.-F.; Lin S.-F.; Lin J.; Chang C.-S.; Tien H.-F.; Liu T.-W.; PEI-JER CHEN ; Cheng A.-L.Hepatology173
9012014Plasma adipokines and risk of hepatocellular carcinoma in chronic hepatitis B virus-infected carriers: A prospective study in TaiwanChen C.-L.; Yang W.-S.; Yang H.-I.; Chen C.-F.; You S.-L.; Wang L.-Y.; Lu S.-N.; Liu C.-J.; Kao J.-H.; PEI-JER CHEN ; Chen D.-S.; Chen C.-J.Cancer Epidemiology Biomarkers and Prevention15
9022014Hepatitis B surface antigen level complements viral load in predicting viral reactivation in spontaneous HBeAg seroconvertersTseng T.-C.; Liu C.-J.; Yang W.-T.; Chen C.-L.; Yang H.-C.; Su T.-H.; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; PEI-JER CHEN ; Chen D.-S.; Kao J.-H.Journal of Gastroenterology and Hepatology (Australia)8
9032014Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapySu T.-H.; Liu C.-J.; Yang H.-C.; Jeng Y.-M.; Cheng H.-R.; Liu C.-H.; Tseng T.-C.; Ling T.-Y.; PEI-JER CHEN ; Chen D.-S.; Kao J.-H.Journal of Gastroenterology11
9042014Serum cytokine/chemokine profiles in acute exacerbation of chronic hepatitis B: Clinical and mechanistic implicationsWu H.-L.; Kao J.-H.; Chen T.-C.; Wu W.-H.; Liu C.-H.; Su T.-H.; Yang H.-C.; Chen D.-S.; PEI-JER CHEN ; Liu C.-J.Journal of Gastroenterology and Hepatology (Australia)20
9052014Clinical and virological features of occult hepatitis B in patients with HBsAg seroclearance post-treatment or spontaneouslyCheng H.-R.; Kao J.-H.; Wu H.-L.; Chen T.-C.; Tseng T.-C.; Liu C.-H.; Su T.-H.; PEI-JER CHEN ; Chen D.-S.; Liu C.-J.Liver International10
9062014Value of interleukin-28B genetic polymorphism on retreatment outcomes of chronic hepatitis C genotype 1 relapsers by peginterferon alfa plus ribavirinChen M.-Y.; Liu C.-H.; Chen T.-C.; Su T.-H.; PEI-JER CHEN ; Chen D.-S.; Kao J.-H.; Liu C.-J.Journal of Gastroenterology and Hepatology (Australia)7
9072014Updates on the treatment and outcomes of dual chronic hepatitis C and B virus infectionLiu C.-J.; PEI-JER CHEN World Journal of Gastroenterology19
9082014ReplyHsu C.; PEI-JER CHEN ; Cheng A.-L.Hepatology0
9092014Eltrombopag increases platelet numbers in thrombocytopenic patients with hcv infection and cirrhosis, allowing for effective antiviral therapyAfdhal N.H.; Dusheiko G.M.; Giannini E.G.; PEI-JER CHEN ; Han K.-H.; Mohsin A.; Rodriguez-Torres M.; Rugina S.; Bakulin I.; Lawitz E.; Shiffman M.L.; Tayyab G.-U.-N.; Poordad F.; Kamel Y.M.; Brainsky A.; Geib J.; Vasey S.Y.; Patwardhan R.; Campbell F.M.; Theodore D.Gastroenterology93
9102014Re-evaluating transarterial chemoembolization for the treatment of Hepatocellular Carcinoma: Consensus recommendations and review by an International Expert PanelCheng A.L.; Amarapurkar D.; Chao Y.; PEI-JER CHEN ; Geschwind J.-F.; Goh K.L.; Han K.-H.; Kudo M.; Lee H.C.; Lee R.-C.; Lesmana L.A.; Lim H.Y.; Paik S.W.; Poon R.T.; Tan C.-K.; Tanwandee T.; Teng G.; Park J.-W.Liver International55
9112014SC-60, a dimer-based sorafenib derivative, shows a better anti-hepatocellular carcinoma effect than sorafenib in a preclinical hepatocellular carcinoma modelTai W.-T.; Shiau C.-W.; Li Y.-S.; Chen Y.-L.; Chu P.-Y.; Huang J.-W.; Hsu C.-Y.; Hsu Y.-C.; PEI-JER CHEN ; Chen K.-F.Molecular Cancer Therapeutics6
9122014Reduction of HBV replication prolongs the early immunological response to IFNα therapyTan A.T.; Hoang L.T.; Chin D.; Rasmussen E.; Lopatin U.; Hart S.; Bitter H.; Chu T.; Gruenbaum L.; Ravindran P.; Zhong H.; Gane E.; Lim S.G.; Chow W.C.; PEI-JER CHEN ; Petric R.; Bertoletti A.; Hibberd M.L.Journal of Hepatology57
9132014Discovery of novel src homology region 2 domain-containing phosphatase 1 agonists from sorafenib for the treatment of hepatocellular carcinomaTai W.-T.; Shiau C.-W.; PEI-JER CHEN ; Chu P.-Y.; Huang H.-P.; Liu C.-Y.; Huang J.-W.; Chen K.-F.Hepatology51
9142014Treatment of patients with dual hepatitis C and B by peginterferon α and ribavirin reduced risk of hepatocellular carcinoma and mortalityLiu C.-J.; Chu Y.-T.; Shau W.-Y.; Kuo R.N.; PEI-JER CHEN ; Lai M.-S.Gut34
9152014Predicting HLA genotypes using unphased and flanking single-nucleotide polymorphisms in Han Chinese populationHsieh A.-R.; Chang S.-W.; PEI-LUNG CHEN ; Chu C.-C.; Hsiao C.-L.; Yang W.-S.; Chang C.-C.; Wu J.-Y.; Chen Y.-T.; Chang T.-C.; Fann C.S.J.BMC Genomics11
9162014STAT3 mediates regorafenib-induced apoptosis in hepatocellular carcinomaTai W.-T.; Chu P.-Y.; Shiau C.-W.; Chen Y.-L.; Li Y.-S.; Hung M.-H.; Chen L.-J.; PEI-LUNG CHEN ; Su J.-C.; Lin P.-Y.; Yu H.-C.; Chen K.-F.Clinical Cancer Research53
9172014Genetic analysis of CARD14 in non-familial pityriasis rubra pilaris: A case seriesHong J.-B.; PEI-LUNG CHEN ; Chen Y.-T.; Tsai T.-F.Acta Dermato-Venereologica7
9182014A fault-tolerant method for HLA typing with PacBio dataChang C.-J.; PEI-LUNG CHEN ; Yang W.-S.; Chao K.-M.BMC Bioinformatics12
9192014All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: A multinational, phase 3, multicohort studyManns M.; Pol S.; Jacobson I.M.; Marcellin P.; Gordon S.C.; Peng C.-Y.; Chang T.-T.; Everson G.T.; Heo J.; Gerken G.; Yoffe B.; Towner W.J.; Bourliere M.; Metivier S.; Chu C.-J.; Sievert W.; Bronowicki J.-P.; Thabut D.; Lee Y.-J.; JIA-HORNG KAO ; McPhee F.; Kopit J.; Mendez P.; Linaberry M.; Hughes E.; Noviello S.The Lancet267
9202014Reduced toll-like receptor 9 expression on peripheral C D14+ monocytes of chronic hepatitis B patients and its restoration by effective therapyHuang Y.-W.; Hsu C.-K.; Lin S.-C.; Wei S.-C.; Hu J.-T.; Chang H.-Y.; Liang C.-W.; Chen D.-S.; Chen P.-J.; Hsu P.-N.; Yang S.-S.; JIA-HORNG KAO Antiviral Therapy14
9212014The CRISPR/Cas9 system facilitates clearance of the intrahepatic HBV templates in vivoLin S.-R.; Yang H.-C.; Kuo Y.-T.; Liu C.-J.; Yang T.-Y.; Sung K.-C.; Lin Y.-Y.; Wang H.-Y.; Wang C.-C.; Shen Y.-C.; Wu F.-Y.; JIA-HORNG KAO ; Chen D.-S.; Chen P.-J.Molecular Therapy - Nucleic Acids260
9222014A pilot study of add-on oral hypoglycemic agents in treatment-na?ve genotype-1 chronic hepatitis C patients receiving peginterferon alfa-2b plus ribavirinHsu C.-S.; Hsu S.-J.; Lin H.H.; Tseng T.-C.; Wang C.-C.; Chen D.-S.; JIA-HORNG KAO Journal of the Formosan Medical Association7
9232014Baseline hepatitis B surface antigen quantitation can predict virologic response in entecavir-treated chronic hepatitis B patientsWang C.-C.; Tseng T.-C.; Wang P.-C.; Lin H.H.; JIA-HORNG KAO Journal of the Formosan Medical Association8
9242014Nanomedicines in the treatment of hepatitis C virus infection in Asian patients: Optimizing use of peginterferon alfaLiu C.-H.; JIA-HORNG KAO International Journal of Nanomedicine29
9252014Molecular mechanism and treatment of viral hepatitis-related liver fibrosisSu T.-H.; JIA-HORNG KAO ; Liu C.-J.International Journal of Molecular Sciences45
9262014Triple therapy for hepatitis C virus infection in patients receiving hemodialysisLiu C.-H.; JIA-HORNG KAO Annals of Internal Medicine3
9272014HBeAg-positive chronic hepatitis B: Why do I treat my patients with pegylated interferon?JIA-HORNG KAO Liver International37
9282014Persistence of hepatitis B virus covalently closed circular DNA in hepatocytes: Molecular mechanisms and clinical significanceYang H.-C.; JIA-HORNG KAO Emerging Microbes and Infections85
9292014Risk stratification of HBV infection in Asia-Pacific regionJIA-HORNG KAO Clinical and molecular hepatology0
9302014Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapySu T.-H.; Liu C.-J.; Yang H.-C.; Jeng Y.-M.; Cheng H.-R.; Liu C.-H.; Tseng T.-C.; Ling T.-Y.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO Journal of Gastroenterology11
9312014Hepatic necro-inflammation and elevated liver enzymes: Evaluation with MRI perfusion imaging with gadoxetic acid in chronic hepatitis patientsChen B.-B.; Hsu C.-Y.; Yu C.-W.; JIA-HORNG KAO ; Lee H.-S.; Liang P.-C.; Wei S.-Y.; Hwang R.-M.; Shih T.T.-F.Clinical Radiology7
9322014Factors affecting the diagnostic accuracy of ultrasonography in assessing the severity of hepatic steatosisWang C.-C.; Hsieh T.-C.; Tseng T.-C.; Wang P.-C.; Hsu C.-S.; Lin H.H.; Wang L.-Y.; JIA-HORNG KAO Journal of the Formosan Medical Association6
9332014Plasma adipokines and risk of hepatocellular carcinoma in chronic hepatitis B virus-infected carriers: A prospective study in TaiwanChen C.-L.; Yang W.-S.; Yang H.-I.; Chen C.-F.; You S.-L.; Wang L.-Y.; Lu S.-N.; Liu C.-J.; JIA-HORNG KAO ; Chen P.-J.; Chen D.-S.; Chen C.-J.Cancer Epidemiology Biomarkers and Prevention15
9342014Hepatitis B surface antigen level complements viral load in predicting viral reactivation in spontaneous HBeAg seroconvertersTseng T.-C.; Liu C.-J.; Yang W.-T.; Chen C.-L.; Yang H.-C.; Su T.-H.; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO Journal of Gastroenterology and Hepatology (Australia)8
9352014Higher adherence with 3-year entecavir treatment than lamivudine or telbivudine in treatment-na?ve Taiwanese patients with chronic hepatitis BChien R.-N.; Peng C.-Y.; JIA-HORNG KAO ; Hu T.-H.; Lin C.-C.; Hu C.-T.; Chen C.-Y.; Hsieh T.-Y.; Lin H.-C.; Chuang W.-L.Journal of Gastroenterology and Hepatology (Australia)8
9362014Serum cytokine/chemokine profiles in acute exacerbation of chronic hepatitis B: Clinical and mechanistic implicationsWu H.-L.; JIA-HORNG KAO ; Chen T.-C.; Wu W.-H.; Liu C.-H.; Su T.-H.; Yang H.-C.; Chen D.-S.; Chen P.-J.; Liu C.-J.Journal of Gastroenterology and Hepatology (Australia)20
9372014Clinical and virological features of occult hepatitis B in patients with HBsAg seroclearance post-treatment or spontaneouslyCheng H.-R.; JIA-HORNG KAO ; Wu H.-L.; Chen T.-C.; Tseng T.-C.; Liu C.-H.; Su T.-H.; Chen P.-J.; Chen D.-S.; Liu C.-J.Liver International10
9382014Value of interleukin-28B genetic polymorphism on retreatment outcomes of chronic hepatitis C genotype 1 relapsers by peginterferon alfa plus ribavirinChen M.-Y.; Liu C.-H.; Chen T.-C.; Su T.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO ; Liu C.-J.Journal of Gastroenterology and Hepatology (Australia)7
9392014Vascular and hepatic enhancements at MR imaging: Comparison of Gd-EOB-DTPA and Gd-DTPA in the same subjectsLin Y.-H.; Hwang R.-M.; Chen B.-B.; Hsu C.-Y.; Yu C.-W.; JIA-HORNG KAO ; Lee H.-S.; Liang P.-C.; Wei S.-Y.; Shih T.T.F.Clinical Imaging2
9402014Increased risk of cirrhosis and its decompensation in chronic hepatitis C patients with new-onset diabetes: A nationwide cohort studyHuang Y.-W.; Yang S.-S.; Fu S.-C.; Wang T.-C.; Hsu C.-K.; Chen D.-S.; Hu J.-T.; JIA-HORNG KAO Hepatology73
9412014Peginterferon α in the treatment of chronic hepatitis BTseng T.-C.; JIA-HORNG KAO ; Chen D.-S.Expert Opinion on Biological Therapy12
9422013生殖醫學於多囊性卵巢症候群之新進展WEI-SHIUNG YANG 臺灣醫學 00
94320132013年美國糖尿病學會臨床治療指引摘要WEI-SHIUNG YANG 台北市醫師公會會刊 
9442013A pilot study of hepatic arterial infusion of chemotherapy for patients with advanced hepatocellular carcinoma who have failed anti-angiogenic therapyShao Y.-Y.; Liang P.-C.; Wu Y.-M.; Huang C.-C.; KAI-WEN HUANG ; Cheng J.C.; Hsu C.-H.; Hsu C.; Cheng A.-L.; Lin Z.-Z.Liver International1112
9452013Anti-CEA-functionalized superparamagnetic iron oxide nanoparticles for examining colorectal tumors in vivoKAI-WEN HUANG ; Chieh J.-J.; Lin I.-T.; Horng H.-E.; Yang H.-C.; Hong C.-Y.Nanoscale Research Letters98
9462013Development for high-accuracy in vitro assay of vascular endothelial growth factor using nanomagnetically labeled immunoassayYang C.C.; KAI-WEN HUANG ; Yang S.Y.; Chen H.H.; Chen T.C.; Ho C.S.; Chang S.F.; Chieh J.J.; Horng H.E.; Hong C.Y.; Yang H.C.Journal of Nanomaterials74
9472013Molecule-assisted nanoparticle clustering effect in immunomagnetic reduction assayYang S.Y.; Chieh J.J.; KAI-WEN HUANG ; Yang C.C.; Chen T.C.; Ho C.S.; Chang S.F.; Chen H.H.; Horng H.E.; Hong C.Y.; Yang H.C.Journal of Applied Physics77
9482013Femtosecond laser nonlinear ablation process of biliary nitinol stent for cholangiocarcinomaHung C.-H.; Chang F.-Y.; Chang T.-L.; Chang Y.-T.; KAI-WEN HUANG ; Liang P.-C.Advanced Materials Research40
9492013Optimization of the detection coil of high-Tc superconducting quantum interference device-based nuclear magnetic resonance for discriminating a minimum amount of liver tumor of rats in microtesla fieldsChen H.-H.; KAI-WEN HUANG ; Yang H.-C.; Horng H.-E.; Liao S.-H.Journal of Applied Physics42
9502013Enhancing the tumor discrimination using antibody-activated magnetic nanoparticles in ultra-low magnetic fieldsYang H.C.; KAI-WEN HUANG ; Liao S.H.; Horng H.E.; Chieh J.J.; Chen H.H.; Chen M.J.; Chen K.L.; Wang L.M.Applied Physics Letters86
9512013FJU-C4, a new 2-pyridone compound, attenuates lipopolysaccharide-induced systemic inflammation via p38MAPK and NF-κB in miceLiu J.-S.; Jung F.; Yang S.-H.; Chou S.-S.P.; Huang J.-L.; Lu C.-L.; Huang G.-L.; PAN-CHYR YANG ; Lin J.-C.; Jow G.-M.PLoS ONE43
9522013Genome-wide analysis of three-way interplay among gene expression, cancer cell invasion and anti-cancer compound sensitivityHsu Y.-C.; Chen H.-Y.; Yuan S.; Yu S.-L.; Lin C.-H.; Wu G.; PAN-CHYR YANG ; Li K.-C.BMC Medicine2626
9532013CCN2 inhibits lung cancer metastasis through promoting DAPK-dependent anoikis and inducing EGFR degradationChang C.-C.; Yang M.-H.; Lin B.-R.; Chen S.-T.; Pan S.-H.; Hsiao M.; Lai T.-C.; Lin S.-K.; Jeng Y.-M.; Chu C.-Y.; Chen R.-H.; PAN-CHYR YANG ; Eugene Chin Y.; Kuo M.-L.Cell Death and Differentiation2020
9542013Rapid single cell detection of Staphylococcus aureus by aptamer-conjugated gold nanoparticlesChang Y.-C.; Yang C.-Y.; Sun R.-L.; Cheng Y.-F.; Kao W.-C.; PAN-CHYR YANG Scientific Reports164157
9552013Fucosyltransferase 8 as a functional regulator of nonsmall cell lung cancerChen C.-Y.; Jan Y.-H.; Juan Y.-H.; Yang C.-J.; Huang M.-S.; Yu C.-J.; PAN-CHYR YANG ; Hsiao M.; Hsu T.-L.; Wong C.-H.Proceedings of the National Academy of Sciences of the United States of America155152
9562013Abnormal renal resistive index in patients with mild-to-moderate chronic obstructive pulmonary diseaseChen C.-Y.; Hsu T.-W.; Mao S.J.T.; Chang S.-C.; PAN-CHYR YANG ; Lee Y.-C.; Yang K.-Y.COPD: Journal of Chronic Obstructive Pulmonary Disease88
9572013α-catulin drives metastasis by activating ILK and driving an αvβ3 integrin signaling axisLiang C.-H.; Chiu S.-Y.; Hsu I.-L.; Wu Y.-Y.; Tsai Y.-T.; Ke J.-Y.; Pan S.-H.; Hsu Y.-C.; Li K.-C.; PAN-CHYR YANG ; Chen Y.-L.; Hong T.-M.Cancer Research2322
9582013EGFR exon 19 in-frame deletion and polymorphisms of DNA repair genes in never-smoking female lung adenocarcinoma patientsYang S.-Y.; Yang T.-Y.; Li Y.-J.; Chen K.-C.; Liao K.-M.; Hsu K.-H.; Tsai C.-R.; Chen C.-Y.; Hsu C.-P.; Hsia J.-Y.; Chuang C.-Y.; Tsai Y.-H.; Chen K.-Y.; Huang M.-S.; Su W.-C.; Chen Y.-M.; Hsiung C.A.; Shen C.-Y.; Chang G.-C.; PAN-CHYR YANG ; Chen C.-J.International Journal of Cancer1110
9592013Asynchronous thoraco-abdominal motion contributes to decreased 6-minute walk test in patients with COPDChien J.-Y.; Ruan S.-Y.; Huang Y.-C.T.; Yu C.-J.; PAN-CHYR YANG Respiratory Care1414
9602013Risk factors for primary lung cancer among never smokers by gender in a matched case-control studyLo Y.-L.; Hsiao C.-F.; Chang G.-C.; Tsai Y.-H.; Huang M.-S.; Su W.-C.; Chen Y.-M.; Hsin C.-W.; Chang C.-H.; PAN-CHYR YANG ; Chen C.-J.; Hsiung C.A.Cancer Causes and Control3632
9612013Curcumin-targeting pericellular serine protease matriptase role in suppression of prostate cancer cell invasion, tumor growth, and metastasisCheng T.-S.; Chen W.-C.; Lin Y.-Y.; Tsai C.-H.; Liao C.-I.; Shyu H.-Y.; Ko C.-J.; Tzeng S.-F.; Huang C.-Y.; PAN-CHYR YANG ; Hsiao P.-W.; Lee M.-S.Cancer Prevention Research3737
9622013Frequent EGFR mutations in nonsmall cell lung cancer presenting with miliary intrapulmonary carcinomatosisWu S.-G.; Hu F.-C.; Chang Y.-L.; Lee Y.-C.; Yu C.-J.; Chang Y.-C.; Wu J.-Y.; Shih J.-Y.; PAN-CHYR YANG European Respiratory Journal3031
9632013MicroRNA-135b promotes lung cancer metastasis by regulating multiple targets in the Hippo pathway and LZTS1Lin C.-W.; Chang Y.-L.; Chang Y.-C.; Lin J.-C.; Chen C.-C.; Pan S.-H.; Wu C.-T.; Chen H.-Y.; Yang S.-C.; Hong T.-M.; PAN-CHYR YANG Nature Communications222204
9642013ALDH-positive lung cancer stem cells confer resistance to epidermal growth factor receptor tyrosine kinase inhibitorsHuang C.-P.; Tsai M.-F.; Chang T.-H.; Tang W.-C.; Chen S.-Y.; Lai H.-H.; Lin T.-Y.; Yang J.C.H.; PAN-CHYR YANG ; Shih J.-Y.; Lin S.-B.Cancer Letters8887
9652013EGFR polymorphisms, hormone replacement therapy and lung adenocarcinoma risk: Analysis from a genome-wide association study in never-smoking womenChen K.-Y.; Hsiao C.-F.; Chang G.-C.; Tsai Y.-H.; Su W.-C.; Chen Y.-M.; Huang M.-S.; Hsiung C.A.; Chen C.-J.; PAN-CHYR YANG Carcinogenesis1512
9662013Outcome correlation of smear-positivity for acid-fast bacilli at the fifth month of treatment in non-multidrug-resistant TBChien J.-Y.; Chen Y.-T.; Shu C.-C.; Lee J.-J.; Wang J.-Y.; Yu C.-J.; PAN-CHYR YANG Chest8
9672013MicroRNA: a new type of genePAN-CHYR YANG ; Zhou X.MicroRNA (Sh?riqah, United Arab Emirates)0
9682013Early Detection of Lewis Lung Carcinoma Tumor Control by Irradiation Using Diffusion-Weighted and Dynamic Contrast-Enhanced MRICheng J.C.-H.; Yuan A.; Chen J.-H.; Lu Y.-C.; Cho K.-H.; Wu J.-K.; Wu C.-J.; Chang Y.-C.; PAN-CHYR YANG PLoS ONE104
9692013The Motor Protein KIF14 Inhibits Tumor Growth and Cancer Metastasis in Lung AdenocarcinomaHung P.-F.; Hong T.-M.; Hsu Y.-C.; Chen H.-Y.; Chang Y.-L.; Wu C.-T.; Chang G.-C.; Jou Y.-S.; Pan S.-H.; PAN-CHYR YANG PLoS ONE2724
9702013Multi-gene analyses from waste brushing specimens for patients with peripheral lung cancer receiving EBUS-assisted bronchoscopyTsai T.-H.; PAN-CHYR YANG et al. Lung Cancer3029
9712013Genome-wide association study of genetic predictors of overall survival for non-small cell lung cancer in never smokersWu X.; PAN-CHYR YANG et al. Cancer Research4242
9722013Focal amplification of HOXD-harboring chromosome region is implicated in multiple-walled carbon nanotubes-induced carcinogenicityWu P.; PAN-CHYR YANG et al. Nano Letters99
9732013Simple aspiration and drainage and intrapleural minocycline pleurodesis versus simple aspiration and drainage for the initial treatment of primary spontaneous pneumothorax: An open-label, parallel-group, prospective, randomised, controlled trialChen J.-S.; Chan W.-K.; Tsai K.-T.; Hsu H.-H.; Lin C.-Y.; Yuan A.; Chen W.-J.; Lai H.-S.; PAN-CHYR YANG The Lancet58
9742013Switchable delivery of small interfering RNA using a negatively charged pH-responsive polyethylenimine-based polyelectrolyte complexTseng S.-J.; Zeng Y.-F.; Deng Y.-F.; PAN-CHYR YANG ; Liu J.-R.; Kempson I.M.Chemical Communications2320
9752013Anxiety, depression and related factors in family caregivers of newly diagnosed lung cancer patients before first treatmentLee Y.-H.; Liao Y.-C.; Liao W.-Y.; Shun S.-C.; Liu Y.-C.; Chan J.-C.; Yu C.-J.; PAN-CHYR YANG ; Lai Y.-H.Psycho-Oncology3326
9762013Apoptosis-associated biomarkers in tuberculosis: Promising for diagnosis and prognosis predictionShu C.-C.; Wu M.-F.; Hsu C.-L.; Huang C.-T.; Wang J.-Y.; Hsieh S.-L.; Yu C.-J.; Lee L.-N.; PAN-CHYR YANG BMC Infectious Diseases1414
9772013Circulating interleukin-6 level is a prognostic marker for survival in advanced nonsmall cell lung cancer patients treated with chemotherapyChang C.H.; Hsiao C.F.; Yeh Y.M.; Chang G.C.; Tsai Y.H.; Chen Y.M.; Huang M.S.; Chen H.L.; Li Y.J.; PAN-CHYR YANG ; Chen C.J.; Hsiung C.A.; Su W.C.International Journal of Cancer112109
9782013Depletion of 4E-BP1 and regulation of autophagy lead to YXM110-induced anticancer effectsLai C.-Y.; Pan S.-L.; Yang X.-M.; Chang L.-H.; Chang Y.-L.; PAN-CHYR YANG ; Lee K.-H.; Teng C.-M.Carcinogenesis7
9792013Survival of lung adenocarcinoma patients with malignant pleural effusionWu S.-G.; Yu C.-J.; Tsai M.-F.; Liao W.-Y.; Yang C.-H.; Jan I.-S.; PAN-CHYR YANG ; Shih J.-Y.European Respiratory Journal59
9802013Electrophysiologic changes with incremental exercise in obstructive sleep apneaChien M.-Y.; Chang Y.-J.; Lee P.; PAN-CHYR YANG ; Wu Y.-T.Muscle and Nerve7
9812013A型肝炎與D型肝炎的威脅JIA-HORNG KAO 健康世界 
9822013B肝疫苗效力會消失!?我需要補打B肝疫苗嗎?JIA-HORNG KAO 健康世界 
9832013肝硬化的診斷與治療JIA-HORNG KAO 健康世界 
9842013肥胖的肝臟─脂肪肝JIA-HORNG KAO 健康世界 
9852013自找苦吃的酒精性肝病JIA-HORNG KAO 健康世界 
9862013淺談藥物性肝炎JIA-HORNG KAO 健康世界 
9872013和B型肝炎帶原者發生性行為會怎麼樣?JIA-HORNG KAO 健康世界 
9882013B肝、C肝患者診斷出肝硬化時該怎麼辦?JIA-HORNG KAO 健康世界 
9892013慢性肝炎最終章?肝癌的威脅JIA-HORNG KAO 健康世界 
9902013你今天「爆肝」了嗎?高度威脅生命的猛爆性肝炎JIA-HORNG KAO 健康世界 
9912013Activated human nasal epithelial cells modulate specific antibody response against bacterial or viral antigensYeh, Chiou-Yueh; TE-HUEI YEH ; Jung, Chiau-Jing; Chen, Pei-Lin; Lien, Huei-Ting; JEAN-SAN CHIA PloS one118
9922013Controlling branching structure formation of the salivary gland by the degree of chitosan deacetylationHsiao Y.-C.; Chen C.-N.; YOU-TZUNG CHEN ; Yang T.-L.Acta Biomaterialia1413
9932013The mesenchymal architecture of the cranial mesoderm of mouse embryos is disrupted by the loss of Twist1 functionBildsoe H.; Loebel D.A.F.; Jones V.J.; Hor A.C.C.; Braithwaite A.W.; YOU-TZUNG CHEN ; Behringer R.R.; Tam P.P.L.Developmental Biology3130
9942013Genetic and physiological data suggest demographic and adaptive responses in complex interactions between populations of figs (Ficus pumila) and their pollinating wasps (Wiebesia pumilae)HURNG-YI WANG ; Hsieh C.-H.; Huang C.-G.; Kong S.-W.; Chang H.-C.; Lee H.-H.; Wang W.-K.; Chen S.-L.; Tzeng H.-Y.; Wu W.-J.Molecular Ecology65
9952013Supporting Rresumed Consent Based on Utility, Reciprocity and Communitarian ValueDANIEL FU-CHANG TSAI Taiwanese Journal for Studies of Science, Technology and Medicine = 科技醫療與社會
9962013Tid1-L inhibits EGFR signaling in lung adenocarcinoma by enhancing EGFR ubiquitinylation and degradationChen C.-Y.; Jan C.-I.; Lo J.-F.; Yang S.-C.; Chang Y.-L.; Pan S.-H.; Wang W.-L.; Hong T.-M.; PAN-CHYR YANG Cancer Research30
9972013Differentiation of human embryonic stem cells into functional ovarian Granulosa-like cellsLan, Chen-Wei; HONG-NERNG HO; MEI-JOU CHEN; Chen, Mei-Jou; Jan, Pey-Shynan; HSIN-FU CHEN ; Chen, Hsin-Fu ; Ho, Hong-Nerng; Ho, Hong-NerngJournal of Clinical Endocrinology and Metabolism 2127
9982013Pleurodesis for primary spontaneous pneumothorax - Authors' replyChen J.-S.; Chan W.-K.; PAN-CHYR YANG The Lancet3
9992013Clinical features and phylogenetic analysis of Coxsackievirus A9 in Northern Taiwan in 2011Huang Y.-C.; Chu Y.-H.; Yen T.-Y.; Huang W.-C.; Huang L.-M.; Cheng A.-L.; HURNG-YI WANG ; Chang L.-Y.BMC Infectious Diseases87
10002013Ethical Issues in Research on Vulnerable SubjectsDANIEL FU-CHANG TSAI ; Yu-Ren HsuFormosan Journal of Medicine00